Document:

Exhibit 4.1

  

   

  

  
    
      CAL FUNDING III LIMITED

    

    Issuer

     

    and

     

    WELLS FARGO BANK, NATIONAL ASSOCIATION

    Indenture Trustee

     

    
      

     

    SERIES 2018-2 SUPPLEMENT

     

    DATED AS OF SEPTEMBER 19, 2018

     

    TO

     

    INDENTURE

     

    DATED AS OF JULY 6, 2017

     

    
      

     

    FIXED RATE ASSET-BACKED NOTES, SERIES 2018-2,

    CLASS A NOTES AND CLASS B NOTES

     

    
      
        

    

    
    TABLE OF CONTENTS

     

    	

          	 	
            Page

          
	 	 	 
	
            ARTICLE I Definitions; Calculation Guidelines

          	
            1

          
	 	 
	
            Section 101.

          	
            Definitions

          	
            1

          
	 	 	 
	
            ARTICLE II Creation of the Series 2018-2 Notes

          	
            15

          
	 	 	 
	
            Section 201.

          	
            Designation

          	
            15

          
	
            Section 202.

          	
            Authentication and Delivery

          	
            17

            

          
	
            Section 203.

          	
            Interest Payments on the Series 2018-2 Notes

          	
            17

          
	
            Section 204.

          	
            Principal Payments on the Series 2018-2 Notes

          	
            18

            

          
	
            Section 205.

          	
            Prepayment of Principal on the Series 2018-2 Notes

          	
            19

            

          
	
            Section 206.

          	
            Payments of Principal and Interest

          	
            20

          
	
            Section 207.

          	
            Restrictions on Transfer

          	
            20

          
	
            Section 208.

          	
            Grant of Security Interest

          	
            24

          
	 	 	 
	
            ARTICLE III Series 2018-2 Series Account and Allocation and Application of Amounts Therein

          	
            25

          
	 	 	 
	
            Section 301.

          	
            Series 2018-2 Series Account

          	
            25

          
	
            Section 302.

          	
            Series 2018-2 Restricted Cash Account

          	
            25

          
	
            Section 303.

          	
            Defaulted Lease Account.

          	
            26

          
	
            Section 304.

          	
            Distributions from Series 2018-2 Series Account

          	
            27

          
	
            Section 305.

          	
            Allocation of Series 2018-2 Shared Available Funds

          	
            34

          
	 	 	 
	
            ARTICLE IV Series-Specific Early
              Amortization Events, Series-Specific Manager Defaults, Series-Specific Events of Default and Covenants for the Series 2018-2 Notes

          	
            37

          
	 	 	 
	
            Section 401.

          	
            Series-Specific Early Amortization Events

          	
            37

            

          
	
            Section 402.

          	
            Series 2018-2 Manager Defaults

          	
            38

          
	
            Section 403.

          	
            Series-Specific Events of Default

          	
            39

          
	
            Section 404.

          	
            Series 2018-2 Management Fee

          	
            40

          
	
            Section 405.

          	
            Additional Covenants

          	
            40

          
	
            Section 406.

          	
            Back-up Manager Event

          	
            40

          
	 	 	 
	
            ARTICLE V Conditions to Issuance

          	
            40

          
	 	 	 
	
            Section 501.

          	
            Conditions to Issuance

          	
            40

          
	 	 	 
	
            ARTICLE VI Representations and Warranties

          	
            40

          
	 	 	 
	
            Section 601.

          	
            Existence

          	
            40

          
	
            Section 602.

          	
            Authorization

          	
            40

          
	
            Section 603.

          	
            No Conflict; Legal Compliance

          	
            40

          
	
            Section 604.

          	
            Validity and Binding Effect

          	
            40

          
	
            Section 605.

          	
            Financial Statements

          	
            42

          
	
            Section 606.

          	
            Place of Business

          	
            42

          
	
            Section 607.

          	
            No Agreements or Contracts

          	42

     

    -i-

    

    
      
        

    

    
    
      TABLE OF CONTENTS

        (continued)

       

    

    	 	 	
            Page

          
	 	 	 
	
            Section 608.

          	
            Consents and Approvals

          	42
	
            Section 609.

          	
            Margin Regulations

          	
            42

          
	
            Section 610.

          	
            Taxes

          	42
	
            Section 611.

          	
            Investment Company Act of 1940

          	
            43

          
	
            Section 612.

          	
            Solvency and Separateness

          	43
	
            Section 613.

          	
            Title; Liens

          	
            44

            

          
	
            Section 614.

          	
            No Default

          	
            44

          
	
            Section 615.

          	
            Litigation and Contingent Liabilities

          	
            44

          
	
            Section 616.

          	
            Subsidiaries

          	44
	
            Section 617.

          	
            No Partnership

          	
            44

          
	
            Section 618.

          	
            Pension and Welfare Plans

          	
            44

          
	
            Section 619.

          	
            Ownership of the Issuer

          	
            45

          
	
            Section 620.

          	
            Security Interest Representations

          	
            45

          
	
            Section 621.

          	
            ERISA Lien

          	
            47

          
	
            Section 622.

          	
            Survival of Representations and Warranties

          	
            47

          
	 	 	 
	
            ARTICLE VII Miscellaneous Provisions

          	
            47

          
	 	 	 
	
            Section 701.

          	
            Ratification of Indenture

          	
            47

          
	
            Section 702.

          	
            Counterparts

          	
            47

          
	
            Section 703.

          	
            Governing Law

          	
            47

          
	
            Section 704.

          	
            Notices

          	47
	
            Section 705.

          	
            Amendments and Modifications

          	
            48

          
	
            Section 706.

          	
            Consent to Jurisdiction

          	
            51

          
	
            Section 707.

          	
            Waiver of Jury Trial

          	
            51

          
	
            Section 708.

          	
            Successors

          	
            51

          
	
            Section 709.

          	
            Nonpetition Covenant

          	
            51

          
	
            Section 710.

          	
            Recourse Against the Issuer

          	
            52

          
	
            Section 711.

          	
            Reports, Financial Statements and Other Information to Series 2018-2 Noteholders

          	
            52

          
	
            Section 712.

          	
            Patriot Act

          	
            52

          
	
            Section 713.

          	
            Definitive Notes

          	
            53

          

     

    -ii-

    

    
      
        

    

    
      
        TABLE OF CONTENTS

          (continued)

      

       

      	 	
              Page

            
	 	 
	
              EXHIBITS

              Exhibit

            	 
              Description

            
	 	 
	
              EXHIBIT A-1

            	
              Form of 144A Book-Entry Note

            
	 	 
	
              EXHIBIT A-2

            	
              Form of Regulation S Temporary Book-Entry Note

            
	 	 
	
              EXHIBIT A-3

            	
              Form of Unrestricted Book-Entry Note

            
	 	 
	
              EXHIBIT A-4

            	
              Form of Note Issued to Institutional Accredited Investors

            
	 	 
	
              EXHIBIT B

            	
              Form of Certificate to be Given by Series 2018-2 Noteholders

            
	 	 
	
              EXHIBIT C

            	
              Form of Certificate to be Given by Euroclear or Clearstream

            
	 	 
	
              EXHIBIT D

            	
              Form of Certificate to be Given by Transferee of Beneficial Interest In a Regulation S Temporary Book-Entry Note

            
	 	 
	
              EXHIBIT E

            	
              Form of Transfer Certificate for Exchange or Transfer From 144A Book-Entry Note to Regulations S Book-Entry Note

            
	 	 
	
              EXHIBIT F

            	
              Form of Initial Purchaser Exchange Instructions

            

      

      

      	
              SCHEDULES

              Schedules

            	 
              Description

            
	 	 
	
              Schedule I

            	
              Minimum Targeted Principal Balances

            
	 	 
	
              Schedule II

            	
              Scheduled Targeted Principal Balances

            
	 	 
	
              Schedule III

            	
              Maximum Concentration of Leases

            

       

      -iii-

      

      
        
          

      

      SERIES 2018-2 SUPPLEMENT, dated as of September 19, 2018 (as
          amended, restated, supplemented or otherwise modified from time to time, this “Supplement”), between CAL FUNDING III LIMITED, an exempted company with
        limited liability incorporated in Bermuda (the “Issuer”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association, as Indenture Trustee (the
        “Indenture Trustee”).

       

      WHEREAS, pursuant to the Indenture, dated as of July 6, 2017 (as amended, restated,
          supplemented or otherwise modified from time to time, the “Indenture”), between the Issuer and the Indenture Trustee, the Issuer may from time to
        time issue any one or more Series of Notes. The Principal Terms of any Series of Notes are to be set forth in a Supplement to the Indenture; and

       

      WHEREAS, the Issuer wishes to create a new Series of Notes that will be designated as the Series 2018-2 Notes and this Supplement shall specify the
        Principal Terms of such Series 2018-2 Notes.

       

      NOW THEREFORE, in consideration of the premises and mutual covenants herein contained, the parties hereto agree as follows:

       

      ARTICLE I

      Definitions; Calculation Guidelines

       

      Section 101.           Definitions.  (a) Whenever used in this Supplement, the following words and phrases shall have the following meanings, and the definitions of such terms are applicable to the singular as well as
          the plural forms of such terms and to the masculine as well as to the feminine and neuter genders of such terms.

       

      “144A Book-Entry Notes”.  The 144A Book-Entry Notes
        substantially in the form of Exhibit A-1 hereto.

       

      “Aggregate Class A Note Principal Balance”.  As of any date
        of determination, an amount equal to the sum of the Class A Note Principal Balances of all Class A Notes then Outstanding.

       

      “Aggregate Class B Note Principal Balance”.  As of any date
        of determination, an amount equal to the sum of the Class B Note Principal Balances of all Class B Notes then Outstanding.

       

      “Aggregate Invested Amount”.  As of any date of
        determination, an amount equal to the sum of the Invested Amounts for all Series of Notes then Outstanding.

       

      “Aggregate Series 2018-2 Note Principal Balance”.  As of
        any date of determination, an amount equal to the sum of the Aggregate Class A Note Principal Balance and the Aggregate Class B Note Principal Balance.

       

      
        
          

      

      
      “Back-up Manager Event”.  For the Series 2018-2 Notes, the
        event on conditions set forth in Section 406 of this Supplement.

       

      “Bankruptcy Event”.  For any Person, any of the following
        events:

       

      (a)         a case or other proceeding shall be commenced,
          without the application or consent of such Person, in any court, seeking the liquidation, reorganization, debt arrangement, dissolution, winding up or composition or readjustment of debts of such Person, the appointment of a trustee, receiver,
          custodian, liquidator, assignee, sequestrator or the like for such Person or any substantial part of its assets, or any similar action with respect to such Person under any law relating to bankruptcy, insolvency, reorganization, winding up or
          composition or adjustment of debts, and such case or proceeding shall continue undismissed, or unstayed and in effect, for a period of 60 days; or an order for relief in respect of such Person shall be entered in an involuntary case under the
          federal bankruptcy laws or other similar laws now or hereafter in effect; or

       

      (b)         such Person shall commence a voluntary case or
          other proceeding under any applicable bankruptcy, insolvency, reorganization, debt arrangement, dissolution or other similar law now or hereafter in effect, or shall consent to the appointment of or taking possession by a receiver, liquidator,
          assignee, trustee, custodian, sequestration or the like, for such Person or any substantial part of its property, or shall make any general assignment for the benefit of creditors, or shall fail to, or admit in writing its inability to, pay its
          debts generally as they become due.

       

      “Capitalized Leases”.  A lease under which CAI or any of
        its Subsidiaries is the lessee or obligor, the discounted future rental payment obligations under which are required to be capitalized on the balance sheet of the lessee or obligor in accordance with GAAP.

       

      “Change of Control”.  With respect to CAI in its capacity
        as Sub-Manager, an event or series of events by which any of the following events occur:

       

      (a)         any “person” or “group” (as such terms are used in
          Sections 13(d) and 14(d) of the Exchange Act, but excluding any employee benefit plan of such person or its subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan)
          becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Exchange Act, except that a person or group shall be deemed to have “beneficial ownership” of all securities that such person or group has the right to acquire, whether
          such right is exercisable immediately or only after the passage of time (such right, an “option right”)), directly or indirectly, of 50% or more of the equity securities of CAI entitled to vote for members of the board of directors or equivalent
          governing body of CAI on a fully-diluted basis (and taking into account all such securities that such “person” or “group” has the right to acquire pursuant to any option right); or

       

      (b)         any Person or two or more Persons acting in concert
          shall have acquired by contract or otherwise, or shall have entered into a contract or arrangement that, upon consummation thereof, will result in its or their acquisition of the power to exercise, directly or indirectly, a controlling influence
          over the management or policies of CAI, or control over the equity securities of CAI entitled to vote for members of the board of directors or equivalent governing body of CAI on a fully-diluted basis (and taking into account all such securities
          that such Person or Persons have the right to acquire pursuant to any option right) representing 50% or more of the combined voting power of such securities.

       

      
        2

        
          

      

      “Class A Advance Rate”.  For the Class A Notes, eighty
        percent (80%).

       

      “Class A Asset Base”. As of any Determination Date, shall
        be equal to the product of (i) the quotient of the Class A Advance Rate divided by the Class B Advance Rate and (ii) the Series 2018-2 Asset Base.

       

      “Class A Minimum Principal Payment Amount”.  On each
        Payment Date, is equal to the excess, if any, of (x) the then Aggregate Class A Note Principal Balance over (y) the Class A Minimum Targeted Principal Balance for such Payment Date.

       

      “Class A Minimum Targeted Principal Balance”. On each
        Payment Date is the applicable amount set forth opposite such Payment Date under “Class A” in Schedule I hereto. For each Payment Date occurring after the latest Payment Date under “Class A” on Schedule I, the Class A Minimum Targeted Principal
        Balance shall be zero.

       

      “Class A Note”.  Any of the $331,500,000 Fixed Rate Asset-Backed Notes, Series 2018-2, Class A issued pursuant to the terms of this Supplement, substantially in the form of any Exhibit A-1, A-2, A-3 or A-4 to this Supplement.

       

      “Class A Note Interest Payment”.  For the Class A Notes on
        each Payment Date, an amount equal to the product of (i) four and thirty four hundredths percent (4.34%) per annum, (ii) the Aggregate Class A Note Principal Balance on the immediately preceding Payment Date, calculated after giving effect to all
        principal payments on the Class A Notes actually paid on such date (or, in the case of the first Payment Date, the Aggregate Class A Note Principal Balance on the Closing Date) and (iii) one twelfth (or, in the case of the first Payment Date, the
        number of days in the first Interest Accrual Period divided by 360).

       

       “Class A Note Principal Balance”.  With respect to any
        Class A Note as of any date of determination, an amount equal to the excess, if any, of (x) the initial principal balance of such Class A Note as of the Closing Date, over (y) the cumulative amount of all Class A Minimum Principal Payment Amounts,
        Class A Scheduled Principal Payment Amounts and any other principal payments (including Prepayments) actually paid to the related Class A Noteholder subsequent to the Closing Date.

       

      “Class A Scheduled Principal Payment Amount”. On each
        Payment Date is equal to the excess, if any, of (x) the then Aggregate Class A Note Principal Balance (after giving effect to the portion of the Class A Minimum Principal Payment Amount for the Class A Notes actually paid on such Payment Date),
        over (y) the Class A Scheduled Targeted Principal Balance for such Payment Date.

       

      “Class A Scheduled Targeted Principal Balance”. On each
        Payment Date is the applicable amount set forth opposite such Payment Date under “Class A” in Schedule II hereto, as such Schedule II may be adjusted from time to time in accordance with Section 205(b) of this Supplement. For each Payment Date occurring after the latest Payment Date under “Class A” on Schedule II, the Class A Scheduled Targeted Principal Balance shall be zero.

       

      
        3

        
          

      

      “Class A Supplemental Principal Payment Amount”.  On each
        Payment Date is equal to the excess, if any, of (i) the Aggregate Class A Note Principal Balance (calculated after giving effect to any payment of the Class A Minimum Principal Payment Amount and the Class A Scheduled Principal Payment Amount
        actually paid on such Payment Date), over (ii) the Class A Asset Base (determined as of the last day of the month immediately preceding such Payment Date).

       

      “Class B Advance Rate”.  For the Class B Notes, eighty
        three percent (83%).

       

      “Class B Minimum Principal Payment Amount”. On each Payment
        Date is equal to the excess, if any, of (x) the then Aggregate Class B Note Principal Balance over (y) the Class B Minimum Targeted Principal Balance for such Payment Date.

       

      “Class B Minimum Targeted Principal Balance”. On each
        Payment Date is the applicable amount set forth opposite such Payment Date under “Class B” in Schedule I hereto. For each Payment Date occurring after the latest Payment Date under “Class B” on Schedule I, the Class B Minimum Targeted Principal
        Balance shall be zero.

       

      “Class B Note”. The $12,000,000 Fixed Rate Asset-Backed Notes, Series 2018-2, Class B.

       

      “Class B Note Interest Payment”.  For the Class B Notes on
        each Payment Date, an amount equal to the product of (i) five and twenty two hundredths percent (5.22%) per annum, (ii) the Aggregate Class B Note Principal Balance on the immediately preceding Payment Date, calculated after giving effect to all
        principal payments on the Class B Notes actually paid on such date (or, in the case of the first Payment Date, the Aggregate Class B Note Principal Balance on the Closing Date) and (iii) one twelfth (or, in the case of the first Payment Date, the
        number of days in the first Interest Accrual Period divided by 360).

       

      “Class B Note Principal Balance”. With respect to any Class
        B Note as of any date of determination, an amount equal to the excess, if any, of (x) the initial principal balance of such Class B Note as of the Closing Date, over (y) the cumulative amount of all Class B Minimum Principal Payment Amounts, Class
        B Scheduled Principal Payment Amounts and any other principal payments (including Prepayments) actually paid to the related Class B Noteholder subsequent to the Closing Date.

       

      “Class B Scheduled Principal Payment Amount”. On each
        Payment Date is equal to the excess, if any, of (x) the then Aggregate Class B Note Principal Balance (after giving effect to the portion of the Class B Minimum Principal Payment Amount for the Class B Notes actually paid on such Payment Date),
        over (y) the Class B Scheduled Targeted Principal Balance for such Payment Date.

       

      “Class B Scheduled Targeted Principal Balance”. On each
        Payment Date is the applicable amount set forth opposite such Payment Date under “Class B” in Schedule II hereto, as such Schedule II may be adjusted from time to time in accordance with Section 205(b) of this Supplement. For each Payment Date occurring after the latest Payment Date under “Class B” on Schedule II, the Class B Scheduled Targeted Principal Balance shall be zero.

       

      “Class B Supplemental Principal Payment Amount”. On each
        Payment Date is equal to the excess, if any, of (i) the Aggregate Series 2018-2 Note Principal Balance (calculated after giving effect to all Class A Minimum Principal Payment Amounts, Class A Scheduled Principal Payment Amounts, Class A
        Supplemental Principal Payment Amounts, Class B Minimum Principal Payment Amounts and Class B Scheduled Principal Payment Amounts actually paid on such date) over (ii) the Series 2018-2 Asset Base (determined as of the last day of the month
        immediately preceding such Payment Date).

       

      
        4

        
          

      

      “Closing Date”. September 19, 2018.

       

      “Consolidated Funded Debt”.  At any time of determination,
        with respect to CAI and its Subsidiaries, the sum, without duplication, of (a) the aggregate amount of Indebtedness of CAI and its Subsidiaries, on a consolidated basis, relating to (i) the borrowing of money or the obtaining of credit, including
        the issuance of notes or bonds, (ii) the deferred purchase price of assets (other than trade payables (including trade payables to manufacturers) incurred in the ordinary course of business), (iii) Capitalized Leases, and (iv) the maximum drawing
        amount of all letters of credit outstanding plus (b) Indebtedness of the type referred to in clause (a) of another Person guaranteed by CAI or any of its Subsidiaries.

       

      “Consolidated Leverage Ratio”.  As of any date of
        determination, the ratio of (a) the Consolidated Funded Debt to (b) Consolidated Tangible Net Worth.

       

      “Consolidated Tangible Net Worth”.  As of any date of determination, for CAI and its Subsidiaries on a consolidated basis, Shareholders’ Equity of CAI and its Subsidiaries on such date minus the Intangible Assets of CAI and its Subsidiaries on such date; provided that the calculation of Consolidated
        Tangible Net Worth shall exclude any unrealized adjustments, whether positive or negative, resulting from interest rate protection agreements or swap contracts in respect of currency hedging entered into in the ordinary course of business.

       

      “Default Fees”. With respect to the Series 2018-2 Notes,
        the incremental fee specified in Section 203(b) payable by the Issuer to the Noteholders of such Class resulting from the failure of the Issuer to pay amounts when due under this Supplement or the Indenture.

       

      “Defaulted Lease Account”.  The account designated as such
        that has been established by the Issuer for the benefit of the Series 2018-2 Noteholders in accordance with Section 303 of this Supplement.

       

      “Delinquent Bankrupt Lessee”.  Each Lessee of a Managed
        Container that meets both of the following criteria:

       

      (A)           such Lessee is then the subject of a Bankruptcy
          Event; and

       

      (B)           such Lessee is not current on its rental
          obligations under the related Lease(s) within one hundred eighty (180) days after the commencement of such Bankruptcy Event.

       

      “DTC”. This term has the meaning set forth in Section
        207(b)(v).

       

      “Excess Defaulted Lessee Balance”.  As of any date of
        determination, an amount equal to the excess of (x) an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) an amount equal to the sum of the then Net Book Values of all Unrecovered Containers, over (y) an
        amount equal to the product of (a) five percent (5%), (b) the Series 2018-2 Asset Allocation Percentage and (c) the then Aggregate Net Book Value.

       

      
        5

        
          

      

       “Indebtedness”.  As to any Person and whether recourse is
        secured by or is otherwise available against all or only a portion of the assets of such Person and whether or not contingent, but without duplication:

       

      (a)          every obligation of such Person for money
          borrowed,

       

      (b)         every obligation of such Person evidenced by bonds,
          debentures, notes or other similar instruments, including obligations incurred in connection with the acquisition of property, assets or businesses,

       

      (c)         every reimbursement obligation of such Person with
          respect to letters of credit, bankers’ acceptances or similar facilities issued for the account of such Person,

       

      (d)         every obligation of such Person issued or assumed
          as the deferred purchase price of property or services (including securities repurchase agreements but excluding trade accounts payable or accrued liabilities arising in the ordinary course of business which are not overdue or which are being
          contested in good faith),

       

      (e)          every obligation of such Person under any
          Capitalized Lease,

       

      (f)          every obligation of such Person under any
          Synthetic Lease,

       

      (g)         all sales by such Person of (i) accounts or general
          intangibles for money due or to become due, (ii) chattel paper, instruments or documents creating or evidencing a right to payment of money or (iii) other receivables (collectively “receivables”), whether pursuant to a purchase facility or
          otherwise, other than in connection with the disposition of the business operations of such Person relating thereto or a disposition of defaulted receivables for collection and not as a financing arrangement, and together with any obligation of
          such Person to pay any discount, interest, fees, indemnities, penalties, recourse, expenses or other amounts in connection therewith,

       

      (h)         every obligation of such Person (an “equity related
          purchase obligation”) to purchase, redeem, retire or otherwise acquire for value any shares of Capital Stock issued by such Person or any rights measured by the value of such Capital Stock,

       

      (i)         every obligation of such Person under any forward
          contract, futures contract, swap, option or other financing agreement or arrangement (including, without limitation, caps, floors, collars and similar agreements), the value of which is dependent upon interest rates, currency exchange rates,
          commodities or other indices (a “derivative contract”),

       

      (j)         every obligation in respect of Indebtedness of any
          other entity (including any partnership in which such Person is a general partner) to the extent that such Person is liable therefor as a result of such Person’s ownership interest in or other relationship with such entity, except to the extent
          that the terms of such Indebtedness provide that such Person is not liable therefor and such terms are enforceable under applicable law, and

       

      
        6

        
          

      

      (k)        every obligation, contingent or otherwise, of such
          Person guaranteeing, or having the economic effect of guarantying or otherwise acting as surety for, any obligation of a type described in any of clauses (a) through (j) (the “primary obligation”) of another Person (the “primary obligor”), in any
          manner, whether directly or indirectly, and including, without limitation, any obligation of such Person (i) to purchase or pay (or advance or supply funds for the purchase of) any security for the payment of such primary obligation, (ii) to
          purchase property, securities or services for the purpose of assuring the payment of such primary obligation, or (iii) to maintain working capital, equity capital or other financial statement condition or liquidity of the primary obligor so as to
          enable the primary obligor to pay such primary obligation.

       

      provided, however, that, for the avoidance of doubt, any trade payables owing to manufacturers incurred in the ordinary course of business that is not delinquent shall not be deemed Indebtedness for the purposes of this definition.

       

      The “amount” or “principal amount” of any Indebtedness at any time of determination represented by (i) any Indebtedness, issued at a price that is less than the principal amount at maturity thereof, shall be the amount of the liability in
        respect thereof determined in accordance with GAAP, (ii) any Capitalized Lease shall be the principal component of the aggregate of the rental obligation under such Capitalized Lease payable over the term thereof that is not subject to termination
        by the lessee, (iii) any sale of receivables shall be the amount of unrecovered capital or principal investment of the purchaser (other than the Issuer or any of its wholly-owned Subsidiaries) thereof, excluding amounts representative of yield or
        interest earned on such investment, (iv) any Synthetic Lease shall be the stipulated loss value, termination value or other equivalent amount, (v) any derivative contract shall be the maximum amount of any termination or loss payment required to be
        paid by such Person if such derivative contract were, at the time of determination, to be terminated by reason of any event of default or early termination event thereunder, whether or not such event of default or early termination event has in
        fact occurred, (vi) any equity related purchase obligation shall be the maximum fixed redemption or purchase price thereof inclusive of any accrued and unpaid dividends to be comprised in such redemption or purchase price, and (vii) any guaranty or
        other contingent liability referred to in clause (k) shall be an amount equal to the stated or determinable amount of the primary obligation in respect of which such guaranty or other contingent obligation is made or, if not stated or determinable,
        the maximum reasonably anticipated liability in respect thereof (assuming such Person is required to perform thereunder) as determined by such Person in good faith.

       

      “Initial Purchasers”. Each of (i) Merrill Lynch, Pierce, Fenner & Smith Incorporated, (ii) Wells Fargo Securities, LLC, (iii) BBVA Securities Inc., (iv) Fifth Third Securities, Inc. and (v) MUFG Securities Americas Inc.

       

      “Institutional Accredited Investors”. Institutional
        “accredited investors” within the meaning of paragraphs (1), (2), (3) or (7) of Rule 501(a) under the Securities Act.

       

      “Intangible Assets”.  Assets that are considered to be
        intangible assets under GAAP, including customer lists, goodwill, computer software, copyrights, trade names, trademarks, patents, franchises, licenses, unamortized deferred charges, unamortized debt discount and capitalized research and
        development costs.

       

      
        7

        
          

      

      “Interest Accrual Period”. With respect to each Payment
        Date, the period commencing on and including the immediately preceding Payment Date (or in the case of the initial Payment Date with respect to a Series, commencing on and including the Closing Date) and ending on but excluding the current Payment
        Date, based on a 30-day month. For Series 2018-2, each Interest Accrual Period (other than the initial Interest Accrual Period) shall be deemed to have a duration of 30 days. The initial Interest Accrual Period for Series 2018-2 shall have a
        duration of twenty eight (28) days.

       

       “Issuance Date Restricted Cash Amount”. An amount equal to the sum of the Series 2018-2 Restricted Cash Amount on the Closing Date; this amount shall be Eleven Million, Two Hundred Sixty Thousand, One
        Hundred Twenty Five Dollars ($11,260,125).

       

      “Issuance Date Series 2018-2 Note Principal Balance”.  The
        Unpaid Principal Balance on the Closing Date; this amount shall be Three Hundred Forty Three Million, Five Hundred Thousand Dollars ($343,500,000).

       

       “Majority of Holders”.  With respect to the Series 2018-2
        Notes means, as of any date of determination, (A) so long as the Class A Notes are Outstanding, Class A Noteholders holding Class A Notes constituting more than fifty percent (50%) of the then Aggregate Class A Note Principal Balance; and (B) at
        all times not covered by clause (A), Class B Noteholders holding Class B Notes constituting more than fifty percent (50%) of the Aggregate Class B Note Principal Balance.

       

      “Minimum Principal Payment Amount”. With respect to Series
        2018-2, the Class A Minimum Principal Payment Amount and the Class B Minimum Principal Payment Amount.

       

      “Percentage”.  With respect to any Series 2018-2 Noteholder
        as of any date of determination, the percentage equivalent of a fraction, the numerator of which is the Class A Note Principal Balance or Class B Note Principal Balance, as the case may be, of the Class A Note or Class B Note, as the case may be,
        owned by such Series 2018-2 Noteholder and the denominator of which is equal to the then Aggregate Class A Note Principal Balance or Class B Note Principal Balance, as the case may be.

       

      “Permitted Non-U.S. Person”. Any Person (i) who is not a
        U.S. Person and (ii) to whom the offer and sale of the Series 2018-2 Notes may be made without registration under the Securities Act in reliance upon Regulation S.

       

      “Permitted Payment Date Withdrawals”.  Both of the
        following with respect to the Series 2018-2 Notes: (i) on any Payment Date other than the Series 2018-2 Legal Final Payment Date, the amounts required to pay any shortfall in the Class A Note Interest Payment and the Class B Note Interest Payment
        (calculated after giving effect to the application of all Series 2018-2 Available Funds on such Payment Date); and (ii) on the Series 2018-2 Legal Final Payment Date for the Series 2018-2 Note, the amount required to pay any shortfall in the unpaid
        principal balance of all of the Series 2018-2 Notes (calculated after giving effect to the application of the Series 2018-2 Available Funds on such Payment Date).

       

       “Qualified Institutional Buyers”. This term has the
        meaning set forth in Section 207(a)(i).

       

      
        8

        
          

      

      “Regulation S”. Regulation S under the Securities Act.

       

      “Regulation S Temporary Book-Entry Notes”. The Regulation S
        Temporary Book-Entry Notes substantially in the form of Exhibit A-2.

       

      “Related Documents”.  With respect to any Series, the
        Contribution and Sale Agreement, the Indenture, the related Supplement, the Notes of such Series, the Note Purchase Agreement for such Series, the Management Agreement, the Manager Transfer Facilitator Agreement, each Interest Rate Hedge Agreement
        (upon execution thereof), each Letter of Credit (upon delivery thereof), the Performance Guaranty and each other document or instrument executed in connection with the issuance of any Series, as any of the foregoing may from time to time be
        amended, modified, supplemented or renewed.

       

      “Required Payments”.  For Series 2018-2 Notes, the Required
        Payments shall be as follows: (A) if neither an Early Amortization Event for Series 2018-2 nor an Event of Default for Series 2018-2 is then continuing, the payments specified in clauses (1) through (21) inclusive (excluding clause (16)) inclusive
        in Section 304(a), (B) if an Early Amortization Event for Series 2018-2 shall then be continuing but no Event of Default for Series 2018-2 shall then be continuing (or an Event of Default for Series 2018-2 is continuing but the Series 2018-2 Notes
        have not been accelerated in accordance with the Indenture), the payments set forth in clauses (1) through (17) inclusive (excluding clause (14)) in Section 304(b), or (C) if an Event of Default for Series 2018-2 shall then be continuing and the
        Series 2018-2 Notes have been accelerated in accordance with the Indenture and such consequence shall not have been rescinded or annulled, the payments set forth in clauses (1) through (16) (excluding clause (13)) inclusive in Section 304(c).

       

      “Rule 144A”. This term has the meaning set forth in Section 207(a)(i).

       

      “Scheduled Principal Payment Amount”. With respect to
        Series 2018-2, the Class A Scheduled Principal Payment Amount and the Class B Scheduled Principal Payment Amount.

       

      “Series 2018-2 Asset Allocation Percentage”.  As of any
        date of determination, the Asset Allocation Percentage for Series 2018-2.

       

      “Series 2018-2 Asset Base”. As of any Determination Date,
        an amount equal to the sum of (a) the product of (i) Series 2018-2 Asset Allocation Percentage in effect on such Determination Date, (ii) a percentage equal to 100% minus the Series 2018-2 Required Overcollateralization Percentage in effect on such
        Determination Date and (iii) the sum of (x) the Aggregate Net Book Value (measured as of the last day of the immediately preceding calendar month) and (y) the aggregate outstanding balance of receivables resulting from the sale or disposition of
        Eligible Containers which have not been outstanding for more than 60 days, plus (b) an amount equal to the sum of (i) the amount of cash and Eligible Investments on deposit in each of the Series 2018-2 Restricted Cash Account and Defaulted Lease
        Account, and (ii) an amount equal to the product of (x) the Series 2018-2 Asset Allocation Percentage in effect on such Determination Date and (y) the amount of cash and Eligible Investments on deposit in the Excess Funding Account on such
        Determination Date.

       

      
        9

        
          

      

      “Series 2018-2 Available Funds”.  As of any Payment Date,
        an amount equal to the sum of (i) an amount equal to the product of (x) the Available Distribution Amount for the most recently completed Collection Period and (y) the Series 2018-2 Collection Allocation Percentage in effect on the related
        Determination Date, (ii) all amounts transferred to the Series 2018-2 Series Account from the Series 2018-2 Restricted Cash Account or the Series 2018-2 Principal Reserve Account on the related Determination Date pursuant to the Indenture, (iii)
        the amount of funds transferred to the Series 2018-2 Series Account on such Payment Date following transfer from the Excess Funding Account to the Trust Account pursuant to the Indenture, (iv) the amount of any Shared Available Funds (as defined in
        the Supplements for each other Series of Notes then Outstanding) deposited to the Series 2018-2 Series Account on such Payment Date in accordance with the terms of the Supplement for each other Series of Notes then Outstanding, and (v) any other
        amounts deposited into the Series 2018-2 Series Account pursuant to the terms of the Series 2018-2 Supplement.

       

      “Series 2018-2 Collection Allocation Percentage”.  For
        Series 2018-2 Notes as of any date of determination, a fraction (expressed as a percentage) equal to (A) divided by (B), as follows:

       

      (A) the Series 2018-2 Invested Amount; and

       

      (B) the Aggregate Invested Amount (exclusive of the Invested Amount for any Liquidation Deficiency Series).

       

      For purposes of the Indenture and the Series 2018-2 Supplement, the Series 2018-2 Collection Allocation Percentage shall be the “Collection
        Allocation Percentage” for Series 2018-2.

       

      “Series 2018-2 Control Party”.  The Majority of Holders of
        the Series 2018-2 Notes.

       

      “Series 2018-2 Early Amortization Event”.  An Early
        Amortization Event for Series 2018-2.

       

      “Series 2018-2 Event of Default”.  An Event of Default for
        Series 2018-2.

       

      “Series 2018-2 Excess Concentration Percentage”.  As of any
        date of determination, an amount equal to the sum of the following percentages:

       

      
        	

              	(a)	
                Maximum Concentration of Dry Freight Special Containers.  The amount by which (x) the sum of the Net
                  Book Values of all Eligible Containers that are dry freight specialized containers (other than refrigerated containers and generator sets), divided by the Aggregate Net Book Value, expressed as a percentage, exceeds (y) thirty percent
                  (30%);

              

      

       

      
        	

              	(b)	
                Maximum Concentration of Finance Leases (Total).  The amount by which (x) the sum of the Net Book
                  Values of all Eligible Containers that are subject to Finance Leases, divided by the Aggregate Net Book Value, expressed as a percentage, exceeds (y) thirty five percent (35%);

              

      

       

      
        	

              	(c)	
                Maximum Concentration of Non-Monthly Rental Payments.  The amount by which (x) the sum of the Net
                  Book Values of all Eligible Containers subject to Leases for which rentals are payable less frequently than monthly, divided by the Aggregate Net Book Value, expressed as a percentage, exceeds (y) five percent (5%);

              

      

       

      
        10

        
          

      

      
        	

              	(d)	
                Maximum Concentration of Non-U.S. Currency Rentals.  The amount by which (x) the sum of the Net Book
                  Values of all Eligible Containers subject to Leases for which rentals are payable in a currency other than Dollars and which are not the subject of a currency hedge agreement, divided by the Aggregate Net Book Value, expressed as a
                  percentage, exceeds (y) two percent (2%);

              

      

       

      
        	

              	(e)	
                Maximum Concentration of any Three Lessees.  The amount by which (x) the sum of the Net Book Values
                  of all Eligible Containers then on lease to any three lessees or sublessees, divided by the Aggregate Net Book Value, expressed as a percentage, exceeds (y) sixty percent (60%); provided, however, that if two or more lessees shall engage
                  in any transaction (whether through merger, consolidation, stock sale, asset sale or otherwise) pursuant to which a lessee shall become the owner of, or interest holder in, any other lessee’s leasehold interests in one or more Eligible
                  Containers and the effect of such transaction is to cause a breach of the foregoing threshold, then the foregoing threshold shall on the effective date of such transaction be increased to an amount equal to the quotient, expressed as a
                  percentage, (x) the numerator of which shall equal the sum of (A) the sum of the Net Book Values of all Eligible Containers on lease to such transacting lessees immediately prior to such transaction, and (B) the sum of the Net Book Values
                  of all Eligible Containers then on lease to the two other lessees having the most Eligible Containers then on lease with the Issuer (measured by Net Book Value) and (y) the denominator of which shall equal the then Aggregate Net Book
                  Value; and provided further that, if the foregoing limitation has been increased above sixty percent (60%) by operation of the above proviso, then any additional Eligible Containers subsequently leased to any of such three lessees shall
                  not be considered Eligible Containers until such time as the sum of the Net Book Values of all Eligible Containers then on lease to such three lessees does not exceed an amount equal to sixty percent (60%) of the then Aggregate Net Book
                  Value;

              

      

       

      
        	

              	(f)	
                Maximum Concentration of a Single Lessee.  The amount by which (x) the sum of the Net Book Values of
                  all Eligible Containers then on lease to any single lessee, divided by the Aggregate Net Book Value, expressed as a percentage, exceeds either (a) with respect to any of the lessees set forth on Schedule III attached hereto, the percentage of the Aggregate Net Book Value set opposite the name of such lessee on such annex, (b) with respect to all other top twenty-five lessees not covered by
                  clause (a), fifteen percent (15%) of the Aggregate Net Book Value and (c) with respect to any lessee not covered by clauses (a) or (b), seven percent (7%) of the Aggregate Net Book Value; provided, however, that if two or more lessees
                  shall engage in any transaction (whether through merger, consolidation, stock sale, asset sale or otherwise) pursuant to which a lessee shall become the owner of, or interest holder in, any other lessee’s leasehold interests in one or
                  more Eligible Containers, the foregoing threshold set forth in clauses (a) and (b) shall on the effective date of such transaction be increased with respect to such acquiring or, in the case of a merger, surviving lessee to equal the
                  greater of (i) the sum of the applicable percentage limitations for the transacting lessees as set forth in clauses (a) and (b) above, and (ii) a quotient, expressed as a percentage, (x) the numerator of which shall equal the sum of the
                  Net Book Values of all Eligible Containers on Lease to such transacting lessees immediately prior to such transaction and (y) the denominator of which shall equal the then Aggregate Net Book Value; and

              

      

       

      
        11

        
          

      

      
        	

              	(g)	
                Maximum Concentration of Finance Leases by Single Lessee.  The amount by which (x) the sum of the Net
                  Book Values of all Eligible Containers that are subject to a Finance Lease to a single lessee, divided by the Aggregate Net Book Value, expressed as a percentage, exceeds (y) fifteen percent (15%).

              

      

       

      “Series 2018-2 Expected Final Payment Date”.  September 25,
        2028.

       

      “Series 2018-2 Interest Coverage Ratio”.  For any Payment
        Date for Series 2018-2 beginning with the thirteenth Payment Date for Series 2018-2, the ratio calculated according to the following formula:

       

      ICR =       (TCC - FEES - OPEX) / INT

       

      where:      ICR          =       Series 2018-2 Interest Coverage Ratio;

       

      
        	

              	TCC =	
                the product of (i) the Series 2018-2 Collection Allocation Percentage and (ii) the total amount of Gross Revenue, Casualty Proceeds and Sales Proceeds received during the most
                  recently concluded twelve (12) Collection Periods;

              

      

       

      
        	

              	FEES =	
                the sum of (i) the product of (x) the Series 2018-2 Asset Allocation Percentage and (y) the aggregate amount of Issuer Expenses, Management Fees and Transition Manager Fees, and
                  (ii) the Indenture Trustee Fees, in each case which have accrued during the most recently concluded twelve (12) Collection Periods;

              

      

       

      
        	

              	OPEX =	
                the product of (i) the Series 2018-2 Collection Allocation Percentage and (ii) the amount of Operating Expenses for the Managed Containers paid during the most recently concluded
                  twelve (12) Collection Periods; and

              

      

       

      
        	

              	INT =	
                the sum of all interest (but not Default Fees) owing on the Series 2018-2 Notes on the twelve most recent Payment Dates (including the current Payment Date).

              

      

       

      
        12

        
          

      

      “Series 2018-2 Invested Amount”.  As of any date of
        determination for the Series 2018-2 Notes, one of the following: (a) if no Early Amortization Event for any Series or Event of Default for any Series is then continuing, an amount equal to (x) the Issuance Date Series 2018-2 Note Principal Balance
        minus the Issuance Date Restricted Cash Amount for Series 2018-2, divided by (y) 100% minus the Series 2018-2 Required Overcollateralization Percentage in effect on such date of determination; or (b) if any Early Amortization Event for any Series
        or Event of Default for any Series is then continuing, an amount (not less than zero) equal to (x) the Unpaid Principal Balance on the date on which such Early Amortization Event for any Series or Event of Default for any Series occurred, minus the
        amount then on deposit in the Series 2018-2 Restricted Cash Account on the date on which such Early Amortization Event for any Series or Event of Default for any Series occurred, divided by (y) 100% minus the Series 2018-2 Required
        Overcollateralization Percentage on the date on which such Early Amortization Event for any Series or Event of Default for any Series occurred.

       

      “Series 2018-2 Legal Final Payment Date”.  September 25,
        2043.

       

      “Series 2018-2 Management Fee”.  A Management Fee for the
        Series 2018-2 Notes equal to the sum of: (a) 7% of the Series 2018-2 Asset Allocation Percentage of net operating income (“NOI”) of Managed Containers subject to Term Leases (including short term leases), (b) 2% of the Series 2018-2 Asset
        Allocation Percentage of payments received on Finance Leases of the Managed Containers, and (c) 5% of the Series 2018-2 Asset Allocation Percentage of Sales Proceeds from the disposition of any Managed Container (other than dispositions to Manager
        or one of its Affiliates).

       

      “Series 2018-2 Manager Default”.  The occurrence of a
        Series-Specific Manager Default set forth in Section 402 hereof.

       

      “Series 2018-2 Noteholder”.  Any Holder of a Series 2018-2
        Note.

       

      “Series 2018-2 Notes”.  The Series of notes issued pursuant
        to the terms of this Supplement.  The Series 2018-2 Notes are issued in two Classes: Class A Notes and Class B Notes.

       

       “Series 2018-2 Related Documents”. Means any and all of
        the Indenture, this Supplement, the Series 2018-2 Notes, the Management Agreement, the Contribution and Sale Agreement, the Series 2018-2 Note Purchase Agreement, the Manager Transfer Facilitator Agreement, and any and all other agreements,
        documents and instruments executed and delivered by or on behalf or in support of the Issuer with respect to the issuance and sale of the Series 2018-2 Notes, as any of the foregoing may from time to time be amended, modified, supplemented or
        renewed.

       

      “Series 2018-2 Required Overcollateralization Percentage”.
        As of any date of determination, an amount equal to (a) one hundred percent (100%), minus (b) the Class B Advance Rate, plus (c) the Series 2018-2 Excess Concentration Percentage.

       

      “Series 2018-2 Restricted Cash Account”. The account
        established pursuant to Section 302 of this Supplement.

       

      
        13

        
          

      

      “Series 2018-2 Restricted Cash Amount”.  As of any date of
        determination, the amount required to be deposited or maintained in the Series 2018-2 Restricted Cash Account, which shall be equal to the product of (a) nine (9), (b) one-twelfth (1/12), (c) the weighted average (based on unpaid principal
        balances) of the annual rates of interest payable by the Issuer on all Class A Notes and all Class B Notes then Outstanding and (d) the then Aggregate Series 2018-2 Note Principal Balance, calculated after giving effect to all principal payments
        actually paid on all Class A Notes and all Class B Notes on such date.

       

      “Series 2018-2 Series Account”.  The account of that name
        established in accordance with Section 301 herein.

       

      “Series 2018-2 Supplement”.  This Supplement, dated as of
        September 19, 2018, entered into by and between the Issuer and the Indenture Trustee, pursuant to which the Series 2018-2 Notes will be issued.

       

      “Series 2018-2 Specific Collateral”. This term shall have
        the meaning set forth in Section 208 hereto.

       

      “Shareholders’ Equity”.  As of any date of determination, the consolidated shareholders’ equity of CAI and its Subsidiaries as of that
        date determined in accordance with GAAP.

       

      “Targeted Defaulted Lease Account Balance”.  As of any date
        of determination, an amount equal to the excess (but not less than zero) of:

       

      (A)         the Excess Defaulted Lessee Balance on such date of
          determination, minus

       

      (B)         an amount equal to the sum of (1) the amount of
          cash and Eligible Investments on deposit in the Defaulted Lease Account on such date of determination, and (2) an amount equal to the excess of (x) the then Series 2018-2 Asset Base, over (y) an amount equal to the sum of (A) the product of (i)
          the Class B Advance Rate and (ii) the product of (a) the Series 2018-2 Asset Allocation Percentage and (b) the Aggregate Net Book Value, plus (B) the amount of cash and Eligible Investments on deposit in the Series 2018-2 Restricted Cash Account.

       

      “Term Lease”. Any Lease other than a Finance Lease.

       

      “Transaction Parties”. This term has the meaning set forth
        in Section 207(b)(iv)(I).

       

      “Unrecovered Container”.  Each Managed Container this is,
        or was on, lease to a Delinquent Bankrupt Lessee and such Managed Container has not been returned to (i) the Manager or Sub-Manager, (ii) a depot contracted by the Manager or Sub-Manager, or (iii) a location or designee specified by the Manager or
        the Sub-Manager.

       

      An Unrecovered Container shall be re-classified as an Eligible Container (assuming that such Unrecovered Container complies with the requirements
        set forth in the definition of “Eligible Container”) upon the return of such Managed Container as set forth in the immediately preceding paragraph.

       

      
        14

        
          

      

      An Unrecovered Container shall be classified as having been the subject of a Casualty Loss once the Manager or the Sub-Manager has determined, in
        accordance with its normal business practice, that (i) such Container will not be recovered by the Manager or the Sub-Manager, or (ii) the cost of recovering such Container and discharging an liens thereon would exceed the value of such Container.

       

      “Unrestricted Book-Entry Notes”. The Unrestricted
        Book-Entry Notes substantially in the form of Exhibit A-3.

       

      “U.S. Person”. This term has the meaning set forth in
        Regulation S.

       

      “Weighted Average Age”.  For any date of determination
        shall be equal to the quotient of (A) the sum of the products of (i) the age in years (determined from the date of the initial sale thereof by the manufacturer) of each Managed Container being evaluated, multiplied by (ii) the Net Book Value of
        such Managed Container being evaluated, divided by (B) the sum of the Net Book Values of all Managed Containers being evaluated.

       

      (b)         Capitalized terms used herein and not otherwise
          defined shall have the meaning set forth in the Indenture or, if not defined therein, as defined in the Series 2018-2 Note Purchase Agreement, or, if not defined therein, as defined in the Management Agreement.

       

      (c)         References in this Supplement and any other Series
          2018-2 Related Document to any section of the Uniform Commercial Code or the UCC shall mean, on or after the effective date of adoption of any revision to the Uniform Commercial Code or the UCC in the applicable jurisdiction, such revised or
          successor section thereto.

       

      ARTICLE II

      Creation of the Series 2018-2 Notes

       

      Section 201.           Designation.  (a)  There is hereby created a Series of Notes to be issued in two Classes pursuant to the Indenture and this Supplement to be known as (i) “$331,500,000 Fixed Rate Asset-Backed
          Notes, Series 2018-2, Class A”, and (ii) “$12,000,000 Fixed Rate Asset-Backed Notes, Series 2018-2, Class B”.  The Class A Notes will be issued in the initial principal balance of Three Hundred Thirty One Million, Five Hundred Thousand Dollars
          ($331,500,000), and the Class B Notes will be issued in the initial principal balance of Twelve Million Dollars ($12,000,000). The Series 2018-2 Notes will not have priority over any
            other Series, except to the extent set forth in the Supplement for such other Series.  The Class A Notes are the Senior Notes and senior Class of Series 2018-2, and the Class B Notes are the Subordinate Notes and the subordinate Class of
          Series 2018-2.

       

      (b)          Payments of principal on the Series 2018-2 Notes
          shall be payable from funds on deposit in the Series 2018-2 Series Account or otherwise at the times and in the amounts set forth in Article III of the
          Indenture and Article III of this Supplement.

       

      (c)          Each Series 2018-2 Note is classified as a “Term
          Note”, as such term is used in the Indenture.

       

      
        15

        
          

      

      
        (d)          Each of the following terms defined in the
            Indenture shall have the following meanings with respect to the Series 2018-2 Notes:

      

       

        

      (i)             The “Asset Allocation
          Percentage” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Asset Allocation Percentage” (as defined in Section 101(a)).

       

      (ii)            The “Available Funds” (as
          defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Available Funds” (as defined in Section 101(a)).

       

      (iii)           The “Collection Allocation
          Percentage” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Collection Allocation Percentage” (as defined in Section 101(a)).

       

      (iv)           The “Excess Concentration
          Percentage” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Excess Concentration Percentage” (as defined in Section 101(a)).

       

      (v)            The “Expected Final Payment
          Date” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Expected Final Payment Date” (as defined in Section 101(a)).

       

      (vi)           The “Invested Amount” (as
          defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Invested Account” (as defined in Section 101(a)).

       

      (vii)          The “Legal Final Payment
          Date” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Legal Final Payment Date” (as defined in Section 101(a)).

       

      (viii)         The initial “Payment Date”
          (as defined in the Indenture) for Series 2018-2 shall be October 25, 2018.

       

      (ix)           The “Rating Agency” for
          Series 2018-2, as such term is used in the Indenture, shall be S&P Global Ratings.

       

      (x)            The initial “Record Date” (as
          defined in the Indenture) for Series 2018-2 shall be the Closing Date.

       

      (xi)           The “Related Documents” (as
          defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Related Documents” (as defined in Section 101(a)).

       

      (xii)          The “Required
          Overcollateralization Percentage” (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Required Overcollateralization Percentage” (as defined in Section 101(a)).

       

      (xiii)         The “Required Payments” (as
          defined in the Indenture) for Series 2018-2 is the Required Payment (as defined in Section 101(a)).

       

      
        16

        
          

      

      (xiv)         The “Restricted Cash Account”
          (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Restricted Cash Account” (as defined in Section 101(a)).

       

      (xv)          The “Restricted Cash Amount”
          (as defined in the Indenture) for Series 2018-2 shall be the “ Series 2018-2 Restricted Cash Amount” (as defined in Section 101(a)).

       

      (xvi)         The “Series Account” (as
          defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Series Account” (as defined in Section 101(a)).

       

      (xvii)        The “Series-Specific
          Collateral” (as defined in the Indenture) for Series 2018-2 shall be the “ Series 2018-2 Specific Collateral” (as defined in Section 101(a)).

       

      (xviii)       The “Shared Available Funds”
          (as defined in the Indenture) for Series 2018-2 shall be the “Series 2018-2 Shared Available Funds” (as defined in Section 101(a)).

       

      (e)          In the event that any term or provision contained
          herein shall conflict with or be inconsistent with any term or provision contained in the Indenture, the terms and provisions of this Supplement shall govern.

       

      Section 202.           Authentication and Delivery.

       

      (a)         On the Closing Date, the Issuer shall sign, and
          shall direct the Indenture Trustee in writing pursuant to Section 204 of the Indenture to duly authenticate, and the Indenture Trustee, upon receiving such direction, shall authenticate, subject to compliance with the conditions precedent set
          forth in Section 501, the Series 2018-2 Notes in accordance with such written directions.

       

      (b)        In accordance with Section 202 of the Indenture, the
          Series 2018-2 Notes sold in reliance on Rule 144A shall be represented by one or more 144A Book-Entry Notes.  Any Series 2018-2 Notes sold in reliance on Regulation S shall be represented by one or more Regulation S Book-Entry Notes.  Any Series
          2018-2 Notes sold to Institutional Accredited Investors or other Persons that are not Qualified Institutional Buyers or Permitted Non-U.S. Persons shall be represented by one or more Definitive Notes.

       

      (c)         The Series 2018-2 Notes shall be executed by manual
          or facsimile signature on behalf of the Issuer by any officer of the Issuer and shall be substantially in the forms of Exhibit A.

       

      (d)         The Series 2018-2 Notes shall be issued in minimum
          denominations of $250,000 and in integral multiples of $1,000 in excess thereof.

       

      Section 203.           Interest Payments on the Series 2018-2 Notes.

       

      (a)         Interest on Series 2018-2 Notes.  Interest will accrue on the Class A Notes during each Interest Accrual Period and will be due and payable in arrears on each Payment Date in an amount equal to the Class A Note
          Interest Payment.  Interest will accrue on the Class B Notes during each Interest Accrual Period and be due and payable in arrears on each Payment Date in an amount equal to the Class B Note Interest Payment. Interest on the Class A Notes and the
          Class B Notes shall (i) be calculated on the basis of a year consisting of twelve thirty (30) day months, (ii) be due and payable on each Payment Date, and (iii) be payable
          from the Series 2018-2 Series Account in accordance with Section 302 of the Indenture and in accordance with Section 304 hereof.  Payment of the Class B Note Interest Payment due on each Payment Date will be subordinated to payment in full of the
          Class A Note Interest Payment due on such Payment Date in accordance with the priority of payments set forth in Section 304 of this Supplement.

       

      
        17

        
          

      

      (b)         Interest on Overdue Amounts.  If the Issuer shall default in the payment of (i) the Unpaid Principal Balance (or any portion of the principal balance) of all Series 2018-2 Notes on the Series 2018-2 Legal Final
          Payment Date, (ii) Class A Note Interest Payment on any Payment Date, (iii) any Class B Note Interest Payment on any Payment Date or (iv) following the acceleration of the Series 2018-2 Notes in accordance with the terms of the Indenture and this
          Supplement, any other amount owing under the Indenture not covered in clauses (i), (ii) and (iii) which is not paid when due, the Issuer shall, from time to time, pay interest on such unpaid amounts, to the extent permitted by Applicable Law, at
          a rate per annum equal to the sum of (x) the interest rate otherwise in effect hereunder plus (y) two percent (2.00%), for the period during which such
          principal, interest or other amount shall be unpaid from the due date of such payment to but not including the date of actual payment thereof (after as well as before judgment).  Default Fees shall be payable at the times and subject to the
          priorities set forth in Section 304.

       

      (c)         Maximum Interest Rate.  In no event shall the interest charged with respect to a Series 2018-2 Note exceed the maximum amount permitted by Applicable Law.  If at any time the interest rate charged with respect to the
          Series 2018-2 Notes exceeds the maximum rate permitted by Applicable Law, the rate of interest to accrue pursuant to this Supplement and such Series 2018-2 Note shall be limited to the maximum rate permitted by Applicable Law.  If the total
          amount of interest paid or accrued on the Series 2018-2 Note under the foregoing provisions is less than the total amount of interest that would have accrued if the interest rate had at all times been in effect, the Issuer agrees to pay to the
          Series 2018-2 Noteholders an amount equal to the difference between (a) the lesser of (i) the amount of interest that would have accrued if the maximum rate permitted by Applicable Law had at all times been in effect, or (ii) the amount of
          interest that would have accrued if the interest rate had at all times been in effect, and (b) the amount of interest accrued in accordance with the other provisions of this Supplement.

       

      Section 204.           Principal Payments on the Series 2018-2 Notes.

       

      (a)         On each Payment Date, the Issuer will, to the
          extent that funds are available for such purpose in accordance with Section 304, pay the principal balance of the Class A Notes in an amount equal to the Class A Minimum Principal Payment Amount, the Class A Scheduled Principal Payment Amount and
          the Class A Supplemental Principal Payment Amount; provided that if an Early Amortization Event for Series 2018-2 is then continuing or an Event of Default for Series 2018-2 is then continuing but the Series 2018-2 Notes have not been accelerated
          in accordance with the provisions of the Indenture, the then unpaid Aggregate Class A Note Principal Balance shall be payable in full to the extent that funds are available for such purpose in accordance with Section 304.

       

      
        18

        
          

      

      (b)         On each Payment Date, the Issuer will, to the
          extent that funds are available for such purpose in accordance with Section 304 pay the principal balance of the Class B Notes in an amount equal to the Class B Minimum Principal Payment Amount, the Class B Scheduled Principal Payment Amount and
          the Class B Supplemental Principal Payment Amount; provided that if an Early Amortization Event for Series 2018-2 is then continuing or an Event of Default for Series 2018-2 is then continuing but the Series 2018-2 Notes have not been accelerated
          in accordance with the provisions of the Indenture, the then unpaid Aggregate Class B Note Principal Balance shall be payable in full to the extent that funds are available for such purpose in accordance with Section 304.

       

      (c)         Principal payments on the Class B Notes for any
          Payment Date are subordinated to the payment of principal payments on the Class A Notes for such Payment Date in accordance with the priority of payments set forth in this Supplement.

       

      (d)         The unpaid principal amount of each Series 2018-2
          Note together with all unpaid interest (including all Default Fees), fees, expenses, indemnities, costs and other amounts payable by the Issuer to the Series 2018-2 Noteholders and the Indenture Trustee pursuant to the terms of the Indenture and
          this Supplement, shall be due and payable in full on the earlier to occur of (x) the date on which an Event of Default shall occur and the Series 2018-2 Notes have been accelerated in accordance with the provisions of the Indenture and (y) the
          Series 2018-2 Legal Final Payment Date.

       

      Section 205.           Prepayment of Principal on the Series 2018-2 Notes.

       

      (a)         The Issuer will not be permitted to make a
          voluntary prepayment of all, or a portion, of the principal balance of the Series 2018-2 Notes prior to the Payment Date occurring in October 2020.  Beginning on the Payment Date in October 2020, the Issuer will have the option to prepay on any
          Payment Date all, or any portion of, the outstanding principal of the Series 2018-2 Notes, in a minimum amount of One Hundred Thousand Dollars ($100,000), together with accrued interest thereon and any early termination fees owing pursuant to any
          Interest Rate Hedge Agreement in effect for the Series 2018-2 Notes.  Except during the period described above, the Issuer may make voluntary principal prepayments on: (i) only the Class A Notes, or (ii) the Class A Notes and the Class B Notes
          simultaneously, provided that (in the case of prepayments of the Class B Notes), so long as the Class A Notes are Outstanding, at the time of any prepayment of the Class B Notes, and after giving effect thereto, the percentage of the original
          principal amount of the Class B Notes Outstanding shall be equal to, or greater than, the percentage of the original principal amount of the Class A Notes Outstanding. However, the foregoing shall not restrict repayments of the Offered Notes as a
          consequence of a Class A Supplemental Principal Payment Amount or a Class B Supplemental Principal Payment Amount.

       

      (b)         Any optional Prepayments, Supplemental Principal
          Payment Amounts or accelerated principal payments received during the continuation of an Early Amortization Event for Series 2018-2 will apply to each Class of Series 2018-2 Notes will be applied on each Payment Date on which such type of payment
          is received to reduce the Minimum Targeted Principal Balances and Scheduled Targeted Principal Balances of the affected Class of Notes in respect of each subsequent Payment Date by a percentage, the numerator of which is the amount of such
          optional Prepayment, Supplemental Principal Payment Amount for such Class, or accelerated principal payment, and the denominator of which is the Aggregate Class A Note Principal Balance or the Aggregate Class B Note Principal Balance, as the case
          may be, on such Payment Date (determined without giving effect to such optional Prepayment, Supplemental Principal Payment Amount for such Class or accelerated payment).  The Issuer shall promptly (but in any event within five (5) Business Days
          after the date on which such payments are made) thereafter recalculate the Minimum Targeted Principal Balances and Scheduled Targeted Principal Balance of the affected Classes of Notes for each future Payment Date.

       

      
        19

        
          

      

      Section 206.           Payments of Principal and Interest.  All payments of principal and interest on the Series 2018-2 Notes shall be paid to the Series 2018-2 Noteholders reflected in the Note Register as of the
          related Record Date by wire transfer of immediately available funds for receipt prior to 11:00 a.m. (New York City time) on the related Payment Date.  Any payments received by the Series 2018-2 Noteholders after 11:00 a.m. (New York City time) on
          any day shall be considered to have been received on the next succeeding Business Day.

       

      Section 207.          Restrictions on Transfer.  On the Closing Date, the Issuer shall sell the Series 2018-2 Notes to the Initial Purchasers pursuant to the Series 2018-2 Note Purchase Agreement and deliver such Series
          2018-2 Notes in accordance herewith and therewith.  Thereafter, no Series 2018-2 Note may be sold, transferred or otherwise disposed of except in compliance with the provisions of the Indenture and except as follows:

       

      (i)            to Persons that take delivery
          of such Series 2018-2 Note in an amount of at least $250,000 and that the transferring Person reasonably believes are qualified institutional buyers as defined in Rule 144A (“Qualified Institutional Buyers”) in reliance on the exemption from the registration requirements of the Securities Act provided by Rule 144A promulgated thereunder (“Rule 144A”);

       

      (ii)            to Permitted Non-U.S.
          Persons that take delivery of such Series 2018-2 Note in an amount of at least $250,000;

       

      (iii)           to Institutional Accredited
          Investors that take delivery of such Series 2018-2 Note in an amount of at least $250,000 and that deliver to the Indenture Trustee a letter substantially in the form of Exhibit D to the Indenture to the Indenture Trustee; or

       

      (iv)          to a Person that is taking
          delivery of such Series 2018-2 Note in an amount of at least $250,000 and that is otherwise exempt from the registration requirements of the Securities Act and from any applicable State law securities registration or qualification requirements,
          as confirmed in an Opinion of Counsel addressed to the Indenture Trustee and the Issuer, which counsel and opinion are satisfactory to the Indenture Trustee and the Issuer.

       

      The Indenture Trustee shall have no obligations or duties with respect to determining whether any transfers of the Series 2018-2 Notes are made in accordance with the
        Securities Act or any other law; provided that with respect to Definitive Notes, the Indenture Trustee shall enforce such transfer restrictions in accordance
        with the terms set forth in this Supplement.

       

      
        20

        
          

      

      (b)          Each purchaser (other than any Initial Purchaser)
          of the Series 2018-2 Notes (including any purchaser, other than any Initial Purchaser, of an interest in the Series 2018-2 Notes which are Book-Entry Notes) shall be deemed to have acknowledged and agreed as follows:

       

      (i)           It is (A) Qualified
          Institutional Buyer and is acquiring such Series 2018-2 Notes for its own institutional account or for the account or accounts of a Qualified Institutional Buyer or (B) purchasing such Series 2018-2 Notes in a transaction exempt from registration
          under the Securities Act and in compliance with the provisions of this Supplement and in compliance with the legend set forth in Section 207(b)(v) below or
          (C) not a U.S. Person and is acquiring such Series 2018-2 Notes outside of the United States.

       

      (ii)           It is purchasing one or more
          Series 2018-2 Notes in an amount of at least $250,000 and it understands that such Series 2018-2 Notes may be resold, pledged or otherwise transferred only in an amount of at least $250,000.

       

      (iii)          It represents and warrants to
          the Initial Purchasers, the Issuer, and the Indenture Trustee that either (i) it is not acquiring and will not hold the Series 2018-2 Note with the plan assets of a Plan or any other plan that is subject to federal, state, local or other laws or
          regulations comparable to Title I of ERISA and Section 4975 of the Code (“Similar Law”) or (ii) (a) the Series 2018-2 Notes are rated investment grade or
          better and have not been characterized as other indebtedness for applicable local law purposes and (b) the acquisition, holding and disposition of the Series 2018-2 Note will not give rise to a non-exempt prohibited transaction under Section 406
          of ERISA, Section 4975 of the Code or Similar Law;

       

      (iv)          It understands that the Series
          2018-2 Notes are being transferred to it in a transaction not involving any public offering within the meaning of the Securities Act, and that, if in the future it decides to resell, pledge or otherwise transfer any Series 2018-2 Notes, such
          Series 2018-2 Notes may be resold, pledged or transferred only in accordance with applicable state securities laws and (1) in a transaction meeting the requirements of Rule 144A, to a Person that the seller reasonably believes is a Qualified
          Institutional Buyer that purchases for its own account (or for the account or accounts of a Qualified Institutional Buyer) and to whom notice is given that the resale, pledge or transfer is being made in reliance on Rule 144A, or (2) (A) to a
          Person that is an Institutional Accredited Investor, is taking delivery of such Series 2018-2 Notes in an amount of at least $250,000, and delivers to the Indenture Trustee a letter substantially in the form of Exhibit D to the Indenture or (B)
          to a Person that is taking delivery of such Series 2018-2 Notes pursuant to a transaction that is otherwise exempt from the registration requirements of the Securities Act and from any applicable state law securities registration or qualification
          requirements, as confirmed in an Opinion of Counsel addressed to the Indenture Trustee, the Issuer and the transferor, which counsel and Opinion are satisfactory to the Indenture Trustee, the Issuer and the transferor, or (3) in an offshore
          transaction in accordance with Rule 903 or 904 of Regulation S.

       

      (v)            It understands that each
          Series 2018-2 Note shall bear a legend substantially to the following effect:

       

      
        21

        
          

      

      [For Book-Entry Notes Only:  UNLESS THIS SERIES 2018-2 NOTE IS PRESENTED BY AN
          AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE TRANSFEROR OF SUCH SERIES 2018-2 NOTE (THE “TRANSFEROR”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SERIES 2018-2 NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND
          ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR THE USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER
          HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. ]

       

      THIS SERIES 2018-2 NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
          AMENDED (THE “SECURITIES ACT”).  THE HOLDER HEREOF, BY PURCHASING
          THIS SERIES 2018-2 NOTE, AGREES THAT SUCH SERIES 2018-2 NOTE MAY BE RESOLD, PLEDGED OR TRANSFERRED ONLY IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS AND (1) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES
          ACT (“RULE 144A”), TO A PERSON THAT TAKES DELIVERY OF SUCH SERIES
          2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND THAT THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT (OR FOR THE ACCOUNT OR ACCOUNTS OF A QUALIFIED INSTITUTIONAL BUYER) AND TO WHOM NOTICE IS
          GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, OR (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT WITH SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT
          LEAST $250,000 OR (3) TO A PERSON (A) THAT IS AN INSTITUTIONAL “ACCREDITED INVESTOR,” WITHIN THE MEANING OF RULE 501(A)(1), (2), (3) OR (7) OF REGULATION D UNDER THE SECURITIES ACT, IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND DELIVERS TO THE INDENTURE TRUSTEE A LETTER
          SUBSTANTIALLY IN THE FORM OF EXHIBIT S TO THE INDENTURE OR (B) THAT IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 PURSUANT TO A TRANSACTION THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE
          SECURITIES ACT AND FROM ANY APPLICABLE STATE LAW SECURITIES REGISTRATION OR QUALIFICATION REQUIREMENTS, AS CONFIRMED IN AN OPINION OF COUNSEL ADDRESSED TO THE INDENTURE TRUSTEE AND THE ISSUER, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE
          ISSUER AND THE INDENTURE TRUSTEE.

       

      
        22

        
          

      

      EACH PURCHASER AND TRANSFEREE (AND ITS FIDUCIARY, IF APPLICABLE) OF A NOTE (OR INTEREST HEREIN) WILL BE DEEMED TO REPRESENT AND WARRANT THAT EITHER
        (I) IT IS NOT ACQUIRING AND WILL NOT HOLD THE NOTE WITH THE PLAN ASSETS OF AN “EMPLOYEE BENEFIT PLAN” AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), WHICH IS SUBJECT TO THE PROVISIONS OF
        TITLE I OF ERISA, A “PLAN” DESCRIBED IN AND SUBJECT TO SECTION 4975OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” OF ANY OF THE FOREGOING BY REASON OF AN EMPLOYEE BENEFIT
        PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY (EACH OF THE FOREGOING, A “BENEFIT PLAN”) OR ANY OTHER PLAN THAT IS SUBJECT TO A LAW THAT IS SIMILAR TO TITLE I OF ERISA OR SECTION 4975 OF THE CODE OR (II) (A) THE SERIES 2018-2 NOTES ARE RATED INVESTMENT
        GRADE OR BETTER AND HAVE NOT BEEN CHARACTERIZED AS OTHER THAN INDEBTEDNESS FOR APPLICABLE LOCAL LAW PURPOSES AND (B) THE ACQUISITION, HOLDING AND DISPOSITION OF THE NOTE WILL NOT GIVE RISE TO A NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF
        ERISA, SECTION 4975 OF THE CODE OR A VIOLATION OF ANY SIMILAR APPLICABLE LAW.

       

      THIS SERIES 2018-2 NOTE IS NOT GUARANTEED OR INSURED BY ANY GOVERNMENTAL AGENCY OR INSTRUMENTALITY.

       

      (vi)           Each Series 2018-2 Noteholder
          that is a Permitted Non-U.S. Person described in Section 207(b)(i)(C) understands that the Series 2018-2 Notes have not and will not be registered under
          the Securities Act, that any offers, sales or deliveries of the Series 2018-2 Notes purchased by it in the United States or to U.S. Persons prior to the date that is 40 days after the later of (i) the commencement of the distribution of the
          Series 2018-2 Notes and (ii) the Closing Date, may constitute a violation of United States law, and that distributions of principal and interest will be made in respect of such Series 2018-2 Notes only following the delivery by the holder of a
          certification of non-U.S. beneficial ownership or the exchange of beneficial interest in Regulation S Temporary Book-Entry Notes for beneficial interests in the related Unrestricted Book-Entry Notes (which in each case will itself require a
          certification of non-U.S. beneficial ownership), at the times and in the manner set forth in this Supplement.

       

      (vii)         The Regulation S Temporary
          Book-Entry Notes representing the Series 2018-2 Notes sold to each Series 2018-2 Noteholder that is a Permitted Non-U.S. Person described in Section 207(b)(i)(C) will

          bear a legend to the following effect, unless the Issuer determines otherwise consistent with Applicable Law:

       

      [FOR REGULATION S BOOK-ENTRY NOTES ONLY:  THIS SERIES 2018-2 NOTE HAS NOT BEEN AND
          WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) AND, PRIOR TO THE DATE THAT IS 40 DAYS AFTER THE LATER OF (I) THE COMPLETION OF THE DISTRIBUTION OF THE SERIES 2018-2 NOTES AND (II) THE CLOSING DATE, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
          TRANSFERRED IN THE UNITED STATES OR TO A U.S. PERSON EXCEPT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.]

       

      
        23

        
          

      

      (viii)        The Indenture Trustee shall not
          permit the transfer of any Series 2018-2 Notes unless such transfer complies with the terms of the foregoing legends and, in the case of a transfer (i) to an Institutional Accredited Investor (other than a Qualified Institutional Buyer), the
          transferee delivers to the Indenture Trustee a letter substantially in the form of Exhibit D to the Indenture, or (ii) to a Person other than a Qualified Institutional Buyer, an Institutional Accredited Investor or a Permitted Non-U.S. Person,
          upon delivery of an Opinion of Counsel satisfactory to the Indenture Trustee and the applicable transferor, to the effect that the transferee is taking delivery of the Series 2018-2 Notes in a transaction that is otherwise exempt from the
          registration requirements of the Securities Act and from any applicable state law securities registration or qualification requirements.

       

      The applicable transferor and transferee shall execute and deliver, or in the case of a Series 2018-2 Noteholder, is deemed to have executed and delivered, to the
        Indenture Trustee documentation in substantially the forms of (i) Exhibit(s) B through F hereto or (ii) Exhibit D to the Indenture, as appropriate, in connection with any transfer of Series 2018-2 Notes. The
        foregoing transfer restriction shall supersede the transfer restriction set forth in Section 205 of the Indenture.

       

      Section 208.           Grant of Security Interest.

       

      (a)        In order to secure and provide for the repayment and
          payment of the Series 2018-2 Notes, the Issuer hereby grants a security interest to the Indenture Trustee, for the benefit of the Series 2018-2 Noteholders, in all of the Issuer’s right, title and interest in and to the following (whether
          existing or accrued after the Closing Date):  (i) the Series 2018-2 Restricted Cash Account, the Defaulted Lease Account and the Series 2018-2 Series Account; (ii) all funds on deposit Series 2018-2 Restricted Cash Account, the Defaulted Lease
          Account and Series 2018-2 Series Account and all Security Entitlements credited thereto from time to time; (iii) all investments made at any time and from time to time with monies in the Series 2018-2 Restricted Cash Account, the Defaulted Lease
          Account and the Series 2018-2 Series Account, whether constituting securities, instruments, general intangibles, investment property, financial assets or other property; (iv) all interest, dividends, cash, instruments and other property from time
          to time received, receivable or otherwise distributed in respect of, or in exchange for, such Series 2018-2 Restricted Cash Account, the Defaulted Lease Account and the Series 2018-2 Series Account, the funds on deposit therein from time to time
          or the investments made with such funds; and (v) all proceeds of any and all of the foregoing, including, without limitation, cash (the property described in clause (i) through (v) collectively, the “Series 2018-2 Specific Collateral” or the
          “Series Specific Collateral for  Series 2018-2”).  The Indenture Trustee shall possess all right, title and interest in and to all funds on deposit from time to time in the Series 2018-2 Restricted Cash Account, the Defaulted Lease Account and
          the Series 2018-2 Series Account and in all proceeds thereof, and shall be the only person authorized to originate Entitlement Orders with respect thereto.  No other Series of Notes shall have interest in the Series-Specific Collateral for Series
          2018-2. The Series 2018-2 Control Party shall direct the exercise of remedies regarding the Series-Specific Collateral for Series 2018-2.

       

      (b)        The Issuer hereby irrevocably authorizes the Manager
          and the Indenture Trustee at any time, and from time to time, to file in any filing office in any UCC jurisdiction any financing statements with respect to the foregoing, including financing statements claiming a security interest in the Series
          2018-2 Specific Collateral; provided, however, that neither the Manager nor the Indenture Trustee shall have any responsibility or liability for or with respect to the perfection of any security interest.

       

      
        24

        
          

      

      (c)         In furtherance of the foregoing, the Issuer hereby
          grants, assigns, conveys, mortgages, pledges, charges, hypothecates and transfers to the Indenture Trustee, for the benefit of the Series 2018-2 Noteholders, a floating charge over all of the Series 2018-2 Specific Collateral.

       

      (d)          Upon the occurrence of a Series-Specific Event of
          Default, the Series 2018-2 Control Party shall direct the exercise of remedies with respect to the Series 2018-2 Specific Collateral.

       

      ARTICLE III

      Series 2018-2 Series Account and

      Allocation and Application of Amounts Therein

       

      Section 301.           Series 2018-2 Series Account.  The Issuer has established and maintains at the Corporate Trust Office at the Indenture Trustee, in the name of the Issuer, the Series 2018-2 Series
          Account, which Series 2018-2 Series Account has been pledged to the Indenture Trustee for the benefit of the Series 2018-2 Noteholders pursuant to the Indenture and this Supplement.  All deposits of funds by, or for the benefit of, the Series
          2018-2 Noteholders from the Trust Account and the Excess Funding Account, shall be accumulated in, and withdrawn from, the Series 2018-2 Series Account in accordance with the provisions of the Indenture and this Supplement.  Any funds on deposit
          in the Series 2018-2 Series Account shall be invested in accordance with the provisions of Section 303 of the Indenture.

       

      Section 302.           Series 2018-2 Restricted Cash Account.

       

      (a)          The Issuer has established and maintains at the
          Corporate Trust Office of the Indenture Trustee, in the name of the Issuer, the Series 2018-2 Restricted Cash Account, which Series 2018-2 Restricted Cash Account has been pledged to the Indenture Trustee for the benefit of the Holders of the
          Series 2018-2 Notes.  On the Closing Date, the Issuer will have deposited, or have caused to be deposited, cash and/or Eligible Investments having a value of not less than the Series 2018-2 Restricted Cash Amount in the Series 2018-2 Restricted
          Cash Account. Thereafter, additional amounts will be deposited in the Series 2018-2 Restricted Cash Account in accordance with Section 304 of this Supplement.  Any and all monies on deposit in the Series 2018-2 Restricted Cash Account shall be
          invested in Eligible Investments in accordance with Section 303 of Indenture and shall be distributed in accordance with this Supplement.

       

      (b)         On each Payment Date, the Indenture Trustee shall,
          in accordance with the priority set forth in Section 304, transfer from the Series 2018-2 Series Account to the Series 2018-2 Restricted Cash funds in an amount necessary to restore the balance of cash and Eligible Investments on deposit in the
          Series 2018-2 Restricted Cash Account to an amount equal to the Series 2018-2 Restricted Cash Amount for such Payment Date.

       

      
        25

        
          

      

      (c)          On each Determination Date, the Indenture Trustee
          will, in accordance with the Manager Report (or, in the absence of any Manager Report, in accordance with written instructions from the Series 2018-2 Control Party), withdraw from the Series 2018-2 Restricted Cash Account an amount equal to the
          Permitted Payment Date Withdrawals (determined after giving effect to all other deposits to the Series 2018-2 Series Account (other than funds transferred from the Series 2018-2 Restricted Cash Account)) on or prior to such Determination Date. 
          Such amounts may only be used to pay amounts specified in the definition of “Permitted Payment Date Withdrawals”.  If there are insufficient funds in the Series 2018-2 Restricted Cash Account to fully fund the Permitted Payment Date Withdrawal,
          payments will be paid to the Class A Noteholders and the Class B Noteholders in the same priority as the priority of payments from the Series 2018-2 Series Account.

       

      (d)         Notice of each such drawing will be delivered to
          the Manager, by hand delivery or facsimile transmission (or, if applicable, included in the respective Manager Report delivered to the Indenture Trustee).  Any such funds actually received by the Indenture Trustee pursuant to Section 302(c) shall be used solely to make payments of the Class A Note Interest Payments, Class B Note Interest Payments or payment of the Unpaid Principal
          Balance, as the case may be.

       

      (e)        On each Payment Date, the Indenture Trustee shall,
          in accordance with the Manager Report (or in the absence of any Manager Report, in accordance with written instructions from the Series 2018-2 Control Party), deposit in the Series 2018-2 Series Account for distribution in accordance with this
          Supplement the excess, if any, of (i) the amounts then on deposit in the Series 2018-2 Restricted Cash Account (after giving effect to any withdrawals therefrom on such Payment Date), over (ii) an amount equal to the Series 2018-2 Restricted Cash
          Amount for such Payment Date. On the Series 2018-2 Legal Final Payment Date or, at the direction of the Control Party upon the occurrence of an Event of Default for Series 2018-2, any remaining funds in the Series 2018-2 Restricted Cash Account
          will be deposited in the Series 2018-2 Series Account and be distributed in accordance with this Supplement.

       

      (f)         If on any Payment Date the aggregate amount of cash
          and Eligible Investments then on deposit in the Series 2018-2 Restricted Cash Account is equal to, or greater than, the Aggregate Series 2018-2 Note Principal Balance and accrued interest thereon, the Indenture Trustee shall, in accordance with
          the Manager Report, prepay in full on such Payment Date the then Unpaid Principal Balance of, and accrued interest on, all Series 2018-2 Notes.

       

      Section 303.           Defaulted Lease Account.

       

      (a)         The Issuer has established and maintains at the
          Corporate Trust Office of the Indenture Trustee, in the name of the Issuer, the Defaulted Lease Account, which Defaulted Lease Account has been pledged to the Indenture Trustee for the benefit of the Holders of the Series 2018-2 Notes.  Any and
          all monies on deposit in the Defaulted Lease Account shall be invested in Eligible Investments in accordance with Section 303 of the Indenture and shall be distributed in accordance with this Supplement.

       

      (b)        On each Payment Date, the Indenture Trustee shall,
          in accordance with the priority of payments set forth in Section 304, transfer from the Series 2018-2 Series Account to the Defaulted Lease Account funds in an amount to bring the balance of cash and Eligible Investments on deposit therein to the
          Targeted Defaulted Lease Account Balance (if any).

       

      
        26

        
          

      

      (c)         On each Payment Date on which no Early Amortization
          Event for Series 2018-2 nor an Event of Default for Series 2018-2 is then continuing, the Indenture Trustee shall, in accordance with the Manager Report (or in the absence of any Manager Report, in accordance with written instructions from the
          Series 2018-2 Control Party), deposit in the Series 2018-2 Series Account for distribution in accordance with this Supplement the excess, if any, of (i) the amounts then on deposit in the Defaulted Lease Account, over (ii) an amount equal to the
          Targeted Defaulted Lease Account Balance.

       

      (d)         On the Series 2018-2 Legal Final Payment Date or,
          at the direction of the Control Party upon the occurrence of an Event of Default for Series 2018-2, any funds in the Series 2018-2 Defaulted Lease Account will be deposited in the Series 2018-2 Series Account and be distributed in accordance with
          the terms of this Supplement.

       

      Section 304.           Distributions from Series 2018-2 Series Account.  On each Payment Date, the Indenture Trustee, based on the information contained in the Manager Report (or, in the absence of any Manager Report, in
          accordance with the written direction of the Series 2018-2 Control Party), is required to make payments from the Series 2018-2 Available Funds then on deposit in the Series 2018-2 Series Account.  The calculation and relative priorities of such
          specified payments will vary depending on whether an Early Amortization Event for Series 2018-2 or an Event of Default for Series 2018-2 has occurred and is continuing on such Payment Date.  The alternative payment priorities for each Payment
          Date are set forth below:

       

      (I)          If neither an Early Amortization Event for Series
          2018-2 nor an Event of Default for Series 2018-2 shall then be continuing:

       

      (1)         To the Indenture Trustee, an amount equal to the
          sum of (A) the Indenture Trustee’s Fees then due and payable for the Series 2018-2 Notes (subject to, in the case of expenses and indemnities only, a per annum dollar limitation of $40,000) and (B) an amount equal to the product of (i) the Series
          2018-2 Asset Allocation Percentage and (ii) any amounts payable to the Indenture Trustee on such Payment Date in accordance with a specified provision of the Indenture regarding enforcement of the obligations of the Issuer under the Indenture;
          provided, however, that to the extent that the amounts in clause (B) have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not be divided among the Series according to the Asset Allocation
          Percentages;

       

      (2)         To the Manager, an amount equal to the sum of (i)
          an amount equal to the Series 2018-2 Management Fee then due and payable with respect to the Series 2018-2 Notes, and (ii) the amount of any Management Fee Arrearage then due and payable with respect to the Series 2018-2 Notes;

       

      (3)         To the Manager, an amount equal to the product of
          (i) the Series 2018-2 Asset Allocation Percentage and (ii) any unreimbursed Manager Advances made in accordance with the terms of the Management Agreement;

       

      (4)         To each of the following on a pro rata basis: (A)
          to the Manager Transfer Facilitator, an amount equal to the product of (x) Manager Transfer Facilitator Fees, expenses and indemnities (subject to, in the case of expenses and indemnities only, a per annum dollar limitation of $40,000) and (y)
          the Series 2018-2 Asset Allocation Percentage of any amounts incurred by the Manager Transfer Facilitator, including those related to the actual transfer from the Manager to the Back-up Manager, and (B) to Back-up Manager, an amount equal to the
          product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) any Back-Up Manager fees then due and payable;

       

      
        27

        
          

      

      (5)         To the Independent Management Provider, an amount
          equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) that portion of the Independent Management Provider Fee then owing;

       

      (6)         To the Persons entitled thereto, the Issuer
          Expenses then due and payable, so long as the aggregate amount paid pursuant to this clause (6) in any calendar year would not exceed an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) Fifty Thousand
          Dollars ($50,000) in aggregate;

       

      (7)         To each Holder of a Class A Note on the immediately
          preceding Record Date, on a pro rata basis, an amount equal to its Percentage of the Class A Note Interest Payment (exclusive of Default Fees on the Class A Notes) for such Payment Date;

       

      (8)         To each Holder of a Class B Note on the immediately
          preceding Record Date, on a pro rata basis, an amount equal to its Percentage of the Class B Note Interest Payment (exclusive of Default Fees on the Class B Notes) for such Payment Date;

       

      (9)         To the Series 2018-2 Restricted Cash Account, an
          amount sufficient so that the total amount on deposit in the Series 2018-2 Restricted Cash Account is equal to the Series 2018-2 Restricted Cash Amount for such Payment Date;

       

      (10)       To each Holder of a Class A Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class A Minimum Principal Payment Amount for the Class A Notes on such Payment Date;

       

      (11)       To each Holder of a Class A Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class A Scheduled Principal Payment Amount for the Class A Notes on such Payment Date;

       

      (12)       To each Holder of a Class A Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class A Supplemental Principal Payment Amount for the Class A Notes on such Payment Date;

       

      (13)       To each Holder of a Class B Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class B Minimum Principal Payment Amount for the Class B Notes on such Payment Date;

       

      (14)       To each Holder of a Class B Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class B Scheduled Principal Payment Amount for the Class B Notes on such Payment Date;

       

      
        28

        
          

      

      (15)       To each Holder of a Class B Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class B Supplemental Principal Payment Amount for the Class B Notes on such Payment Date;

       

      (16)       To the Series Account for each other Series of Notes
          then Outstanding (excluding the Series 2018-2 Notes), all remaining Series 2018-2 Available Funds to be allocated to such other Series of Notes in accordance with the terms of the Series 2018-2 Supplement;

       

      (17)       To each Class A Noteholder on the immediately
          preceding Record Date, an amount equal to Default Fees (if any) on the Class A Notes and all indemnities, costs, expenses and other amounts then due and payable to the Class A Noteholders pursuant to the Series 2018-2 Related Documents;

       

      (18)       To each Class B Noteholder on the immediately
          preceding Record Date, an amount equal to Default Fees on the Class B Notes (if any) and all indemnities, costs, expenses and other amounts then due and payable to the Class B Noteholders pursuant to the Series 2018-2 Related Documents;

       

      (19)       On a pro rata basis (a) to the Manager Transfer
          Facilitator, any amounts due and payable to the Manager Transfer Facilitator and (b) to the Back-up Manager, any unpaid amounts due to Back-up Manager, in each case calculated after giving effect to payments remaining after clause (4) above;

       

      (20)       To the Indenture Trustee, an amount equal to the
          product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) Indenture Trustee’s Fees and indemnified amounts then due and payable to the Indenture Trustee after giving effect to the payment made pursuant to clause (1) above; provided,
          however, that to the extent such amounts have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not be divided among the Series according to the Asset Allocation Percentages;

       

      (21)       To each of the following on a pro rata basis: (A) to
          the Issuer, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments payable to the officers, directors and/or managers of the Issuer required to be made by the Issuer, and
          (B) to the Manager, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments required to be made to the Manager;

       

      (22)       If the Aggregate Required Asset Base exceeds the
          Aggregate Asset Base (determined prior to giving effect to any deposits to the Excess Funding Account made pursuant to this clause (22), any remaining Series 2018-2 Available Funds will be deposited in the Excess Funding Account until such
          condition is remedied;

       

      (23)       To the Defaulted Lease Account in an amount
          necessary to bring the amount of cash and Eligible Investments on deposit in the Defaulted Lease Account to the Targeted Defaulted Lease Account Balance; and

       

      (24)       To the Issuer, any remaining Series 2018-2 Available
          Funds.

       

      
        29

        
          

      

      (II)        If an Early Amortization Event for Series 2018-2
          shall then be continuing, but no Event of Default for Series 2018-2 shall then be continuing (or an Event of Default for Series 2018-2 is continuing but the Series 2018-2 Notes have not been accelerated in accordance with the Indenture):

       

      (1)         To the Indenture Trustee, an amount equal to the
          sum of (A) the Indenture Trustee’s Fees then due and payable for the Series 2018-2 Notes (subject to, in the case of expenses and indemnities only, a per annum dollar limitation of $40,000) and (B) an amount equal to the product of (i) the Series
          2018-2 Asset Allocation Percentage and (ii) any amounts payable to the Indenture Trustee on such Payment Date in accordance with a specified provision of the Indenture regarding enforcement of the obligations of the Issuer under the Indenture;
          provided, however, that to the extent that the amounts in clause (B) have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not be divided among the Series according to the Asset Allocation
          Percentages;

       

      (2)         To the Manager, an amount equal to the sum of (i)
          an amount equal to the Series 2018-2 Management Fee then due and payable with respect to the Series 2018-2 Notes, and (ii) the amount of any Management Fee Arrearage then due and payable with respect to the Series 2018-2 Notes;

       

      (3)         To the Manager, an amount equal to the product of
          (i) the Series 2018-2 Asset Allocation Percentage and (ii) any unreimbursed Manager Advances made in accordance with the terms of the Management Agreement;

       

      (4)         To each of the following on a pro rata basis: (A)
          to the Manager Transfer Facilitator, an amount equal to the product of (x) Manager Transfer Facilitator Fees, expenses and indemnities (subject to, in the case of expenses and indemnities only, a per annum dollar limitation of $40,000) and (y)
          the Series 2018-2 Asset Allocation Percentage of any amounts incurred by the Manager Transfer Facilitator, including those related to the actual transfer from the Manager to the Back-up Manager, and (B) to Back-up Manager, an amount equal to the
          product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) any Back-Up Manager fees then due and payable;

       

      (5)         To the Independent Management Provider, an amount
          equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) that portion of the Independent Management Provider Fees then owing;

       

      (6)         To the Persons entitled thereto, Issuer Expenses
          then due and payable, so long as the aggregate amount paid pursuant to this clause (6) in any calendar year would not exceed an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) Fifty Thousand Dollars
          ($50,000) in aggregate;

       

      (7)         To each Holder of a Class A Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class A Note Interest Payment (exclusive of any Default Fees on the Class A Notes) for such Payment Date;

       

      (8)         To each Holder of a Class B Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class B Note Interest Payment (exclusive of any Default Fees on the Class B Notes) for such Payment Date;

       

      
        30

        
          

      

      (9)         To the Series 2018-2 Restricted Cash Account, an
          amount sufficient so that the total amount on deposit in the Series 2018-2 Restricted Cash Account, is equal to the Series 2018-2 Restricted Cash Amount for such Payment Date;

       

      (10)       To each Holder of a Class A Note on the immediately
          preceding Record Date, all remaining Series 2018-2 Available Funds until the Aggregate Class A Note Principal Balance is reduced to zero;

       

      (11)       To each Holder of a Class B Note on the immediately
          preceding Record Date, all remaining Series 2018-2 Available Funds until the Aggregate Class B Note Principal Balance is reduced to zero;

       

      (12)       To each Holder of a Class A Note on the immediately
          preceding Record Date, all Default Fees on the Class A Note and all indemnities, costs, expenses and other amounts then due and payable to the Class A Noteholders pursuant to the Series 2018-2 Related Documents;

       

      (13)       To each Holder of a Class B Note on the immediately
          preceding Record Date, all Default Fees and all indemnities, costs, expenses and other amounts then due and payable to the Class B Noteholders pursuant to the Series 2018-2 Related Documents;

       

      (14)       To the Series Account for each other Series of Notes
          then Outstanding (excluding the Series 2018-2 Notes), all remaining Series 2018-2 Available Funds to be allocated to such other Series of Notes in accordance with the terms of the Series 2018-2 Supplement;

       

      (15)          On a pro rata basis (a) to the Manager Transfer
          Facilitator, any amounts due and payable to the Manager Transfer Facilitator and (b) to the Back-up Manager, any unpaid amounts due to Back-up Manager, in each case calculated after giving effect to payments remaining after clause (4) above;

       

      (16)       To the Indenture Trustee, an amount equal to the
          product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) Indenture Trustee’s Fees and indemnified amounts then due and payable to the Indenture Trustee after giving effect to the payment made pursuant to clause (1) above; provided,
          however, that to the extent such amounts have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not be divided among the Series according to the Asset Allocation Percentages;

       

      (17)       To each of the following on a pro rata basis: (i) to
          the Issuer, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments payable to the officers, directors and/or managers of the Issuer required to be made by the Issuer, and
          (ii) to the Manager, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments required to be made to the Manager;

       

      (18)       If the Aggregate Required Asset Base exceeds the
          Aggregate Asset Base (determined prior to giving effect to any deposits to the Excess Funding Account pursuant to this clause (18)), any remaining Series 2018-2 Available Funds will be deposited in the Excess Funding Account until such condition
          is remedied; and

       

      
        31

        
          

      

      (19)       To the Issuer, any remaining Series 2018-2 Available
          Funds.

       

      (III)       If an Event of Default for Series 2018-2 shall have
          occurred and then be continuing and the Series 2018-2 Notes have been accelerated in accordance with the Indenture and such consequence shall not have been rescinded or annulled:

       

      (1)         To the Indenture Trustee, an amount equal to the
          sum of (i) the fee payable to the Indenture Trustee with respect to Series 2018-2, (ii) all out of pocket expenses owing to the Indenture Trustee, and indemnification payments owing to the Indenture Trustee, to the extent directly attributable by
          the Indenture Trustee to Series 2018-2, and (iii) the product of (x) the Series 2018-2 Indenture Trustee Default Expense Allocation Percentage and (y) an amount equal to the excess of (A) all out of pocket expenses owing to the Indenture Trustee,
          and indemnification payments owing to the Indenture Trustee, to the extent not directly attributed by the Indenture Trustee to a specific Series, minus (B) all expenses and indemnification described in clause (A) that have been paid from the
          Series Account for any other Series of Notes then Outstanding; provided, however, that to the extent that the amounts in clause (iii) have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not
          be divided among the Series according to the Asset Allocation Percentages;

       

      (2)         To the Manager, an amount equal to the sum of (i)
          an amount equal to the Series 2018-2 Management Fee then due and payable with respect to the Series 2018-2 Notes, and (ii) the amount of any Management Fee Arrearage then due and payable with respect to the Series 2018-2 Notes;

       

      (3)         To the Manager, an amount equal to the product of
          (i) the Series 2018-2 Asset Allocation Percentage and (ii) any unreimbursed Manager Advances made in accordance with the terms of the Management Agreement;

       

      (4)         To each of the following on a pro rata basis: (A)
          to the Manager Transfer Facilitator, an amount equal to the product of (x) Manager Transfer Facilitator Fees, expenses and indemnities and (y) the Series 2018-2 Asset Allocation Percentage of any amounts incurred by the Manager Transfer
          Facilitator, including those related to the actual transfer from the Manager to the Back-up Manager, and (B) to Back-up Manager, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) any Back-Up Manager fees
          then due and payable;

       

      (5)         To the Independent Management Provider, an amount
          equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) that portion of the Independent Management Provider Fees then owing;

       

      (6)         To the Persons entitled thereto, Issuer Expenses
          then due and payable, so long as the aggregate amount paid pursuant to this clause (6) in any calendar year would not exceed an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) One Hundred Thousand Dollars
          ($100,000);

       

      (7)         To each Holder of a Class A Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class A Note Interest Payment (exclusive of any Default Fees on the Class A Notes) for such Payment Date;

       

      
        32

        
          

      

      (8)         To each Holder of a Class B Note on the immediately
          preceding Record Date, an amount equal to its Percentage of the Class B Note Interest Payment (exclusive of any Default Fees on the Class B Notes) for such Payment Date;

       

      (9)         To each Holder of a Class A Note on the immediately
          preceding Record Date, all remaining Series 2018-2 Available Funds until the Aggregate Class A Note Principal Balance is reduced to zero;

       

      (10)        To each Holder of a Class B Note on the immediately
          preceding Record Date, all remaining Series 2018-2 Available Funds until the Aggregate Class B Note Principal Balance is reduced to zero;

       

      (11)       To each Holder of a Class A Note on the immediately
          preceding Record Date, all Default Fees on the Class A Note and all indemnities, costs, expenses and other amounts then due and payable to the Class A Noteholder pursuant to the Series 2018-2 Related Documents;

       

      (12)       To each Holder of a Class B Note on the immediately
          preceding Record Date, all Default Fees on the Class B Notes and all indemnities, costs, expenses and other amounts then due and payable to the Class B Noteholder pursuant to the Series 2018-2 Related Documents;

       

      (13)       To the Series Account for each other Series of Notes
          then Outstanding (excluding the Series 2018-2 Notes), all remaining Series 2018-2 Available Funds to be allocated to such other Series of Notes in accordance with the methodology described in the Series 2018-2 Supplement;

       

      (14)       On a pro rata basis (a) to the Manager Transfer
          Facilitator, any amounts due and payable to the Manager Transfer Facilitator and (b) to the Back-up Manager, any unpaid amounts due to Back-up Manager, in each case calculated after giving effect to payments remaining after clause (4) above;

       

      (15)       To the Indenture Trustee, an amount equal to the
          product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) Indenture Trustee’s Fees and indemnified amounts then due and payable to the Indenture Trustee after giving effect to the payment made pursuant to clause (1) above; provided,
          however, that to the extent such amounts have been incurred solely with respect to Series 2018-2, such amounts will be paid by Series 2018-2 and will not be divided among the Series according to the Asset Allocation Percentages;

       

      (16)       To each of the following on a pro rata basis: (i) to
          the Issuer, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments payable to the officers, directors and/or managers of the Issuer required to be made by the Issuer, and
          (ii) to the Manager, an amount equal to the product of (i) the Series 2018-2 Asset Allocation Percentage and (ii) the amount of any indemnity payments required to be paid by the Manager;

       

      (17)      If the Aggregate Required Asset Base exceeds the
          Aggregate Asset Base (determined prior to giving effect to any deposits to the Excess Funding Account pursuant to this clause (17)), any remaining Series 2018-2 Available Funds will be deposited into the Excess Funding Account until such
          condition is remedied; and

       

      
        33

        
          

      

      (18)       To the Issuer, any remaining Series 2018-2 Available
          Funds.

       

      Section 305.           Allocation of Series 2018-2 Shared Available Funds.

       

      (a)          All Shared Available Funds for Series 2018-2 that
          are available for distribution to other Series of Notes shall be allocated by the Manager to all Series of Notes then Outstanding (other than the Liquidation Deficiency Series) that have a Required Payment Deficiency on such Determination Date. 
          (Allocation of Shared Available Funds for Series 2018-2 to Liquidation Deficiency Series will be in accordance with paragraph (b) of this Section 305.)  Allocations shall be made to each Series having a Required Payment Deficiency in accordance
          with the following order of priorities, with no payment being made at any level of priority until all prior priorities have been paid in full:

       

      First, to each Series that has not paid in full the
        Indenture Trustee Fees, indemnities and expenses payable by, or allocable to, such Series, the amount of such unpaid Indenture Trustee Fees, indemnities and expenses;

       

      Second, to each Series that has not paid in full the
        Management Fee and Management Fee arrearages payable by, or allocable to, such Series, the amount of such unpaid Management Fee and Management Fee Arrearages;

       

      Third, to each Series that has not paid in full the
        Manager Advances payable by, or allocable to, such Series, the amount of such unpaid Manager Advances;

       

      Fourth, to each Series that has not paid in full the
        Manager Transfer Facilitator Fees and Back-up Management Fees payable by, or allocable to, such Series, the amount of such unpaid Manager Transfer Facilitator Fees and Back-up Management Fees and any other amount due and owing to the Manager
        Transfer Facilitator;

       

      Fifth, to each Series that has not paid in full the
        Issuer Expenses payable by, or allocable to, such Series, the amount of such unpaid Issuer Expenses;

       

      Sixth, to each Series that has not paid in full all
        interest payments (excluding Default Fees) payable with respect to the senior Class of such Series and all commitment fees payable with respect to the senior Class of such Series, the amount of such unpaid interest payments and commitment fees;

       

      Seventh, to each Series that has not paid in full
        all regularly scheduled payments (excluding termination payments) owing to each Interest Rate Hedge Counterparty that has entered into an Interest Rate Hedge Agreement with respect to one or more of the senior Class of such Series, the amount of
        such unpaid regularly scheduled payments;

       

      Eighth, to each Series that has not paid in full all
        interest payments (excluding Default Fees) payable with respect to the subordinate Class of such Series and all commitment fees payable with respect to the subordinate Class of such Series, the amount of such unpaid interest payments and commitment
        fees;

       

      
        34

        
          

      

      Ninth, to each Series that has not paid in full all
        Minimum Principal Payment Amounts for the senior Class of such Series, the amount of such unpaid Minimum Principal Payment Amounts;

       

      Tenth, to each Series that has not paid in full all
        Scheduled Principal Payment Amounts for the senior Class of such Series, the amount of such unpaid Scheduled Principal Payment Amounts;

       

      Eleventh, to each Series that has not paid in full
        all Supplemental Principal Payment Amounts for the senior Class of such Series, the amount of such unpaid Supplemental Principal Payment Amounts;

       

      Twelfth, to each Series that has not paid in full
        all regularly scheduled payments (excluding termination payments) owing to each Interest Rate Hedge Counterparty that has entered into an Interest Rate Hedge Agreement with respect to the subordinate Class of such Series, the amount of such unpaid
        regularly scheduled payments;

       

      Thirteenth, to each Series that has not paid in full
        all Minimum Principal Payment Amounts for the subordinate Class of such Series, the amount of such unpaid Minimum Principal Payment Amounts;

       

      Fourteenth, to each Series that has not paid in full
        all Scheduled Principal Payment Amounts for the subordinate Class of such Series, the amount of such unpaid Scheduled Principal Payment Amounts;

       

      Fifteenth, to each Series that has not paid in full
        all Supplemental Principal Payment Amounts for the subordinate Class of such Series, the amount of such unpaid Supplemental Principal Payment Amounts;

       

      Sixteenth, to each Series that has a principal
        reserve account (or another Series Account that serves a similar purpose), the amount necessary to restore the balance in such account to the balance specified in the related Supplement;

       

      Seventeenth, (a) to the Manager Transfer
        Facilitator, any amounts due and payable to the Manager Transfer Facilitator and (b) to the Back-up Manager, any unpaid amounts due to Back-up Manager;

       

      Eighteenth, to the Indenture Trustee, any remaining
        unpaid expenses and indemnified amounts;

       

      Nineteenth, (a) to the Issuer, any unpaid
        indemnified amounts, and (b) to the Manager, any unpaid indemnified amounts; and

       

      Nineteenth, to each Series of Notes that has not
        been paid in full, all other amounts owing to the Noteholders of such Series.

       

      If more than one Series shall be entitled to a distribution pursuant to a particular priority set forth in the flow of funds set forth immediately
        above, funds shall be allocated among each such entitled Series on a pro rata basis based on the relative amount owing to each such Series pursuant to such payment priority.

       

      
        35

        
          

      

      (b)         After the application of the allocation set forth
          in the flow of funds set forth in Section 305(a) above, any remaining Shared Available Funds shall be allocated to each Liquidation Deficiency Series in accordance with the following order of priorities, with no payment being made at any level of
          priority until all prior priorities have been paid in full:

       

      First, to each Liquidation Deficiency Series that
        has not paid in full the Indenture Trustee Fees, indemnities and expenses payable by, or allocable to, such Liquidation Deficiency Series, the amount of such unpaid Indenture Trustee Fees, indemnities and expenses;

       

      Second, to each Liquidation Deficiency Series that
        has not paid in full the Management Fee and Management Fee arrearages payable by, or allocable to, such Liquidation Deficiency Series, the amount of such unpaid Management Fee and Management Fee Arrearages;

       

      Third, to each Liquidation Deficiency Series that
        has not paid in full the Manager Advances payable by, or allocable to, such Liquidation Deficiency Series, the amount of such unpaid Manager Advances;

       

      Fourth, to each Liquidation Deficiency Series that
        has not paid in full the Manager Transfer Facilitator Fees and Back-up Management Fees payable by, or allocable to, such Liquidation Deficiency Series, the amount of such unpaid Manager Transfer Facilitator Fees and Back-up Management Fees and any
        other amount due and owing to the Manager Transfer Facilitator;

       

      Fifth, to each Liquidation Deficiency Series that
        has not paid in full all interest payments (excluding Default Fees) and commitment fees payable with respect to the senior Class of such Liquidation Deficiency Series, the amount of such unpaid interest payments and commitment fees;

       

      Sixth, to each Liquidation Deficiency Series that
        has not paid in full all regularly scheduled payments (excluding termination payments) owing to each Interest Rate Hedge Counterparty that has entered into an Interest Rate Hedge Agreement with respect to such Liquidation Deficiency Series, the
        amount of such unpaid regularly scheduled payments;

       

      Seventh, to each Liquidation Deficiency Series that
        has not paid in full all Minimum Principal Payment Amounts to the senior Class of such Liquidation Deficiency Series, the amount of such unpaid Minimum Principal Payment Amounts;

       

      Eighth, to each Liquidation Deficiency Series that
        has not paid in full all Scheduled Principal Payment Amounts to the senior Class of such Liquidation Deficiency Series, the amount of such unpaid Scheduled Principal Payment Amounts;

       

      Ninth, to each Liquidation Deficiency Series that
        has not paid in full all termination and all other payments owing to each Interest Rate Hedge Counterparty that has entered into an Interest Rate Hedge Agreement with respect to such Liquidation Deficiency Series, the amount of such unpaid
        termination and other payments;

       

      
        36

        
          

      

      Tenth, to each Liquidation Deficiency Series that
        has not paid in full all Minimum Principal Payment Amounts to the subordinate Class of such Liquidation Deficiency Series, the amount of such unpaid Minimum Principal Payment Amounts; and

       

      Eleventh, to each Liquidation Deficiency Series that
        has not paid in full all Scheduled Principal Payment Amounts to the subordinate Class of such Liquidation Deficiency Series, the amount of such unpaid Scheduled Principal Payment Amounts.

       

      If more than one Liquidation Deficiency Series shall be entitled to a distribution pursuant to a particular priority set forth above, funds shall be
        allocated among each such entitled Liquidation Deficiency Series on a pro rata basis based on the relative amount owing to each such Liquidation Deficiency Series pursuant to such payment priority.

       

      (c)     All Shared Available Funds remaining after the payments
          set forth in Section 305 (a) and (b) have been paid, shall be used
          to pay, for each Series for which the Unpaid Principal Balance of, and accrued interest on, the Notes of such Series have been paid in full but for which fees, indemnities and other amounts owing to any Person, the aggregate amount of such unpaid
          fees, indemnities and other amounts.  If more than one Series are entitled to such payments, then such payments shall be allocated among such Series on a pro rata basis based on the amounts owing.

       

      ARTICLE IV

      Series-Specific Early Amortization Events, Series-Specific Manager Defaults, Series-Specific Events of Default and Covenants for the Series 2018-2 Notes

       

      Section 401.           Series-Specific Early Amortization Events.

       

      The existence of any one of the following events or conditions will constitute a “Series-Specific Early Amortization Event” for the Series 2018-2
        Notes that can be enforced by the Indenture Trustee, at the direction of, and/or waived by, the Series 2018-2 Control Party:

       

      (a)         Commencing with the thirteenth Payment Date
          following the Series 2018-2 Closing Date, the Series 2018-2 Interest Coverage Ratio is less than 2.50:1.00 for four consecutive Payment Dates; or

       

      (b)         The Manager Report delivered for any Payment Date
          indicates that the Weighted Average Age of the Eligible Containers is greater than ten (10) years; or

       

      (c)         A default shall occur governing any Indebtedness of
          CAI and/or its Subsidiaries that, individually or in the aggregate, exceeds $50,000,000, and such default continues for such period of time as would permit (assuming the giving of appropriate notice if required) the holder or holders thereof or
          of any obligations issued thereunder to accelerate the maturity of all or part of such Indebtedness, or any such holder or holders shall rescind or shall have a right to rescind the purchase of any such obligations.

       

      
        37

        
          

      

      Any Series-Specific Early Amortization Event described in the foregoing clause (a) and (b) shall, for purposes of the Series 2018-2 Related
        Documents, be deemed no longer to be continuing, if such condition does not exist on any two consecutive subsequent Payment Dates, immediately upon such second consecutive Payment Date.  Any Series-Specific Early Amortization Event described in the
        foregoing clause (c) shall, for purposes of the Series 2018-2 Related Documents, be deemed no longer to be continuing immediately upon the cure or waiver thereof for purposes of the related debt documents.  Except as described in the preceding two
        sentences, if a Series-Specific Early Amortization Event exists on any Payment Date, then such Series-Specific Early Amortization Event shall be deemed to continue until the Business Day on which the Series 2018-2 Control Party waives, in writing,
        such Series-Specific Early Amortization Event.  The Indenture Trustee shall promptly provide notice of any such waiver to each Rating Agency for the Series 2018-2 Notes.

       

      (d)         If an Early Amortization Event for Series 2018-2
          shall have occurred and then be continuing, the Indenture Trustee shall have, in addition to the rights provided in the Related Documents, all rights and remedies provided under all applicable laws.

       

      Section 402.           Series 2018-2 Manager Defaults.

       

      (a)          The existence of any one of the following events
          or conditions shall constitute a Series-Specific Manager Default with respect to the Series 2018-2 Notes:

       

      (i)             The occurrence and
          continuance of a Trust Manager Default.

       

      (ii)            The Consolidated Leverage
          Ratio of CAI and its consolidated subsidiaries as of the last day of a fiscal quarter exceeds 4.50 to 1.00;

       

      (iii)            A default shall occur
          governing any Indebtedness of CAI and/or its Subsidiaries that, individually or in the aggregate, exceeds $50,000,000, and such default continues for such period of time as would permit (assuming the giving of appropriate notice if required) the
          holder or holders thereof to accelerate the maturity of all or part of such Indebtedness, or any such holder or holders shall rescind or shall have a right to rescind the purchase of any such obligations;

       

      (iv)           A Change of Control shall
          occur unless the Rating Agency Condition is satisfied in each instance.

       

      A Series-Specific Manager Default of the type described in clause (i) above shall cease upon the cure or waiver of the Trust Manager Default in
        accordance with the Management Agreement.  A Series-Specific Manager Default of the type described in either clause (ii) or (iii) shall be cured upon the first subsequent date on which a Manager Report is delivered indicating that such condition
        does not exist on any subsequent Payment Date.  Except as set forth in the two immediately preceding sentences, any Series-Specific Manager Default shall be deemed to continue until the Business Day on which the Control Party for Series 2018-2
        waives, in writing, such Series-Specific Manager Default (and any such waiver by the Control Party for Series 2018-2 of any Series-Specific Manager Default shall be binding for purposes of all Series of Notes issued under the Indenture). The
        Indenture Trustee shall promptly provide notice of any such waiver of a Series-Specific Manager Default to each Rating Agency for the Series 2018-2 Notes.

       

      
        38

        
          

      

      (b)          The Series 2018-2 Control Party may waive any
          Series-Specific Manager Default with respect to Series 2018-2 and may amend or consent to any amendment of the provisions of Section 402(a).

       

      Section 403.           Series-Specific Events of Default.

       

      (a)          Each of the following will constitute a
          “Series-Specific Event of Default” for the Series 2018-2 Notes:

       

      (i)            Failure to pay (1) on any
          Payment Date, the full amount of the Class A Note Interest Payment and Class B Note Interest Payment on the Series 2018-2 Notes and such condition continues for three (3) Business Days, or (2) on the Series 2018-2 Legal Final Payment Date for the
          Unpaid Principal Balance for the Series 2018-2 Notes and such condition continues for three (3) Business Days;

       

      (ii)          Except as dealt with in clause
          (i) above or included as a Trust Event of Default, breach of any covenant of the Issuer or any Seller in any Series 2018-2 Related Document, which breach (1) materially and adversely affects the interest of any Series 2018-2 Noteholder, and (2)
          continues for a period of 60 days after (y) an authorized officer of the Issuer or the applicable Seller first having notice thereof, or (z) notice is received from the Indenture Trustee (to the extent a responsible officer of the Indenture
          Trustee has received written notice or actual knowledge) or a Noteholder (subject to an additional 60-day cure period for defaults that the Issuer or Seller is diligently attempting to cure);

       

      (iii)         Any representation or warranty
          of the Issuer or any Seller made in any Series 2018-2 Related Document shall prove to be incorrect in any material respect as of the time when the same shall have been made, which incorrectness (1) materially and adversely affects the interest of
          any Series 2018-2 Noteholder, and (2) if capable of cure, continues for a period of 30 days (subject to an additional 30-day cure period for defaults that the Issuer or Seller is diligently attempting to cure); or

       

      (iv)          The Indenture Trustee shall
          fail to have a first priority perfected security interest in the Series Specific Collateral for the Series 2018-2 Notes.

       

      (b)         Upon the occurrence and during the continuance of a
          Series-Specific Event of Default, the Control Party may (i) declare the Series 2018-2 Notes to be immediately due and payable, (ii) institute judicial proceedings for collection of the Series 2018-2 Notes, (iii) direct a sale of the Collateral
          (with the consent of the Requisite Global Majority if a Series-Specific Event of Default is continuing for all Series of Notes then Outstanding) or a partial sale of the Collateral (without the consent of the Requisite Global Majority) under the
          circumstances and in accordance with the terms of, and using the selection procedures set forth in, the Indenture, (iv) exercise any other remedies that may be available to the Series 2018-2 Noteholder under the Indenture or Applicable Law, and
          (v) exercise remedies with respect to the Series 2018-2 Series-Specific Collateral.

       

      
        39

        
          

      

      (c)           The Control Party may waive any Series-Specific
          Event of Default set forth in clauses (ii), (iii) and (iv) above.  Each affected Series 2018-2 Noteholder must waive a Series-Specific Event of Default of the type described in clause (c) above.  Subject to the foregoing and the restrictions set
          forth in Section 705(b), the Control Party may amend or consent to any amendment of the provisions of Section 403(a).

       

      Section 404.           Series 2018-2 Management Fee.

       

      As contemplated by the Management Agreement, the Manager shall be entitled to a management fee for Series 2018-2 for each Collection Period in an
        amount equal to the Series 2018-2 Management Fee.

       

      Section 405.           Additional Covenants.  In addition to the covenants set forth in Article VI of the Indenture, the Issuer
          hereby makes the following additional covenants for the benefit of the Series 2018-2 Noteholders:

       

      (a)         Rule 144A.  So long as any of the Series 2018-2 Notes are “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, the Issuer shall, unless it becomes subject to and complies with the
          reporting requirements of Section 13 or 15(d) of the Exchange Act, or rule 12g3-2(b) thereunder, (i) provide to any Series 2018-2 Noteholder of such restricted securities, or to any prospective Series 2018-2 Noteholder of such restricted
          securities designated by a Series 2018-2 Noteholder, upon the request of such Series 2018-2 Noteholder or prospective Series 2018-2 Noteholder, any information required to be provided by Rule 144A(d)(4) under the Securities Act and (ii) update
          such information to prevent such information from becoming materially false and materially misleading in a manner adverse to any Series 2018-2 Noteholder.

       

      (b)         Use of Proceeds.  The Issuer will apply the net proceeds from the sale of the Offered Notes: (i) to pay the purchase price of Eligible Containers to be acquired from CAL on the Closing Date, (ii) to fund the initial
          deposit into the Series 2018-2 Restricted Cash Account, (iii) to pay the costs of issuance of the Series 2018-2 Notes and (iv) for other general business purposes.

       

      (c)         Perfection Requirements.  The Issuer will not (x) change any of (i) its corporate name, (ii) the name under which it does business or (iii) the jurisdiction in which it is incorporated or (y) amend any provision of
          its memorandum of association or bye-laws, in each case, without the prior written consent of the Series 2018-2 Control Party.  The Issuer shall make such filing and take such actions as the Series 2018-2 Noteholder may request in order to
          maintain the Lien of the Indenture Trustee in the Collateral.

       

      (d)          United States Federal Income Tax Election.  The Issuer shall not make an election to be classified as an association taxable as a corporation pursuant to Section 301.7701-3 of the United States Treasury Regulations.

       

      Section 406.           Back-up Manager Event.  A Back-up Manager Default will occur with respect to Series 2018-2 if the Consolidated Leverage Ratio of CAI and its consolidated subsidiary of the last day of a fiscal
          quarter exceeds 4.25 to 1.00.

       

      
        40

        
          

      

      ARTICLE V

      Conditions to Issuance

       

      Section 501.          Conditions to Issuance.  The Indenture Trustee shall not authenticate the Series 2018-2 Notes unless the Issuer shall have delivered a certificate to the Indenture Trustee to the effect that all conditions set
          forth in the Series 2018-2 Note Purchase Agreement, other than the condition precedent set forth in Section 8(p) thereof, shall have been satisfied or waived.

       

      ARTICLE VI

      Representations and Warranties

       

      To induce the Series 2018-2 Noteholders to purchase the Series 2018-2 Notes hereunder, the Issuer hereby represents and warrants as of the Closing
        Date to the Indenture Trustee for the benefit of the Series 2018-2 Noteholders that:

       

      Section 601.           Existence.  The Issuer is a company duly incorporated, validly existing and in compliance under the laws of Bermuda.  The Issuer is in good standing and is duly qualified to do business in each
          jurisdiction where the failure to do so would have a material adverse effect upon the Issuer and in each jurisdiction in which a failure to so qualify would materially and adversely affect the ability of the Indenture Trustee to enforce its
          security interest in the Collateral.

       

      Section 602.          Authorization.  The Issuer has the necessary corporate power and is duly authorized to execute and deliver this Supplement and the other Series 2018-2 Related Documents to which it is a party; the Issuer is and
          will continue to be duly authorized to borrow monies hereunder; and the Issuer is and will continue to be authorized to perform its obligations under this Supplement and under the other Series 2018-2 Related Documents.  The execution, delivery
          and performance by the Issuer of this Supplement and the other Series 2018-2 Related Documents to which it is a party and the borrowings hereunder do not and will not require any consent or approval of any Governmental Authority, shareholder or
          any other Person which has not already been obtained.

       

      Section 603.           No Conflict; Legal Compliance.  The execution, delivery and performance of this Supplement and each of the other Series 2018-2 Related Documents and the execution, delivery and payment of the
          Series 2018-2 Notes will not: (a) contravene any provision of the Issuer’s Bye-Laws or Memorandum of Association; (b) contravene, conflict with or violate any Applicable Law or regulation, or any order, writ, judgment, injunction, decree,
          determination or award of any Governmental Authority; or (c) violate or result in the breach of, or constitute a default under the Indenture, the Series 2018-2 Related Documents, any other indenture or other loan or credit agreement, or other
          agreement or instrument to which the Issuer is a party or by which the Issuer, or its property and assets may be bound or affected. The Issuer is not in violation or breach of or default under any law, rule, regulation, order, writ, judgment,
          injunction, decree, determination or award or any contract, agreement, lease, license, indenture or other instrument to which it is a party.

       

      Section 604.           Validity and Binding Effect.  This Supplement is, and each Series 2018-2 Related Document to which the Issuer is a party, when duly executed and delivered, will be, the legal, valid and binding
          obligation of the Issuer, enforceable against the Issuer in accordance with its terms, except as enforceability may be limited by bankruptcy, insolvency or other similar laws of general application affecting the enforcement of creditors’ rights
          or by general principles of equity limiting the availability of equitable remedies.

       

      
        41

        
          

      

      Section 605.           Financial Statements.  Since December 31, 2017, there has been no Material Adverse Change in the financial
          condition of any of the Issuer, the Seller or the Manager.

       

      Section 606.           Place of Business.  The sole “place of business” (within the meaning of Section 9-307 of the UCC) of the Issuer is located at Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda.  The Issuer
          does not maintain an office or assets in the United States, other than (i) the Trust Account, the Series 2018-2 Restricted Cash Account, the Excess Funding Account, the Defaulted Lease Account and the Series 2018-2 Series Account and (ii)
          off-hire containers located in depots in the United States and Managed Containers described in Section 606(g) of the Indenture and Leases pursuant to Section 7.7 of the Management Agreement.

       

      Section 607.           No Agreements or Contracts.  The Issuer is not a party to any contract or agreement (whether written or oral) other than the Related Documents.

       

      Section 608.           Consents and Approvals.  No approval, authorization or consent of any trustee or holder of any Indebtedness or obligation of the Issuer or of any other Person under any agreement, contract, lease
          or license or similar document or instrument to which the Issuer is a party or by which the Issuer is bound, is required to be obtained by the Issuer in order to make or consummate the transactions contemplated under the Series 2018-2 Related
          Documents, except for those approvals, authorizations and consents that have been obtained on or prior to the Closing Date.  All consents and approvals of, filings and registrations with, and other actions in respect of, all Governmental
          Authorities required to be obtained by the Issuer in order to make or consummate the transactions contemplated under the Series 2018-2 Related Documents have been, or prior to the time when required will have been, obtained, given, filed or taken
          and are or will be in full force and effect.

       

      Section 609.         Margin Regulations.  The Issuer does not own any “margin security”, as that term is defined in Regulation U of the Federal Reserve Board, and the proceeds of the Series 2018-2 Notes issued under this Supplement
          will be used only for the purposes contemplated hereunder. None of such proceeds will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing or retiring any indebtedness which
          was originally incurred to purchase or carry any margin security or for any other purpose which might cause any of the loans under this Supplement to be considered a “purpose credit” within the meaning of Regulations T, U and X.  The Issuer will
          not take or permit any agent acting on its behalf to take any action which might cause this Supplement or any document or instrument delivered pursuant hereto to violate any regulation of the Federal Reserve Board.

       

      Section 610.           Taxes.  All federal, state, local and foreign Tax returns, reports and statements required to be filed by the Issuer have been filed with the appropriate Governmental Authorities, and all Taxes and
          other impositions shown thereon to be due and payable by the Issuer have been paid prior to the date on which any fine, penalty, interest or late charge may be added thereto for nonpayment thereof, or any such fine, penalty, interest, late charge
          or loss has been paid, or the Issuer is contesting its liability therefor in good faith and has fully reserved all such amounts according to GAAP in the financial statements provided to the Series 2018-2 Noteholders pursuant to Section 626 of the
          Indenture.  The Issuer has paid when due and payable all material charges upon the books of the Issuer and no Governmental Authority has asserted any Lien against the Issuer with respect to unpaid Taxes. Proper and accurate amounts have been
          withheld by the Issuer from its employees for all periods in full and complete compliance with the Tax, social security and unemployment withholding provisions of applicable federal, state, local and foreign law and such withholdings have been
          timely paid to the respective Governmental Authorities.

       

      
        42

        
          

      

    

    
      Section 611.           Investment Company Act of 1940.  The Issuer is not, and is not controlled by, an “investment company” registered or required to be registered under the Investment Company Act. The Issuer is not an
          “investment company” as defined in Section 3(a)(1) of the Investment Company Act, although other exemptions or exclusions may be available.  The Issuer is not relying on the exemptions set forth in Section 3(c)(1) or Section 3(c)(7) of the
          Investment Company Act.  The Issuer is structured so as not to constitute a “covered fund” for purposes of the Volcker Rule under the Dodd-Frank Act.

       

      Section 612.           Solvency and Separateness.

       

      (a)          The capital of the Issuer is adequate for the
          business and undertakings of the Issuer.

       

      (b)        Other than with respect to the transactions
          contemplated hereby and by the other Related Documents (including without limitation the Management Agreement and the Contribution and Sale Agreement), the Issuer is not engaged in any business transactions with the Sellers or the Manager.

       

      (c)         The bye-laws of the Issuer provide that the Issuer
          shall have three directors of which one director shall be an Independent Director (as defined in such bye-laws).  No action can be taken to institute voluntary Insolvency Proceedings on behalf of the Issuer unless such action shall have been
          approved or authorized by (x) all of the Directors (which approval shall include the Independent Director) and (y) a resolution of the Members of the Issuer representing one hundred percent (100%) of all shares of the Issuer then issued and
          outstanding.

       

      (d)         The Issuer’s funds and assets are not, and will not
          be, commingled with those of the Seller or the Manager, except as permitted by the Management Agreement.

       

      (e)         The bye-laws of the Issuer require it to maintain
          correct and complete books and records of account, and Bermuda law requires it to maintain minutes of the meetings and other proceedings of its members.

       

      (f)          The Issuer is not insolvent under the Insolvency
          Law and will not be rendered insolvent by the transactions contemplated by the Series 2018-2 Related Documents and after giving effect to such transactions, the Issuer will not be left with an unreasonably small amount of capital with which to
          engage in its business nor will the Issuer have intended to incur, or believe that it has incurred, debts beyond its ability to pay such debts as they mature.  The Issuer does not contemplate the commencement of insolvency, bankruptcy,
          liquidation or consolidation proceedings or the appointment of a receiver, liquidator, trustee or similar official in respect of the Issuer or any of its assets.

       

      
        43

        
          

      

      Section 613.           Title; Liens.  On the Closing Date, the Issuer will have good, legal and marketable title to each of its respective assets, and none of such assets is subject to any Lien, except for Permitted
          Encumbrances.

       

      Section 614.           No Default.  No Trust Event of Default, Series-Specific Event of Default, Trust Early Amortization Event, Series-Specific Early Amortization Event, Trust Manager Default, or Series-Specific Manager
          Default (or event or condition which with the giving of notice or passage of time or both would become a Trust Event of Default, Series-Specific Event of Default, Trust Early Amortization Event, Series-Specific Early Amortization Event Trust
          Manager Default, or Series-Specific Manager Default) has occurred and is continuing.

       

      Section 615.          Litigation and Contingent Liabilities.  No claims, litigation, arbitration proceedings or governmental Proceedings by any Governmental Authority are pending or threatened against or are affecting the Issuer or
          any of its Affiliates the results of which might interfere with the consummation of any of the transactions contemplated by this Supplement or any document issued or delivered in connection herewith.

       

      Section 616.           Subsidiaries.  The Issuer has no subsidiaries.

       

      Section 617.           No Partnership.  The Issuer is not a partner or joint venturer in any partnership or joint venture.

       

      Section 618.          Pension and Welfare Plans.  No accumulated funding deficiency (as defined in Section 412 of the Code or Section 302 of ERISA) or reportable event (within the meaning of section 4043 of ERISA), has occurred with
          respect to any Plan of the Issuer or any ERISA Affiliate.  The present value of all benefit liabilities under all Plans of the Issuer or any ERISA Affiliate subject to Title IV of ERISA, as defined in Section 4001(a)(16) of ERISA, exceeds the
          fair market value of all assets of Plans subject to Title IV of ERISA (determined as of the most recent valuation date for such Plan on the basis of assumptions prescribed by the Pension Benefit Guaranty Corporation for the purpose of Section
          4044 of ERISA), by no more than $1.9 million.  Neither the Issuer nor any ERISA Affiliate is subject to any present or potential withdrawal liability pursuant to Title IV of ERISA and no multi-employer plan (with the meaning of Section 4001(a)(3)
          of ERISA) to which the Issuer or any ERISA Affiliate has an obligation to contribute or any liability, is or is likely to be disqualified for Tax purposes, in reorganization within the meaning of Section 4241 of ERISA or Section 418 of the Code)
          or is insolvent (as defined in Section 4245 of ERISA).  No liability (other than liability to make periodic contributions to fund benefits) with respect to any Plan of the Issuer, or Plan subject to Title IV of ERISA or any ERISA Affiliate, has
          been, or is expected to be, incurred by the Issuer or an ERISA Affiliate, either directly or indirectly.  All Plans of the Issuer are in material compliance with ERISA and the Code.  No lien under Section 412 of the Code or 302(f) of ERISA or
          requirement to provide security under the Code or ERISA has been or is reasonably expected by the Issuer to be imposed on its assets.  The Issuer does not have any obligation under any collective bargaining agreement.  As of the Closing Date, the
          Issuer is not an employee benefit plan with the meaning of ERISA or a “plan” within the meaning of Section 4975 of the Code and assets of the Issuer do not constitute “plan assets” within the meaning of Section 2510.3-101 of the regulations of
          the Department of Labor.

       

      
        44

        
          

      

      Section 619.           Ownership of the Issuer.  As of the Closing Date, all of the shares of the Issuer are owned by Container Applications Limited, a company organized under the laws of Barbados.

       

      Section 620.           Security Interest Representations.

       

      (a)         This Supplement creates a valid and continuing
          security interest (as defined in the UCC) in the Series 2018-2 Specific Collateral in favor of the Indenture Trustee, for the benefit of the Series 2018-2 Noteholders, which security interest is prior to all other Liens (other than Permitted
          Encumbrances), and is enforceable as such as against creditors of and purchasers from the Issuer.

       

      (b)         The Managed Containers constitute “goods” or
          “inventory” within the meaning of the applicable UCC.  The Leases constitute “tangible chattel paper” within the meaning of the UCC.  The lease receivables constitute “accounts” or “proceeds” of the Leases within the meaning of the UCC.  The
          Trust Account, the Series 2018-2 Restricted Cash Account, the Excess Funding Account, the Defaulted Lease Account and the Series 2018-2 Series Account constitute “securities accounts” within the meaning of the UCC.  The Issuer’s contractual
          rights under the Contribution and Sale Agreement and the Management Agreement constitute “general intangibles” within the meaning of the UCC.

       

      (c)          The Issuer owns and has good and marketable title
          to the Collateral and the Series-Specific Collateral, free and clear of any Lien (whether senior, junior or pari passu), claim or encumbrance of any Person, except for Permitted Encumbrances.

       

      (d)        The Issuer has caused the filing of all appropriate
          financing statements or documents of similar import in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect the security interest in the Collateral and any Series-Specific Collateral granted to the
          Indenture Trustee in this Supplement and the Indenture.  All financing statements filed against the Issuer in favor of the Indenture Trustee in connection herewith describing the Collateral and any Series-Specific Collateral contain a statement
          to the following effect: “A purchase of or security interest in any collateral described in this financing statement will violate the rights of the Indenture Trustee.”

       

      (e)          Other than the security interest granted to the
          Indenture Trustee pursuant to this Supplement and the Indenture, the Issuer has not pledged, assigned, sold, granted a security interest in, or otherwise conveyed any of the Collateral and any Series-Specific Collateral, except as permitted
          pursuant to the Indenture.  The Issuer has not authorized the filing of, and is not aware of, any financing statements against the Issuer that include a description of collateral covering the Collateral and any Series-Specific Collateral other
          than any financing statement or document of similar import (i) relating to the security interest granted to the Indenture Trustee in this Supplement or the Indenture or (ii) that has been terminated.  The Issuer is not aware of any judgment or
          Tax lien filings against the Issuer.

       

      (f)          The Issuer has received a written acknowledgment
          from the Manager that the Manager or an Affiliate thereof is holding the Leases, to the extent they relate to the Managed Containers, on behalf of, and for the benefit of, the Indenture Trustee and the other Persons set forth in the Indenture. 
          None of the Leases that constitute or evidence the Collateral and any Series-Specific Collateral have any marks or notations indicating that they have been pledged, assigned or otherwise conveyed to any Person.  The Seller has caused the filing
          of all appropriate financing statements or documents of similar import in the proper filing office in the appropriate jurisdictions under Applicable Law in order to perfect the security interest of the Issuer (and the Indenture Trustee as its
          assignee) in the Leases (to the extent that such Leases relate to the Managed Containers) granted to the Issuer in the Contribution and Sale Agreement.

       

      
        45

        
          

      

      (g)         The Issuer has received all necessary consents and
          approvals required by the terms of the Collateral and any Series-Specific Collateral to the pledge to the Indenture Trustee of its interest and rights in such Collateral and any Series-Specific Collateral hereunder or under the Indenture.

       

      (h)         The Issuer has taken all steps necessary to cause
          Wells Fargo Bank, National Association (in its capacity as securities intermediary) to identify in its records the Indenture Trustee as the Person having a Securities Entitlement in each of the Trust Account, the Series 2018-2 Restricted Cash
          Account, the Excess Funding Account, the Defaulted Lease Account and the Series 2018-2 Series Account.

       

      (i)           The Trust Account, the Series 2018-2 Restricted
          Cash Account, the Excess Funding Account, the Defaulted Lease Account and Series 2018-2 Series Account are not in the name of any Person other than the Issuer or the Indenture Trustee.  The Issuer has not consented to Wells Fargo Bank, National
          Association (as the Securities Intermediary of the Trust Account, the Series 2018-2 Restricted Cash Account, the Excess Funding Account, the Defaulted Lease Account and the Series 2018-2 Series Account) entering into any agreement in which it has
          agreed to comply with entitlement orders of any Person other than the Indenture Trustee.

       

      (j)          All Eligible Investments owned by the Issuer have
          been and will have been credited to one of the Trust Account, the Excess Funding Account, the Series 2018-2 Restricted Cash Account, the Defaulted Lease Account and the Series 2018-2 Series Account.  The securities intermediary for each of the
          Trust Account, the Excess Funding Account, the Defaulted Lease Account, the Series 2018-2 Restricted Cash Account and the Series 2018-2 Series Account has agreed to treat all assets credited to the Trust Account, the Excess Funding Account, the
          Series 2018-2 Restricted Cash Account,  the Defaulted Lease Account and the Series 2018-2 Series Account as “financial assets” within the meaning of the UCC.

       

      (k)        The Issuer has delivered to Indenture Trustee a
          fully executed agreement pursuant to which the securities intermediary has agreed to comply with all instructions originated by the Indenture Trustee relating to the Trust Account, the Excess Funding Account, the Series 2018-2 Restricted Cash
          Account, the Defaulted Lease Account and the Series 2018-2 Series Account without further consent by the Issuer.

       

      (l)          No creditor of the Issuer (other than (x) with
          respect to the Managed Containers, the related Lessee and (y) the Manager in its capacity as Manager under the Management Agreement) has in its possession any goods that constitute or evidence the Collateral or any Series-Specific Collateral.

       

      
        46

        
          

      

      The falsity of any of the representations and warranties set forth in this Section
          620 may be waived by the Indenture Trustee, only with the prior written consent of the Control Party and with the prior satisfaction of the Rating Agency Condition.

       

      Section 621.           ERISA Lien.  As of the Closing Date, the Issuer has not received notice that any Lien arising under ERISA has been filed against the assets of the Issuer.

       

      Section 622.          Survival of Representations and Warranties.  So long as any of the Series 2018-2 Notes shall be Outstanding and until payment and performance in full of the Outstanding Obligations relating to the Series 2018-2
          Notes or otherwise under this Supplement, the representations and warranties contained herein shall have a continuing effect as having been true when made.

       

      ARTICLE VII

      Miscellaneous Provisions

       

      Section 701.           Ratification of Indenture.  As supplemented by this Supplement, the Indenture is in all respects ratified and confirmed and the Indenture as so supplemented by this Supplement shall be read, taken
          and construed as one and the same instrument.

       

      Section 702.          Counterparts.  This Supplement may be executed in two or more counterparts, and by different parties on separate counterparts, each of which shall be an original, but all of which shall constitute
          one and the same instrument.  Delivery of an executed counterpart of this Supplement by facsimile or by electronic means shall be equally effective as of the delivery of an originally executed counterpart.

       

      Section 703.          Governing Law.  THIS SUPPLEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE NEW YORK GENERAL OBLIGATIONS
          LAWS BUT OTHERWISE WITHOUT REFERENCE TO ITS CONFLICTS OF LAW PROVISIONS, AND THE OBLIGATIONS, RIGHTS AND REMEDIES OF THE PARTIES HEREUNDER SHALL BE DETERMINED IN ACCORDANCE WITH SUCH LAWS.

       

      Section 704.           Notices.  All demands, notices and communications hereunder shall be in writing, personally delivered, or by facsimile (with subsequent telephone confirmation of receipt thereof), or sent by
          internationally recognized overnight courier service, or, in the case of S&P Global Ratings, by email correspondence, (a) in the case of the Indenture Trustee, at the following address: MAC N9300-061, 600 S. 4th Street, Minneapolis, MN 55479;
          Attention:  Corporate Trust Services - Asset-Backed Administration, Telephone: (612) 667-8058, Facsimile: (612) 667-3464 (b) in the case of the Issuer, at the following address: Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda,
          Telephone:  (441) 295-5950, Telefax:  (441) 292-4720, Attention:  Secretary, with a copy to each:  (i) CAI at its address at 1 Market Plaza, Suite 900, San Francisco, CA 94105, Telephone:  (415) 788-0100, Telefax:  (415) 788-3430, Attention:  CEO
          & CFO, (ii) Container Applications Limited at its address at Suite 102, Bush Hill, Bay Street, St. Michael, Barbados, West Indies, Telephone:  (246) 430-5310, Telefax:  (246) 430-5312, Attention:  CEO and CFO, (c) in the case of S&P
          Global Ratings, at the following email address: servicer_reports@standardandpoors.com; for information that cannot be sent electronically, at the following address:
          S&P Global Ratings, 55 Water Street, 41st Floor, New York, New York 10041-0003, Attention: New Asset Surveillance Group, or (d) at such other address as shall be designated by such party in a written notice to the other parties.  Any notice
          required or permitted to be given to a Series 2018-2 Noteholder shall be given by certified first class mail, postage prepaid (return receipt requested), or by courier, or by facsimile, with subsequent telephone confirmation of receipt thereof,
          in each case at the address of such Series 2018-2 Noteholder as shown in the Note Register or to the telephone and fax number furnished by such Series 2018-2 Noteholder. Notice shall be effective and deemed received (A) upon receipt, if sent by
          courier or U.S. mail, (B) upon receipt of confirmation of transmission, if sent by facsimile, or (C) when delivered, if delivered by hand. Any rights to notices conveyed to a Rating Agency pursuant to the terms hereof with respect to any Series
          shall terminate immediately if such Rating Agency no longer has a rating outstanding with respect to such Series.

       

      
        47

        
          

      

      Section 705.           Amendments and Modifications.

       

      (a)         Subject to the provisions of Sections 705(b) through (e), the terms of this Supplement may be
          waived, modified or amended in accordance with the provisions of this Supplement in a written instrument signed by each of the Issuer and the Indenture Trustee. For purposes of clarification, no change in the Depreciation Policy, for purposes
          other than calculating the Asset Base, by operation of paragraph (ii) of the definition of “Depreciation Policy” shall be deemed an amendment or modification to this Supplement subject to the requirements of this Section 705.

       

      (b)         Notwithstanding Section 705(a), but subject to Section 705(d), without the consent of any Holder and based on
          an Opinion of Counsel in form and substance reasonably acceptable to the Indenture Trustee to the effect that such Supplement is for one of the purposes set forth in clauses (i) through (viii) below, the Issuer and the Indenture Trustee, at any
          time and from time to time, may enter into one or more Supplements in form satisfactory to the Indenture Trustee, for any of the following purposes:

       

      (i)             to add to the covenants of
          the Issuer in this Supplement for the benefit of the Series 2018-2 Noteholders, or to surrender any right or power conferred upon the Issuer in this Supplement;

       

      (ii)            to cure any ambiguity, to
          correct or supplement any provision in this Supplement that may be inconsistent with any other provision in this Supplement, or to make any other provisions with respect to matters or questions arising under this Supplement;

       

      (iii)          to correct or amplify the
          description of any property at any time subject to the Lien created pursuant to this Supplement, or better to assure, convey and confirm unto the Indenture Trustee any property subject or required to be subjected to the Lien created pursuant to
          this Supplement, or to subject additional property to the Lien of this Supplement;

       

      
        48

        
          

      

      (iv)           to add to the conditions,
          limitations and restrictions on the authorized amount, terms and purposes of issue, authentication and delivery of the Series 2018-2 Notes, or additional conditions, limitations and restrictions thereafter to be observed by the Issuer with
          respect to the Series 2018-2 Notes;

       

      (v)            to convey, transfer, assign,
          mortgage or pledge any additional property to the Indenture Trustee for the benefit of the Series 2018-2 Noteholders;

       

      (vi)           conform to the terms of this
          Supplement to the terms of the offering memorandum for such Series of Notes;

       

      (vii)          to decrease any component of
          the Class A Advance Rate or the Class B Advance Rate; or

       

      (viii)         to add any additional
          Series-Specific Events of Default, Series-Specific Early Amortization Events or Series-Specific Manager Defaults for the Series 2018-2 Notes.

       

      (c)         If Section 705(b) does not apply to an amendment, modification or waiver of this Supplement, then the Issuer and the Indenture Trustee (acting at the direction of, and with the consent of, the Series
          2018-2 Control Party) may enter into an amendment, modification or waiver for the purpose of adding any provisions to, or changing in any manner or eliminating any of, the provisions of this Supplement or of modifying in any manner the rights of
          the Series 2018-2 Noteholders under this Supplement; provided, however, that no such amendment, modification or waiver shall, without the consent of each
          Holder of a Series 2018-2 Note affected thereunder:

       

      (i)            reduce the principal amount of
          any Series 2018-2 Note of such Holder, lengthen the Legal Final Payment Date of any Series 2018-2 Note of such Holder, reduce the rate of interest payable on any Series 2018-2 Note of such Holder, amend the allocation methodology or payment
          priority set forth for payments from the Series 2018-2 Series Account (other than to increase the amount of any allocation) or change the date on which or the amount of which, or the place of payment where, or the coin or currency in which, any
          Series 2018-2 Note of such Holder or the interest thereon, is payable, or impair the right of such Holder to institute suit for the enforcement of any such payment on or after the Legal Final Payment Date of any Series 2018-2 Note of such Holder;

       

      (ii)            modify any provision of this
          Supplement which specifies that such provision cannot be modified or waived without the consent of each Series 2018-2 Noteholder affected thereby;

       

      (iii)           modify or alter this
          proviso;

       

      (iv)          amend the definition of “Class
          A Asset Base” or “Series 2018-2 Asset Base” (provided, however, that an amendment to the Depreciation Policy in accordance with the terms of the Indenture shall not be deemed to constitute an amendment to the definition of “Class A Asset Base” or
          “Series 2018-2 Asset Base”), “Series 2018-2 Asset Allocation Percentage”, “Series 2018-2 Required Overcollateralization Percentage” or “Control Party” or to increase either the Class A Advance Rate or the Class B Advance Rate; or

       

      
        49

        
          

      

      (v)            permit the creation of any
          Lien ranking prior to, or on a parity with, the Lien in the Series-Specific Collateral for Series 2018-2 created pursuant to this Supplement or terminate the Lien in the Series-Specific Collateral for Series 2018-2 on any property at any time
          subject to the Lien in the Series-Specific Collateral for Series 2018-2 or deprive in any material respect the Series 2018-2 Noteholders of the security afforded by the Lien in the Series-Specific Collateral for Series 2018-2, except as otherwise
          permitted in this Supplement.

       

      In addition to the foregoing, any amendment to any of the Series 2018-2 Manager Defaults, the Series 2018-2 Management Fee or the Back-up Manager
        Events shall require the prior written consent of the Manager, the Performance Guarantor and the Sub-Manager.

       

      (d)           The obligation of the Indenture Trustee to execute
          and deliver a waiver, modification or amendment with respect to this Supplement is subject to the satisfaction of all of the following conditions:

       

      (i)             the Issuer shall have given
          the Indenture Trustee and the Manager not less than two days’ notice of such amendment and a copy of such proposed amendment, it being understood that the Indenture Trustee and the Manager from time to time may waive the right to receive such
          notice;

       

      (ii)           such amendment either (A) will
          not result in a Trust Early Amortization Event or a Trust Event of Default or cause the Aggregate Required Asset Base to exceed the Aggregate Asset Base (in each case calculated after giving effect to such proposed amendment) or (B) in all other
          cases shall have been approved in accordance with the terms of the Indenture, and in either case the Issuer shall have delivered to the Indenture Trustee an Officer’s Certificate stating the foregoing;

       

      (iii)          such other conditions as shall
          be specified in such amendment; and

       

      (iv)          the Issuer shall have delivered
          to the Indenture Trustee an Officer’s Certificate that all of the conditions specified in clauses (i) through (iii) have been satisfied.

       

      (e)         The provisions of Sections 401, 402 and 403 may be waived or amended in accordance with the provisions of such Sections.

       

      (f)          Prior to the execution of any written instrument
          pursuant to this Section 705, the Issuer shall provide a written notice to the Rating Agency (if any) setting forth in general terms the substance of any
          such written instrument.

       

      (g)         Promptly after the execution by the Issuer and the
          Indenture Trustee of any written instrument pursuant to this Section 705, the Indenture Trustee shall mail to the Series 2018-2 Noteholders and the Rating
          Agency (if any) a copy of the text of such written instrument. Any failure of the Indenture Trustee to mail such copy, or any defect therein, shall not, however, in any way impair or affect the validity of any such written instrument.

       

      (h)        (i)           Any amendment or waiver of any Series-Specific Early Amortization Event, Series-Specific Manager Default or Series-Specific Event of Default in accordance with this Section 705 shall be effective for purposes of all Series of Notes (and, similarly, any amendment or waiver of any Series-Specific Early Amortization Event for any other Series of Notes,
          Series-Specific Manager Default for any other Series of Notes or Series-Specific Event of Default for any other Series of Notes in accordance with the provisions of the related Supplement shall be effective for purposes of the Series 2018-2
          Notes).

       

      
        50

        
          

      

      (ii)           Any amendment or waiver of any
          Trust Early Amortization Event, Trust Manager Default or Trust Event of Default in accordance with this Section 705 shall be effective as applied to Series
          2018-2 only (and not for purposes of any other Series of Notes), unless similarly amended or waived in accordance with the Indenture or the related Supplement for any other Series of Notes.

       

      Section 706.           Consent to Jurisdiction.  ANY LEGAL SUIT, ACTION OR PROCEEDING AGAINST THE ISSUER ARISING OUT OF OR RELATING TO THIS SUPPLEMENT, OR ANY TRANSACTION CONTEMPLATED HEREBY, MAY BE INSTITUTED IN ANY
          FEDERAL OR STATE COURT IN THE CITY OF NEW YORK, STATE OF NEW YORK AND THE ISSUER HEREBY WAIVES ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING, AND, SOLELY FOR THE PURPOSES OF
          ENFORCING THIS SUPPLEMENT, THE ISSUER HEREBY IRREVOCABLY SUBMITS TO THE NON-EXCLUSIVE JURISDICTION OF ANY SUCH COURT IN ANY SUCH SUIT, ACTION OR PROCEEDING.

       

      Section 707.         Waiver of Jury Trial.  EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, AS AGAINST THE OTHER PARTIES HERETO, ANY RIGHTS IT MAY HAVE TO A JURY TRIAL IN RESPECT OF ANY CIVIL ACTION OR PROCEEDING (WHETHER
          ARISING IN CONTRACT OR TORT OR OTHERWISE), INCLUDING ANY COUNTERCLAIM, ARISING UNDER OR RELATING TO THIS SUPPLEMENT OR ANY OTHER SERIES 2018-2 RELATED DOCUMENT, INCLUDING IN RESPECT OF THE NEGOTIATION, ADMINISTRATION OR ENFORCEMENT HEREOF OR
          THEREOF.

       

      Section 708.           Successors.  This Supplement shall inure to the benefit of and be binding upon the Issuer, the Indenture Trustee and, by its acceptance of any Series 2018-2 Note or any legal or beneficial interest
          therein, each Series 2018-2 Noteholder, and each of such Person’s successors and assigns.

       

      Section 709.         Nonpetition Covenant.  Each Series 2018-2 Noteholder by its acquisition of a Series 2018-2 Note shall be deemed to covenant and agree that it will not institute against the Issuer any bankruptcy,
          reorganization, arrangement insolvency or liquidation Proceedings, or other Proceedings under any federal or state bankruptcy or similar law, at any time other than on a date which is at least one (1) year and one (1) day after the last date on
          which any Note of any Series was Outstanding.

       

      
        51

        
          

      

      Section 710.          Recourse Against the Issuer.  No recourse under or with respect to any obligation, covenant or agreement (including, without limitation, the payment of any fees or any other obligations) of the Issuer as
          contained in this Supplement or any other agreement, instrument or document entered into by the Issuer pursuant hereto or in connection herewith shall be had against any administrator of the Issuer or any incorporator, affiliate, shareholder,
          officer, employee, manager or director of the Issuer or of any such administrator, as such, by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any statute or otherwise; it being expressly agreed and
          understood that the agreements of the Issuer contained in this Supplement and all of the other agreements, instruments and documents entered into by the Issuer pursuant hereto or in connection herewith are, in each case, solely the corporate
          obligations of the Issuer, and that no personal liability whatsoever shall attach to or be incurred by any administrator of the Issuer or any incorporator, shareholder, affiliate, officer, employee, manager or director of the Issuer or of any
          such administrator, as such, or any other of them, under or by reason of any of the obligations, covenants or agreements of the Issuer contained in this Supplement or in any other such instruments, documents or agreements, or which are implied
          therefrom, and that any and all personal liability of every such administrator of the Issuer and each incorporator, shareholder, affiliate, officer, employee, manager or director of the Issuer or of any such administrator, as such, or any of
          them, for breaches by the Issuer of any such obligations, covenants or agreements, which liability may arise either at common law or at equity, by statute or constitution, or otherwise, is hereby expressly waived as a condition of and in
          consideration for the execution of this Supplement.  The provisions of this Section 710 shall survive the termination of this Supplement.

       

      Section 711.          Reports, Financial Statements and Other Information to Series 2018-2 Noteholders.  The Indenture Trustee will make available promptly upon receipt thereof to the Series 2018-2 Noteholders via the Indenture
          Trustee’s internet website at www.CTSLink.com the financial statements referred to in Section 7.2 of the Management Agreement, the Manager Report, the Asset Base
          Report, and the annual insurance confirmation; provided, that, as a condition to access to the Indenture Trustee’s website, the Indenture Trustee shall
          require each such Series 2018-2 Noteholder to execute the Indenture Trustee’s standard form documentation, and upon such execution, each such Series 2018-2 Noteholder shall be deemed to have certified to the Indenture Trustee it (i) is a Series
          2018-2 Noteholder, (ii) understands that such items contain material nonpublic information (within the meaning of U.S. Federal Securities laws), (iii) is requesting the information solely for use in evaluating such party’s investment in the
          Series 2018-2 Notes and will keep such information strictly confidential (with such exceptions and restrictions to distribution of the information as are more fully set forth in the information request certification) and (iv) is not a Competitor.
          Each time a Series 2018-2 Noteholder accesses the internet website, it will be deemed to have confirmed the representations and warranties made pursuant to the confirmation as of the date of such access. The Indenture Trustee will provide the
          Issuer with copies of such information request certification. Assistance in using the Indenture Trustee’s website can be obtained by calling the Indenture Trustee’s customer service desk at (866) 846-4526.  The Indenture Trustee makes no
          representation or warranty as to the accuracy of such documents and assumes no responsibility.

       

      Section 712.          Patriot Act.  The parties hereto acknowledge that in accordance with the Customer Identification Program (CIP) requirements under the USA PATRIOT Act and its implementing regulations, the Indenture Trustee in
          order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Indenture Trustee. 
          Each party hereby agrees that it shall provide the Indenture Trustee with such information as the Indenture Trustee may request that will help Indenture Trustee to identify and verify each party's identity, including without limitation each
          party's name, physical address, tax identification number, organizational documents, certificate of good standing, license to do business, or other pertinent identifying information.

       

      
        52

        
          

      

      Section 713.           Definitive Notes.  To the extent that Definitive Notes are issued hereunder, each relevant Series 2018-2 Noteholder provide Noteholder Tax Identification Information (including, if requested, a
          transfer statement in accordance with Treasury Regulation section 1.6045A-1(a)(1)) requested by the Indenture Trustee to comply with its cost basis reporting obligations under the Code.  Each Noteholder or holder of an interest in a Note, by
          acceptance of such Series 2018-2 Note or such interest in such Series 2018-2 Note, will be deemed to have agreed to provide the Issuer and the Indenture Trustee with such Noteholder Tax Identification Information referred to in the preceding
          sentence as requested from time to time by the Issuer or the Indenture Trustee.

       

      Section 714.           Noteholder Information.  Each Noteholder or holder of an interest in a Series 2018-2 Note, by acceptance of such Series 2018-2 Note or such interest in such Series 2018-2 Note, will be deemed to
          have agreed to provide the Issuer and the Indenture Trustee with such Noteholder Tax Identification Information as requested from time to time by the Issuer or the Indenture Trustee.  Each Noteholder or holder of an interest in a Series 2018-2
          Note will be deemed to understand that each of the Issuer and the Indenture Trustee has the right to (i) withhold tax (including, without limitation, FATCA Withholding Tax) on interest and other applicable amounts under the Code (without any
          corresponding gross-up) payable with respect to each holder of a Series 2018-2 Note, or to any beneficial owner of an interest in a Series 2018-2 Note, that fails to comply with the foregoing requirements, fails to establish an exemption of such
          withholding or as otherwise required under the Code or other Applicable Law (including, for the avoidance of doubt, FATCA) and (ii) provide such information and documentation and any other information concerning its interest in the applicable
          Series 2018-2 Note to the IRS and any other relevant U.S. or foreign tax authority. Upon request from the Indenture Trustee, the Issuer will provide such additional information that it may have to assist the Indenture Trustee in making any
          withholdings or informational reports.

       

      [Signature pages follow]

       

      
        53

        
          

      

      
        IN WITNESS WHEREOF, the Issuer and the Indenture Trustee have caused this Supplement to be duly executed and delivered by their
          respective officers all as of the day and year first above written.

         

        	 	
                CAL FUNDING III LIMITED

              
	 	 
	 	By:	
                /s/ Timothy B. Page

              

        	 	 	 
	 	Name:	
                Timothy B. Page

              
	 	 	 
	 	Title:	
                Chief Financial Officer

              

         
          Series 2018-2 Supplement

           

          

        

        
          
            

        

        	 	
                WELLS FARGO BANK, NATIONAL 

                ASSOCIATION, as Indenture Trustee

              
	 	 
	 	
                By:

              	
                /s/ G. Brad Martin

              

        	 	 	 
	 	
                Name:

              	
                G. Brad Martin

              
	 	 	 
	 	
                Title:

              	
                Vice President

              

         
          Series 2018-2 Supplement

           

          

        

        
          
            

        

        	
                Acknowledged by:

              	
                CONTAINER APPLICATIONS LIMITED,

              
	 	
                as Manager

              
	 	 	 
	
                

                

              	By:	
                /s/ Timothy B. Page

              

        	 	 	 
	 	
                Name:

              	
                Timothy B. Page

              
	 	 	 
	 	
                Title:

              	
                Chief Financial Officer

              

        

        

        	
                Acknowledged by:

              	
                CAI INTERNATIONAL INC.,

              
	 	
                as Performance Guarantor and Sub-Manager

              
	 	 	 
	 	
                By:

              	
                /s/ Timothy B. Page

              

        	 	 	 
	 	
                Name:

              	
                Timothy B. Page

              
	 	 	 
	 	
                Title:

              	
                Chief Financial Officer

              

         
          Series 2018-2 Supplement

           

          

        

        
          
            

        

        

    

    
      EXHIBIT A-1

       

      FORM OF 144A BOOK-ENTRY NOTE

      

      

      UNLESS THIS SERIES 2018-2 NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE
        TRANSFEROR OF SUCH NOTE (THE “TRANSFEROR”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SERIES 2018-2 NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
        REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR THE USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH
        AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

       

      
        THIS SERIES 2018-2 NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THE HOLDER HEREOF, BY
          PURCHASING THIS SERIES 2018-2 NOTE, AGREES THAT SUCH SERIES 2018-2 NOTE MAY BE RESOLD, PLEDGED OR TRANSFERRED ONLY IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS AND (1) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE
          SECURITIES ACT (“RULE 144A”), TO A PERSON THAT TAKES DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND THAT THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT (OR FOR THE
          ACCOUNT OR ACCOUNTS OF A QUALIFIED INSTITUTIONAL BUYER) AND TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, OR (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF
          REGULATION S UNDER THE SECURITIES ACT WITH SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 OR (3) TO A PERSON (A) THAT IS AN INSTITUTIONAL “ACCREDITED INVESTOR,” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D
          UNDER THE SECURITIES ACT, IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND DELIVERS TO THE INDENTURE TRUSTEE A LETTER SUBSTANTIALLY IN THE FORM OF EXHIBIT C TO THE INDENTURE OR (B) THAT IS TAKING DELIVERY OF
          SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 PURSUANT TO A TRANSACTION THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND FROM ANY APPLICABLE STATE LAW SECURITIES REGISTRATION OR QUALIFICATION
          REQUIREMENTS, AS CONFIRMED IN AN OPINION OF COUNSEL ADDRESSED TO THE INDENTURE TRUSTEE AND THE ISSUER, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE ISSUER AND THE INDENTURE TRUSTEE.

      

       

      
        1

        
          

      

      EACH PURCHASER AND TRANSFEREE (AND ITS FIDUCIARY, IF APPLICABLE) OF A SERIES 2018-2 NOTE (OR INTEREST HEREIN) WILL BE DEEMED TO REPRESENT AND
        WARRANT THAT EITHER (I) IT IS NOT ACQUIRING AND WILL NOT HOLD THE SERIES 2018-2 NOTE WITH THE PLAN ASSETS OF AN “EMPLOYEE BENEFIT PLAN” AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), WHICH
        IS SUBJECT TO THE PROVISIONS OF TITLE I OF ERISA, A “PLAN” DESCRIBED IN AND SUBJECT TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” OF ANY OF THE FOREGOING BY
        REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY (EACH OF THE FOREGOING, A “BENEFIT PLAN”) OR ANY OTHER PLAN THAT IS SUBJECT TO A LAW THAT IS SIMILAR TO TITLE I OF ERISA OR SECTION 4975 OF THE CODE OR (II) (A) THE SERIES
        2018-2 NOTES ARE RATED INVESTMENT GRADE OR BETTER AND HAVE NOT BEEN CHARACTERIZED AS OTHER THAN INDEBTEDNESS FOR APPLICABLE LOCAL LAW PURPOSES AND (B) THE ACQUISITION, HOLDING AND DISPOSITION OF THE SERIES 2018-2 NOTE WILL NOT GIVE RISE TO A
        NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA, SECTION 4975 OF THE CODE OR A VIOLATION OF ANY SIMILAR APPLICABLE LAW.

       

      THIS SERIES 2018-2 NOTE IS NOT GUARANTEED OR INSURED BY ANY GOVERNMENTAL AGENCY OR INSTRUMENTALITY.

       

      
        2

        
          

      

    

    
      CAL FUNDING III LIMITED

      FIXED RATE ASSET-BACKED NOTES, SERIES 2018-2, [CLASS A][CLASS B]

      

      

      	
              $[XX]

            	
              CUSIP No.:      _____________

            
	 	
              No. 1

            
	 	
              _____________ ___, 20___

            

      

      

      KNOW ALL PERSONS BY THESE PRESENTS that CAL Funding III Limited, a company incorporated under the laws of Bermuda (the “Issuer”), for value received, hereby promises to pay to Cede & Co., or its registered assigns, at the principal corporate trust office of the Indenture Trustee named below, (i) the
        principal sum of up to XX.00 Dollars ($XX.00), which sum shall be payable on the dates and in the amounts set forth in the Indenture, dated as of July 6, 2017 (as amended, restated, supplemented or otherwise modified from time to time in accordance
        with its terms, the “Indenture”), and the Series 2018-2 Supplement, dated as of September __, 2018 (as amended, restated, supplemented or otherwise modified from time to
        time in accordance with its terms, the “Series 2018-2 Supplement”), each between the Issuer and Wells Fargo Bank, National Association, as indenture trustee (the “Indenture Trustee”), and (ii) interest on the outstanding principal amount of this Series 2018-2 Note on the dates and in the amounts set forth in the Indenture and the Series
        2018-2 Supplement.  Capitalized terms not otherwise defined herein will have the meaning set forth in the Indenture and the Series 2018-2 Supplement.

       

      Payment of the principal of and interest on this Series 2018-2 Note shall be made in lawful money of the United States of America which at the time
        of payment is legal tender for payment of public and private debts.  The principal balance of, and interest on this Series 2018-2 Note is payable at the times and in the amounts set forth in the Indenture and the Series 2018-2 Supplement by wire
        transfer of immediately available funds to the account designated by the Holder of record on the immediately preceding Record Date.

       

      This Series 2018-2 Note is one of the authorized Notes identified in the title hereto and issued in the aggregate principal amount of up to [  ]
        Dollars ($[  ]) pursuant to the Indenture and the Series 2018-2 Supplement.

       

      The Notes shall be an obligation of the Issuer and shall be secured by the Collateral, all as defined in, and subject to limitations set forth in,
        the Indenture and the Series 2018-2 Supplement.

       

      This Series 2018-2 Note is transferable as provided in the Indenture and the Series 2018-2 Supplement, subject to certain limitations therein
        contained, only upon the books for registration and transfer kept by the Indenture Trustee, and only upon surrender of this Series 2018-2 Note for transfer to the Indenture Trustee duly endorsed by, or accompanied by a written instrument of
        transfer in form reasonably satisfactory to the Indenture Trustee duly executed by, the registered Holder hereof or his attorney duly authorized in writing.  The Indenture Trustee or the Issuer may require payment by the Holder of a sum sufficient
        to cover any tax expense or other governmental charge payable in connection with any transfer or exchange of the Notes.

       

      
        3

        
          

      

    

    
      The Issuer, the Indenture Trustee and any other agent of the Issuer may treat the Person in whose name this Series 2018-2 Note is registered as the
        absolute owner hereof for all purposes, and neither the Issuer, the Indenture Trustee, nor any other such agent shall be affected by notice to the contrary.

       

      The Notes are subject to Prepayment, at the times and subject to the conditions set forth in the Indenture and the Series 2018-2 Supplement.

       

      If an Event of Default shall occur and be continuing, the principal of and accrued interest on this Series 2018-2 Note may be declared to be due and
        payable in the manner and with the effect provided in the Indenture and the Series 2018-2 Supplement.

       

      The Indenture permits, with certain exceptions as therein provided, the issuance of supplemental indentures with the consent of the Requisite Global
        Majority, in certain specifically described instances.  Any consent given by the Requisite Global Majority shall be conclusive and binding upon the Holder of this Series 2018-2 Note and on all future holders of this Series 2018-2 Note and of any
        Note issued in lieu hereof whether or not notation of such consent is made upon this Series 2018-2 Note.  Supplements and amendments to the Indenture and the Series 2018-2 Supplement may be made only to the extent and in circumstances permitted by
        the Indenture and the Series 2018-2 Supplement.

       

      The Holder of this Series 2018-2 Note shall have no right to enforce the provisions of the Indenture and the Series 2018-2 Supplement or to
        institute action to enforce the covenants, or to take any action with respect to a default under the Indenture and the Series 2018-2 Supplement, or to institute, appear in or defend any suit or other Proceedings with respect thereto, except as
        provided under certain circumstances described in the Indenture and the Series 2018-2 Supplement; provided, however, that nothing contained in the Indenture and the Series 2018-2 Supplement shall affect or impair any right of enforcement conferred
        on the Holder hereof to enforce any payment of the principal of and interest on this Series 2018-2 Note on or after the due date thereof; provided further, however, that by acceptance hereof the Holder is deemed to have covenanted and agreed that
        it will not institute against the Issuer any bankruptcy, reorganization, arrangement, insolvency or liquidation Proceedings, or other Proceedings under any applicable bankruptcy or similar law, at any time other than at such time as permitted by
        Section 1310 of the Indenture and the Series 2018-2 Supplement.

       

      Each purchaser and transferee of a Series 2018-2 Note will be deemed to represent and warrant that either (i) it is not acquiring and will not hold
        the Series 2018-2 Note with the plan assets of an “employee benefit plan” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which is subject to the provisions of Title I of ERISA, a “plan”
        described in and subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), an entity whose underlying assets include “plan assets” of any of the foregoing by reason of an employee benefit plan’s or plan’s investment in
        such entity (each of the foregoing, a “Plan”), or any other plan that is subject to a law that is similar to Title I of ERISA or Section 4975 of the Code or (ii) (a) the Series 2018-2 Notes are rated investment grade or better and have not been
        characterized as other than indebtedness for applicable local law purposes and (b) the acquisition, holding and disposition of the Series 2018-2 Note will not give rise to a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975
        of the Code or a violation of any similar applicable law.

       

      
        4

        
          

      

      Each Holder of a Series 2018-2 Note (i) agrees to treat this Series 2018-2 Note for United States federal, state and local income, single business
        and franchise tax purposes as indebtedness, (ii) agrees that the Series 2018-2 Note shall not have any interest in any Series Account of any other Series or Class and (iii) ratifies and confirms the terms of the Indenture and the other Series
        2018-2 Related Documents.

       

      This Series 2018-2 Note, and the rights and obligations of the parties hereunder, shall be governed by, and construed and interpreted in accordance
        with, the laws of the State of New York without giving effect to the principles of conflict of laws thereof (other than Section 5-1401 of the New York General Obligations Law) that would permit or require the application of the law of any other
        jurisdiction.

       

      All terms and provisions of the Indenture and the Series 2018-2 Supplement are herein incorporated by reference as if set forth herein in their
        entirety.  To the extent any provision of this Series 2018-2 Note conflicts or is inconsistent with the provisions of the Indenture or the Series 2018-2 Supplement, the provisions of the Indenture or Series 2018-2 Supplement, as applicable, shall
        govern and be controlling.

       

      IT IS HEREBY CERTIFIED, RECITED AND DECLARED, that all acts, conditions and things required to exist, happen and be performed precedent to the
        execution and delivery of the Indenture and the Series 2018-2 Supplement and the issuance of this Series 2018-2 Note and the issue of which it is a part, do exist, have happened and have been timely performed in regular form and manner as required
        by law.

       

      Unless the certificate of authentication hereon has been executed by the Indenture Trustee by manual signature of one of its authorized officers,
        this Series 2018-2 Note shall not be entitled to any benefit under the Indenture and the Series 2018-2 Supplement, or be valid or obligatory for any purpose.

       

      
        5

        
          

      

      IN WITNESS WHEREOF, CAL FUNDING III LIMITED has caused this Series 2018-2 Note to be duly executed by its duly authorized representative, on this __
        day of February 2018.

       

      	 	
              CAL FUNDING III LIMITED

            
	 	 	 
	 	
              By:

            	 
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      This Series 2018-2 Note is one of the Notes described in the within-mentioned Indenture and the Series 2018-2 Supplement.

       

      	
              WELLS FARGO BANK, NATIONAL ASSOCIATION,

            
	
              as Indenture Trustee

            
	 	 	 
	
              By:

            	 	 
	 	
              Name:

            	 
	 	
              Title:

            	 

       

      
        
          

      

      
      
        EXHIBIT A-2

         

        FORM OF REGULATION S TEMPORARY BOOK-ENTRY NOTE

        

        

        UNLESS THIS SERIES 2018-2 NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO
          THE TRANSFEROR OF SUCH NOTE (THE “TRANSFEROR”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SERIES 2018-2 NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
          REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR THE USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL
          INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

         

        THIS SERIES 2018-2 NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THE HOLDER HEREOF, BY
          PURCHASING THIS SERIES 2018-2 NOTE, AGREES THAT SUCH SERIES 2018-2 NOTE MAY BE RESOLD, PLEDGED OR TRANSFERRED ONLY IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS AND (1) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE
          SECURITIES ACT (“RULE 144A”), TO A PERSON THAT TAKES DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND THAT THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT (OR FOR THE
          ACCOUNT OR ACCOUNTS OF A QUALIFIED INSTITUTIONAL BUYER) AND TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, OR (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF
          REGULATION S UNDER THE SECURITIES ACT WITH SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 OR (3) TO A PERSON (A) THAT IS AN INSTITUTIONAL “ACCREDITED INVESTOR,” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D
          UNDER THE SECURITIES ACT, IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND DELIVERS TO THE INDENTURE TRUSTEE A LETTER SUBSTANTIALLY IN THE FORM OF EXHIBIT C TO THE INDENTURE OR (B) THAT IS TAKING DELIVERY OF
          SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 PURSUANT TO A TRANSACTION THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND FROM ANY APPLICABLE STATE LAW SECURITIES REGISTRATION OR QUALIFICATION
          REQUIREMENTS, AS CONFIRMED IN AN OPINION OF COUNSEL ADDRESSED TO THE INDENTURE TRUSTEE AND THE ISSUER, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE ISSUER AND THE INDENTURE TRUSTEE.

         

        
          1

          
            

        

        EACH PURCHASER AND TRANSFEREE (AND ITS FIDUCIARY, IF APPLICABLE) OF A SERIES 2018-2 NOTE (OR INTEREST HEREIN) WILL BE DEEMED TO REPRESENT AND
          WARRANT THAT EITHER (I) IT IS NOT ACQUIRING AND WILL NOT HOLD THE SERIES 2018-2 NOTE WITH THE PLAN ASSETS OF AN “EMPLOYEE BENEFIT PLAN” AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), WHICH
          IS SUBJECT TO THE PROVISIONS OF TITLE I OF ERISA, A “PLAN” DESCRIBED IN AND SUBJECT TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” OF ANY OF THE FOREGOING BY
          REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY (EACH OF THE FOREGOING, A “BENEFIT PLAN”) OR ANY OTHER PLAN THAT IS SUBJECT TO A LAW THAT IS SIMILAR TO TITLE I OF ERISA OR SECTION 4975 OF THE CODE OR (II) (A) THE SERIES
          2018-2 NOTES ARE RATED INVESTMENT GRADE OR BETTER AND HAVE NOT BEEN CHARACTERIZED AS OTHER THAN INDEBTEDNESS FOR APPLICABLE LOCAL LAW PURPOSES AND (B) THE ACQUISITION, HOLDING AND DISPOSITION OF THE SERIES 2018-2 NOTE WILL NOT GIVE RISE TO A
          NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA, SECTION 4975 OF THE CODE OR A VIOLATION OF ANY SIMILAR APPLICABLE LAW.

         

        EACH INVESTOR THAT IS A PERSON WHO IS NOT A U.S. PERSON AND TO WHOM THE OFFER AND SALE OF THE SERIES 2018-2 NOTES MAY BE MADE WITHOUT REGISTRATION
          UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S (“PERMITTED NON-U.S. PERSON”) UNDERSTANDS THAT THE SERIES 2018-2 NOTES HAVE NOT AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT, THAT ANY OFFERS, SALES OR DELIVERIES OF THE SERIES 2018-2
          NOTES PURCHASED BY IT IN THE UNITED STATES OR TO U.S. PERSONS PRIOR TO THE DATE THAT IS 40 DAYS AFTER THE LATER OF (I) THE COMMENCEMENT OF THE DISTRIBUTION OF THE SERIES 2018-2 NOTES AND (II) THE CLOSING DATE, MAY CONSTITUTE A VIOLATION OF UNITED
          STATES LAW, AND THAT DISTRIBUTIONS OF PRINCIPAL AND INTEREST WILL BE MADE IN RESPECT OF SUCH SERIES 2018-2 NOTES ONLY FOLLOWING THE DELIVERY BY THE HOLDER OF A CERTIFICATION OF NON-U.S. BENEFICIAL OWNERSHIP OR THE EXCHANGE OF BENEFICIAL INTEREST
          IN REGULATION S TEMPORARY BOOK-ENTRY NOTES FOR BENEFICIAL INTERESTS IN THE RELATED UNRESTRICTED BOOK-ENTRY NOTES (WHICH IN EACH CASE WILL ITSELF REQUIRE A CERTIFICATION OF NON-U.S. BENEFICIAL OWNERSHIP), AT THE TIMES AND IN THE MANNER SET FORTH
          IN THE INDENTURE AND THE SUPPLEMENT.

         

        THIS SERIES 2018-2 NOTE HAS NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
          AND, PRIOR TO THE DATE THAT IS 40 DAYS AFTER THE LATER OF (I) THE COMPLETION OF THE DISTRIBUTION OF THE SERIES 2018-2 NOTES AND (II) THE CLOSING DATE, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR TO A U.S.
          PERSON EXCEPT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

         

        THIS SERIES 2018-2 NOTE IS NOT GUARANTEED OR INSURED BY ANY GOVERNMENTAL AGENCY OR INSTRUMENTALITY.

         

        
          2

          
            

        

      

    

    
      CAL FUNDING III LIMITED

      FIXED RATE ASSET-BACKED NOTES, SERIES 2018-2, [CLASS A][CLASS B]

       

      

      
        	
                $[XX]

                

              	
                CUSIP No.: _____________

              
	
                 

              	
                
                  No. 1

                

              
	 	
                _____________ ___, 20___

              

      

      

      

      KNOW ALL PERSONS BY THESE PRESENTS that CAL Funding III Limited, a company incorporated under the laws of Bermuda (the “Issuer”), for value received, hereby promises to pay to Cede & Co., or its registered assigns, at the principal corporate trust office of the Indenture Trustee named below, (i) the
        principal sum of up to XX Dollars ($XX.00), which sum shall be payable on the dates and in the amounts set forth in the Indenture, dated as of July 6, 2017 (as amended, restated, supplemented or otherwise modified from time to time in accordance
        with its terms, the “Indenture”), and the Series 2018-2 Supplement, dated as of September __, 2018 (as amended, restated, supplemented or otherwise modified from time to
        time in accordance with its terms, the “Series 2018-2 Supplement”), each between the Issuer and Wells Fargo Bank, National Association, as indenture trustee (the “Indenture Trustee”), and (ii) interest on the outstanding principal amount of this Series 2018-2 Note on the dates and in the amounts set forth in the Indenture and the Series
        2018-2 Supplement.  Capitalized terms not otherwise defined herein will have the meaning set forth in the Indenture and the Series 2018-2 Supplement.

       

      Payment of the principal of and interest on this Series 2018-2 Note shall be made in lawful money of the United States of America which at the time
        of payment is legal tender for payment of public and private debts.  The principal balance of, and interest on this Series 2018-2 Note is payable at the times and in the amounts set forth in the Indenture and the Series 2018-2 Supplement by wire
        transfer of immediately available funds to the account designated by the Holder of record on the immediately preceding Record Date.

       

      This Series 2018-2 Note is one of the authorized Notes identified in the title hereto and issued in the aggregate principal amount of up to [  ]
        Dollars ($[  ]) pursuant to the Indenture and the Series 2018-2 Supplement.

       

      The Notes shall be an obligation of the Issuer and shall be secured by the Collateral, all as defined in, and subject to limitations set forth in,
        the Indenture and the Series 2018-2 Supplement.

       

      This Series 2018-2 Note is transferable as provided in the Indenture and the Series 2018-2 Supplement, subject to certain limitations therein
        contained, only upon the books for registration and transfer kept by the Indenture Trustee, and only upon surrender of this Series 2018-2 Note for transfer to the Indenture Trustee duly endorsed by, or accompanied by a written instrument of
        transfer in form reasonably satisfactory to the Indenture Trustee duly executed by, the registered Holder hereof or his attorney duly authorized in writing.  The Indenture Trustee or the Issuer may require payment by the Holder of a sum sufficient
        to cover any tax expense or other governmental charge payable in connection with any transfer or exchange of the Notes.

       

      
        3

        
          

      

      The Issuer, the Indenture Trustee and any other agent of the Issuer may treat the Person in whose name this Series 2018-2 Note is registered as the
        absolute owner hereof for all purposes, and neither the Issuer, the Indenture Trustee, nor any other such agent shall be affected by notice to the contrary.

       

      The Notes are subject to Prepayment, at the times and subject to the conditions set forth in the Indenture and the Series 2018-2 Supplement.

       

      If an Event of Default shall occur and be continuing, the principal of and accrued interest on this Series 2018-2 Note may be declared to be due and
        payable in the manner and with the effect provided in the Indenture and the Series 2018-2 Supplement.

       

      The Indenture permits, with certain exceptions as therein provided, the issuance of supplemental indentures with the consent of the Requisite Global
        Majority, in certain specifically described instances.  Any consent given by the Requisite Global Majority shall be conclusive and binding upon the Holder of this Series 2018-2 Note and on all future holders of this Series 2018-2 Note and of any
        Note issued in lieu hereof whether or not notation of such consent is made upon this Series 2018-2 Note.  Supplements and amendments to the Indenture and the Series 2018-2 Supplement may be made only to the extent and in circumstances permitted by
        the Indenture and the Series 2018-2 Supplement.

       

      The Holder of this Series 2018-2 Note shall have no right to enforce the provisions of the Indenture and the Series 2018-2 Supplement or to
        institute action to enforce the covenants, or to take any action with respect to a default under the Indenture and the Series 2018-2 Supplement, or to institute, appear in or defend any suit or other Proceedings with respect thereto, except as
        provided under certain circumstances described in the Indenture and the Series 2018-2 Supplement; provided, however, that nothing contained in the Indenture and the Series 2018-2 Supplement shall affect or impair any right of enforcement conferred
        on the Holder hereof to enforce any payment of the principal of and interest on this Series 2018-2 Note on or after the due date thereof; provided further, however, that by acceptance hereof the Holder is deemed to have covenanted and agreed that
        it will not institute against the Issuer any bankruptcy, reorganization, arrangement, insolvency or liquidation Proceedings, or other Proceedings under any applicable bankruptcy or similar law, at any time other than at such time as permitted by
        Section 1310 of the Indenture and the Series 2018-2 Supplement.

       

      Each purchaser and transferee of a Series 2018-2 Note will be deemed to represent and warrant that either (i) it is not acquiring and will not hold
        the Series 2018-2 Note with the plan assets of an “employee benefit plan” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which is subject to the provisions of Title I of ERISA, a “plan”
        described in and subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), an entity whose underlying assets include “plan assets” of any of the foregoing by reason of an employee benefit plan’s or plan’s investment in
        such entity (each of the foregoing, a “Plan”), or any other plan that is subject to a law that is similar to Title I of ERISA or Section 4975 of the Code or (ii) (a) the Series 2018-2 Notes are rated investment grade or better and have not been
        characterized as other than indebtedness for applicable local law purposes and (b) the acquisition, holding and disposition of the Series 2018-2 Note will not give rise to a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975
        of the Code or a violation of any similar applicable law.

       

      
        4

        
          

      

      Each Holder of a Series 2018-2 Note (i) agrees to treat this Series 2018-2 Note for United States federal, state and local income, single business
        and franchise tax purposes as indebtedness, (ii) agrees that the Series 2018-2 Note shall not have any interest in any Series Account of any other Series or Class and (iii) ratifies and confirms the terms of the Indenture and the other Series
        2018-2 Related Documents.

       

      This Series 2018-2 Note, and the rights and obligations of the parties hereunder, shall be governed by, and construed and interpreted in accordance
        with, the laws of the State of New York without giving effect to the principles of conflict of laws thereof (other than Section 5-1401 of the New York General Obligations Law) that would permit or require the application of the law of any other
        jurisdiction.

       

      All terms and provisions of the Indenture and the Series 2018-2 Supplement are herein incorporated by reference as if set forth herein in their
        entirety.  To the extent any provision of this Series 2018-2 Note conflicts or is inconsistent with the provisions of the Indenture or the Series 2018-2 Supplement, the provisions of the Indenture or Series 2018-2 Supplement, as applicable, shall
        govern and be controlling.

       

      IT IS HEREBY CERTIFIED, RECITED AND DECLARED, that all acts, conditions and things required to exist, happen and be performed precedent to the
        execution and delivery of the Indenture and the Series 2018-2 Supplement and the issuance of this Series 2018-2 Note and the issue of which it is a part, do exist, have happened and have been timely performed in regular form and manner as required
        by law.

       

      Unless the certificate of authentication hereon has been executed by the Indenture Trustee by manual signature of one of its authorized officers,
        this Series 2018-2 Note shall not be entitled to any benefit under the Indenture and the Series 2018-2 Supplement, or be valid or obligatory for any purpose.

       

      
        5

        
          

      

      IN WITNESS WHEREOF, CAL FUNDING III LIMITED has caused this Series 2018-2 Note to be duly executed by its duly authorized representative, on this __
        day of February 2018.

       

      	
               

            	
              CAL FUNDING III LIMITED

            
	
               

            	
               

            	
               

            
	
               

            	
              By:

            	
               

            
	
               

            	
              Name:

            	
               

            
	
               

            	
              Title:

            	
               

            

      

      

      This Series 2018-2 Note is one of the Notes described in the within-mentioned Indenture and the Series 2018-2 Supplement.

       

      	
              WELLS FARGO BANK, NATIONAL ASSOCIATION,

            
	
              as Indenture Trustee

            
	 	 	 
	
              By:

            	 	 
	 	
              Name:

            	 
	 	
              Title:

            	 

       

      
        
          

      

      

    
      EXHIBIT A-3

       

      FORM OF UNRESTRICTED BOOK-ENTRY NOTE

      

      

      UNLESS THIS SERIES 2018-2 NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE
        TRANSFEROR OF SUCH NOTE (THE “TRANSFEROR”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SERIES 2018-2 NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
        REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR THE USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH
        AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

       

      THIS SERIES 2018-2 NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THE HOLDER HEREOF, BY
        PURCHASING THIS SERIES 2018-2 NOTE, AGREES THAT SUCH SERIES 2018-2 NOTE MAY BE RESOLD, PLEDGED OR TRANSFERRED ONLY IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS AND (1) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE
        SECURITIES ACT (“RULE 144A”), TO A PERSON THAT TAKES DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND THAT THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT (OR FOR THE
        ACCOUNT OR ACCOUNTS OF A QUALIFIED INSTITUTIONAL BUYER) AND TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, OR (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF
        REGULATION S UNDER THE SECURITIES ACT WITH SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 OR (3) TO A PERSON (A) THAT IS AN INSTITUTIONAL “ACCREDITED INVESTOR,” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER
        THE SECURITIES ACT, IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND DELIVERS TO THE INDENTURE TRUSTEE A LETTER SUBSTANTIALLY IN THE FORM OF EXHIBIT C TO THE INDENTURE OR (B) THAT IS TAKING DELIVERY OF SUCH SERIES
        2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 PURSUANT TO A TRANSACTION THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND FROM ANY APPLICABLE STATE LAW SECURITIES REGISTRATION OR QUALIFICATION REQUIREMENTS, AS
        CONFIRMED IN AN OPINION OF COUNSEL ADDRESSED TO THE INDENTURE TRUSTEE AND THE ISSUER, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE ISSUER AND THE INDENTURE TRUSTEE.

       

      
        1

        
          

      

      EACH PURCHASER AND TRANSFEREE (AND ITS FIDUCIARY, IF APPLICABLE) OF A SERIES 2018-2 NOTE (OR INTEREST HEREIN) WILL BE DEEMED TO REPRESENT AND
        WARRANT THAT EITHER (I) IT IS NOT ACQUIRING AND WILL NOT HOLD THE SERIES 2018-2 NOTE WITH THE PLAN ASSETS OF AN “EMPLOYEE BENEFIT PLAN” AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), WHICH
        IS SUBJECT TO THE PROVISIONS OF TITLE I OF ERISA, A “PLAN” DESCRIBED IN AND SUBJECT TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” OF ANY OF THE FOREGOING BY
        REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY (EACH OF THE FOREGOING, A “BENEFIT PLAN”) OR ANY OTHER PLAN THAT IS SUBJECT TO A LAW THAT IS SIMILAR TO TITLE I OF ERISA OR SECTION 4975 OF THE CODE OR (II) (A) THE SERIES
        2018-2 NOTES ARE RATED INVESTMENT GRADE OR BETTER AND HAVE NOT BEEN CHARACTERIZED AS OTHER THAN INDEBTEDNESS FOR APPLICABLE LOCAL LAW PURPOSES AND (B) THE ACQUISITION, HOLDING AND DISPOSITION OF THE SERIES 2018-2 NOTE WILL NOT GIVE RISE TO A
        NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA, SECTION 4975 OF THE CODE OR A VIOLATION OF ANY SIMILAR APPLICABLE LAW.

       

      EACH INVESTOR THAT IS A PERSON WHO IS NOT A U.S. PERSON AND TO WHOM THE OFFER AND SALE OF THE SERIES 2018-2 NOTES MAY BE MADE WITHOUT REGISTRATION
        UNDER THE SECURITIES ACT IN RELIANCE UPON REGULATION S (“PERMITTED NON-U.S. PERSON”) UNDERSTANDS THAT THE SERIES 2018-2 NOTES HAVE NOT AND WILL NOT BE REGISTERED UNDER THE SECURITIES ACT, THAT ANY OFFERS, SALES OR DELIVERIES OF THE SERIES 2018-2
        NOTES PURCHASED BY IT IN THE UNITED STATES OR TO U.S. PERSONS PRIOR TO THE DATE THAT IS 40 DAYS AFTER THE LATER OF (I) THE COMMENCEMENT OF THE DISTRIBUTION OF THE SERIES 2018-2 NOTES AND (II) THE CLOSING DATE, MAY CONSTITUTE A VIOLATION OF UNITED
        STATES LAW, AND THAT DISTRIBUTIONS OF PRINCIPAL AND INTEREST WILL BE MADE IN RESPECT OF SUCH SERIES 2018-2 NOTES ONLY FOLLOWING THE DELIVERY BY THE HOLDER OF A CERTIFICATION OF NON-U.S. BENEFICIAL OWNERSHIP OR THE EXCHANGE OF BENEFICIAL INTEREST IN
        REGULATION S TEMPORARY BOOK-ENTRY NOTES FOR BENEFICIAL INTERESTS IN THE RELATED UNRESTRICTED BOOK-ENTRY NOTES (WHICH IN EACH CASE WILL ITSELF REQUIRE A CERTIFICATION OF NON-U.S. BENEFICIAL OWNERSHIP), AT THE TIMES AND IN THE MANNER SET FORTH IN THE
        INDENTURE AND THE SUPPLEMENT.

       

      THIS SERIES 2018-2 NOTE HAS NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
        AND, PRIOR TO THE DATE THAT IS 40 DAYS AFTER THE LATER OF (I) THE COMPLETION OF THE DISTRIBUTION OF THE SERIES 2018-2 NOTES AND (II) THE CLOSING DATE, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED IN THE UNITED STATES OR TO A U.S.
        PERSON EXCEPT PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT.

       

      THIS SERIES 2018-2 NOTE IS NOT GUARANTEED OR INSURED BY ANY GOVERNMENTAL AGENCY OR INSTRUMENTALITY.

       

      
        2

        
          

      

      CAL FUNDING III LIMITED

      FIXED RATE ASSET-BACKED NOTES, SERIES 2018-2, [CLASS A][CLASS B]

       

      

      
        	
                
                  $[XX]

                

              	
                CUSIP No.: _____________

              
	
                 

              	
                
                  No. 1

                

              
	 	
                _____________ ___, 20___

              

      

      

      

      KNOW ALL PERSONS BY THESE PRESENTS that CAL Funding III Limited, a company incorporated under the laws of Bermuda (the “Issuer”), for value received, hereby promises to pay to Cede & Co., or its registered assigns, at the principal corporate trust office of the Indenture Trustee named below, (i) the
        principal sum of up to XX ($XX.00), which sum shall be payable on the dates and in the amounts set forth in the Indenture, dated as of July 6, 2017 (as amended, restated, supplemented or otherwise modified from time to time in accordance with its
        terms, the “Indenture”), and the Series 2018-2 Supplement, dated as of September __, 2018 (as amended, restated, supplemented or otherwise modified from time to time in
        accordance with its terms, the “Series 2018-2 Supplement”), each between the Issuer and Wells Fargo Bank, National Association, as indenture trustee (the “Indenture Trustee”), and (ii) interest on the outstanding principal amount of this Series 2018-2 Note on the dates and in the amounts set forth in the Indenture and the Series
        2018-2 Supplement.  Capitalized terms not otherwise defined herein will have the meaning set forth in the Indenture and the Series 2018-2 Supplement.

       

      Payment of the principal of and interest on this Series 2018-2 Note shall be made in lawful money of the United States of America which at the time
        of payment is legal tender for payment of public and private debts.  The principal balance of, and interest on this Series 2018-2 Note is payable at the times and in the amounts set forth in the Indenture and the 2018-2 Supplement by wire transfer
        of immediately available funds to the account designated by the Holder of record on the immediately preceding Record Date.

       

      This Series 2018-2 Note is one of the authorized Notes identified in the title hereto and issued in the aggregate principal amount of up to [  ]
        Dollars ($[  ]) pursuant to the Indenture and the Series 2018-2 Supplement.

       

      The Notes shall be an obligation of the Issuer and shall be secured by the Collateral, all as defined in, and subject to limitations set forth in,
        the Indenture and the Series 2018-2 Supplement.

       

      This Series 2018-2 Note is transferable as provided in the Indenture and the Series 2018-2 Supplement, subject to certain limitations therein
        contained, only upon the books for registration and transfer kept by the Indenture Trustee, and only upon surrender of this Series 2018-2 Note for transfer to the Indenture Trustee duly endorsed by, or accompanied by a written instrument of
        transfer in form reasonably satisfactory to the Indenture Trustee duly executed by, the registered Holder hereof or his attorney duly authorized in writing.  The Indenture Trustee or the Issuer may require payment by the Holder of a sum sufficient
        to cover any tax expense or other governmental charge payable in connection with any transfer or exchange of the Notes.

       

      
        3

        
          

      

      The Issuer, the Indenture Trustee and any other agent of the Issuer may treat the Person in whose name this Series 2018-2 Note is registered as the
        absolute owner hereof for all purposes, and neither the Issuer, the Indenture Trustee, nor any other such agent shall be affected by notice to the contrary.

       

      The Notes are subject to Prepayment, at the times and subject to the conditions set forth in the Indenture and the Series 2018-2 Supplement.

       

      If an Event of Default shall occur and be continuing, the principal of and accrued interest on this Series 2018-2 Note may be declared to be due and
        payable in the manner and with the effect provided in the Indenture and the Series 2018-2 Supplement.

       

      The Indenture permits, with certain exceptions as therein provided, the issuance of supplemental indentures with the consent of the Requisite Global
        Majority, in certain specifically described instances.  Any consent given by the Requisite Global Majority shall be conclusive and binding upon the Holder of this Series 2018-2 Note and on all future holders of this Series 2018-2 Note and of any
        Note issued in lieu hereof whether or not notation of such consent is made upon this Series 2018-2 Note.  Supplements and amendments to the Indenture and the Series 2018-2 Supplement may be made only to the extent and in circumstances permitted by
        the Indenture and the Series 2018-2 Supplement.

       

      The Holder of this Series 2018-2 Note shall have no right to enforce the provisions of the Indenture and the Series 2018-2 Supplement or to
        institute action to enforce the covenants, or to take any action with respect to a default under the Indenture and the Series 2018-2 Supplement, or to institute, appear in or defend any suit or other Proceedings with respect thereto, except as
        provided under certain circumstances described in the Indenture and the Series 2018-2 Supplement; provided, however, that nothing contained in the Indenture and the Series 2018-2 Supplement shall affect or impair any right of enforcement conferred
        on the Holder hereof to enforce any payment of the principal of and interest on this Series 2018-2 Note on or after the due date thereof; provided further, however, that by acceptance hereof the Holder is deemed to have covenanted and agreed that
        it will not institute against the Issuer any bankruptcy, reorganization, arrangement, insolvency or liquidation Proceedings, or other Proceedings under any applicable bankruptcy or similar law, at any time other than at such time as permitted by
        Section 1310 of the Indenture and the Series 2018-2 Supplement.

       

      Each purchaser and transferee of a Series 2018-2 Note will be deemed to represent and warrant that either (i) it is not acquiring and will not hold
        the Series 2018-2 Note with the plan assets of an “employee benefit plan” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which is subject to the provisions of Title I of ERISA, a “plan”
        described in and subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), an entity whose underlying assets include “plan assets” of any of the foregoing by reason of an employee benefit plan’s or plan’s investment in
        such entity (each of the foregoing, a “Plan”), or any other plan that is subject to a law that is similar to Title I of ERISA or Section 4975 of the Code or (ii) (a) the Series 2018-2 Notes are rated investment grade or better and have not been
        characterized as other than indebtedness for applicable local law purposes and (b) the acquisition, holding and disposition of the Series 2018-2 Note will not give rise to a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975
        of the Code or a violation of any similar applicable law.

       

      
        4

        
          

      

      Each Holder of a Series 2018-2 Note (i) agrees to treat this Series 2018-2 Note for United States federal, state and local income, single business
        and franchise tax purposes as indebtedness, (ii) agrees that the Series 2018-2 Note shall not have any interest in any Series Account of any other Series or Class and (iii) ratifies and confirms the terms of the Indenture and the other Series
        2018-2 Related Documents.

       

      This Series 2018-2 Note, and the rights and obligations of the parties hereunder, shall be governed by, and construed and interpreted in accordance
        with, the laws of the State of New York without giving effect to the principles of conflict of laws thereof (other than Section 5-1401 of the New York General Obligations Law) that would permit or require the application of the law of any other
        jurisdiction.

       

      All terms and provisions of the Indenture and the Series 2018-2 Supplement are herein incorporated by reference as if set forth herein in their
        entirety.  To the extent any provision of this Series 2018-2 Note conflicts or is inconsistent with the provisions of the Indenture or the Series 2018-2 Supplement, the provisions of the Indenture or Series 2018-2 Supplement, as applicable, shall
        govern and be controlling.

       

      IT IS HEREBY CERTIFIED, RECITED AND DECLARED, that all acts, conditions and things required to exist, happen and be performed precedent to the
        execution and delivery of the Indenture and the Series 2018-2 Supplement and the issuance of this Series 2018-2 Note and the issue of which it is a part, do exist, have happened and have been timely performed in regular form and manner as required
        by law.

       

      Unless the certificate of authentication hereon has been executed by the Indenture Trustee by manual signature of one of its authorized officers,
        this Series 2018-2 Note shall not be entitled to any benefit under the Indenture and the Series 2018-2 Supplement, or be valid or obligatory for any purpose.

       

      
        5

        
          

      

      IN WITNESS WHEREOF, CAL FUNDING III LIMITED has caused this Series 2018-2 Note to be duly executed by its duly authorized representative, on this __
        day of February 2018.

       

      	 	
              CAL FUNDING III LIMITED

            
	 	 	 
	 	
              By:

            	 
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      This Series 2018-2 Note is one of the Notes described in the within-mentioned Indenture and the Series 2018-2 Supplement.

       

      	
              WELLS FARGO BANK, NATIONAL ASSOCIATION,

            
	
              as Indenture Trustee

            
	 	 	 
	
              By:

            	 	 
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      
        
          

      

      
      EXHIBIT A-4

       

      FORM OF SERIES 2018-2 NOTE ISSUED TO INSTITUTIONAL ACCREDITED INVESTORS

      

      

      UNLESS THIS SERIES 2018-2 NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION (“DTC”), TO THE
        TRANSFEROR OF SUCH NOTE (THE “TRANSFEROR”) OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY SERIES 2018-2 NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED
        REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR THE USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH
        AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.

       

      THIS SERIES 2018-2 NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).  THE HOLDER HEREOF, BY
        PURCHASING THIS SERIES 2018-2 NOTE, AGREES THAT SUCH SERIES 2018-2 NOTE MAY BE RESOLD, PLEDGED OR TRANSFERRED ONLY IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES LAWS AND (1) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE
        SECURITIES ACT (“RULE 144A”), TO A PERSON THAT TAKES DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND THAT THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER THAT PURCHASES FOR ITS OWN ACCOUNT (OR FOR THE
        ACCOUNT OR ACCOUNTS OF A QUALIFIED INSTITUTIONAL BUYER) AND TO WHOM NOTICE IS GIVEN THAT THE RESALE, PLEDGE OR OTHER TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A, OR (2) IN AN OFFSHORE TRANSACTION COMPLYING WITH RULE 903 OR RULE 904 OF
        REGULATION S UNDER THE SECURITIES ACT WITH SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 OR (3) TO A PERSON (A) THAT IS AN INSTITUTIONAL “ACCREDITED INVESTOR,” WITHIN THE MEANING OF RULE 501(a)(1), (2), (3) OR (7) OF REGULATION D UNDER
        THE SECURITIES ACT, IS TAKING DELIVERY OF SUCH SERIES 2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 AND DELIVERS TO THE INDENTURE TRUSTEE A LETTER SUBSTANTIALLY IN THE FORM OF EXHIBIT C TO THE INDENTURE OR (B) THAT IS TAKING DELIVERY OF SUCH SERIES
        2018-2 NOTE IN AN AMOUNT OF AT LEAST $250,000 PURSUANT TO A TRANSACTION THAT IS OTHERWISE EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND FROM ANY APPLICABLE STATE LAW SECURITIES REGISTRATION OR QUALIFICATION REQUIREMENTS, AS
        CONFIRMED IN AN OPINION OF COUNSEL ADDRESSED TO THE INDENTURE TRUSTEE AND THE ISSUER, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE ISSUER AND THE INDENTURE TRUSTEE.

       

      
        1

        
          

      

      
      EACH PURCHASER AND TRANSFEREE (AND ITS FIDUCIARY, IF APPLICABLE) OF A SERIES 2018-2 NOTE (OR INTEREST HEREIN) WILL BE DEEMED TO REPRESENT AND
        WARRANT THAT EITHER (I) IT IS NOT ACQUIRING AND WILL NOT HOLD THE SERIES 2018-2 NOTE WITH THE PLAN ASSETS OF AN “EMPLOYEE BENEFIT PLAN” AS DEFINED IN SECTION 3(3) OF THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974, AS AMENDED (“ERISA”), WHICH
        IS SUBJECT TO THE PROVISIONS OF TITLE I OF ERISA, A “PLAN” DESCRIBED IN AND SUBJECT TO SECTION 4975 OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED (THE “CODE”), AN ENTITY WHOSE UNDERLYING ASSETS INCLUDE “PLAN ASSETS” OF ANY OF THE FOREGOING BY
        REASON OF AN EMPLOYEE BENEFIT PLAN’S OR PLAN’S INVESTMENT IN SUCH ENTITY (EACH OF THE FOREGOING, A “BENEFIT PLAN”) OR ANY OTHER PLAN THAT IS SUBJECT TO A LAW THAT IS SIMILAR TO TITLE I OF ERISA OR SECTION 4975 OF THE CODE OR (II) (A) THE SERIES
        2018-2 NOTES ARE RATED INVESTMENT GRADE OR BETTER AND HAVE NOT BEEN CHARACTERIZED AS OTHER THAN INDEBTEDNESS FOR APPLICABLE LOCAL LAW PURPOSES AND (B) THE ACQUISITION, HOLDING AND DISPOSITION OF THE SERIES 2018-2 NOTE WILL NOT GIVE RISE TO A
        NON-EXEMPT PROHIBITED TRANSACTION UNDER SECTION 406 OF ERISA, SECTION 4975 OF THE CODE OR A VIOLATION OF ANY SIMILAR APPLICABLE LAW.

       

      THIS SERIES 2018-2 NOTE IS NOT GUARANTEED OR INSURED BY ANY GOVERNMENTAL AGENCY OR INSTRUMENTALITY.

       

      

      
        2

        
          

      

      CAL FUNDING III LIMITED

      FIXED RATE ASSET-BACKED NOTES, SERIES 2018-2, [CLASS A][CLASS B]

       

      

      
        	
                
                  $XX

                

              	
                
                  CUSIP No.: _____________

                

              
	
                 

              	
                
                  No. 1

                

              
	 	
                _____________ ___, 20___

              

      

      

      KNOW ALL PERSONS BY THESE PRESENTS that CAL Funding III Limited, a company incorporated under the laws of Bermuda (the “Issuer”), for value received, hereby promises to pay to Cede & Co., or its registered assigns, at the principal corporate trust office of the Indenture Trustee named below, (i) the
        principal sum of up to XX Dollars ($XX.00), which sum shall be payable on the dates and in the amounts set forth in the Indenture, dated as of July 6, 2017 (as amended, restated, supplemented or otherwise modified from time to time in accordance
        with its terms, the “Indenture”), and the Series 2018-2 Supplement, dated as of September __, 2018 (as amended, restated, supplemented or otherwise modified from time to
        time in accordance with its terms, the “Series 2018-2 Supplement”), each between the Issuer and Wells Fargo Bank, National Association, as indenture trustee (the “Indenture Trustee”), and (ii) interest on the outstanding principal amount of this Series 2018-2 Note on the dates and in the amounts set forth in the Indenture and the Series
        2018-2 Supplement.  Capitalized terms not otherwise defined herein will have the meaning set forth in the Indenture and the Series 2018-2 Supplement.

       

      Payment of the principal of and interest on this Series 2018-2 Note shall be made in lawful money of the United States of America which at the time
        of payment is legal tender for payment of public and private debts.  The principal balance of, and interest on this Series 2018-2 Note is payable at the times and in the amounts set forth in the Indenture and the Series 2018-2 Supplement by wire
        transfer of immediately available funds to the account designated by the Holder of record on the immediately preceding Record Date.

       

      All borrowings evidenced by this Series 2018-2 Note and all payments and prepayments of the principal hereof and interest hereon and the respective
        dates thereof shall be endorsed by the Holder hereof on the schedule attached hereto and made a part hereof, or on a continuation thereof that shall be attached hereto and made a part hereof, or otherwise recorded by that Holder in its internal
        records; provided, however, that the failure of the holder hereof to make such a notation or any error in such a notation shall not in any manner affect the obligation of the Issuer to make payments of principal and interest in accordance with the
        terms of this Series 2018-2 Note and the Indenture and the Series 2018-2 Supplement.

       

      The final payment on any Definitive Note shall be made only upon presentation and surrender of the Note at the Corporate Trust Office of the
        Indenture Trustee.

       

      This Series 2018-2 Note is one of the authorized Notes identified in the title hereto and issued in the aggregate principal amount of up to [  ]
        Dollars ($[  ]) pursuant to the Indenture and the Series 2018-2 Supplement.

       

      
        3

        
          

      

      The Notes shall be an obligation of the Issuer and shall be secured by the Collateral, all as defined in, and subject to limitations set forth in,
        the Indenture and the Series 2018-2 Supplement.

       

      This Series 2018-2 Note is transferable as provided in the Indenture and the Series 2018-2 Supplement, subject to certain limitations therein
        contained, only upon the books for registration and transfer kept by the Indenture Trustee, and only upon surrender of this Series 2018-2 Note for transfer to the Indenture Trustee duly endorsed by, or accompanied by a written instrument of
        transfer in form reasonably satisfactory to the Indenture Trustee duly executed by, the registered Holder hereof or his attorney duly authorized in writing.  The Indenture Trustee or the Issuer may require payment by the Holder of a sum sufficient
        to cover any tax expense or other governmental charge payable in connection with any transfer or exchange of the Notes.

       

      The Issuer, the Indenture Trustee and any other agent of the Issuer may treat the Person in whose name this Series 2018-2 Note is registered as the
        absolute owner hereof for all purposes, and neither the Issuer, the Indenture Trustee, nor any other such agent shall be affected by notice to the contrary.

       

      The Notes are subject to Prepayment, at the times and subject to the conditions set forth in the Indenture and the Series 2018-2 Supplement.

       

      If an Event of Default shall occur and be continuing, the principal of and accrued interest on this Series 2018-2 Note may be declared to be due and
        payable in the manner and with the effect provided in the Indenture and the Series 2018-2 Supplement.

       

      The Indenture permits, with certain exceptions as therein provided, the issuance of supplemental indentures with the consent of the Requisite Global
        Majority, in certain specifically described instances.  Any consent given by the Requisite Global Majority shall be conclusive and binding upon the Holder of this Series 2018-2 Note and on all future holders of this Series 2018-2 Note and of any
        Note issued in lieu hereof whether or not notation of such consent is made upon this Series 2018-2 Note.  Supplements and amendments to the Indenture and the Series 2018-2 Supplement may be made only to the extent and in circumstances permitted by
        the Indenture and the Series 2018-2 Supplement.

       

      The Holder of this Series 2018-2 Note shall have no right to enforce the provisions of the Indenture and the Series 2018-2 Supplement or to
        institute action to enforce the covenants, or to take any action with respect to a default under the Indenture and the Series 2018-2 Supplement, or to institute, appear in or defend any suit or other Proceedings with respect thereto, except as
        provided under certain circumstances described in the Indenture and the Series 2018-2 Supplement; provided, however, that nothing contained in the Indenture and the Series 2018-2 Supplement shall affect or impair any right of enforcement conferred
        on the Holder hereof to enforce any payment of the principal of and interest on this Series 2018-2 Note on or after the due date thereof; provided further, however, that by acceptance hereof the Holder is deemed to have covenanted and agreed that
        it will not institute against the Issuer any bankruptcy, reorganization, arrangement, insolvency or liquidation Proceedings, or other Proceedings under any applicable bankruptcy or similar law, at any time other than at such time as permitted by
        Section 1310 of the Indenture and the Series 2018-2 Supplement.

       

      
        4

        
          

      

      Each purchaser and transferee of a Series 2018-2 Note will be deemed to represent and warrant that either (i) it is not acquiring and will not hold
        the Series 2018-2 Note with the plan assets of an “employee benefit plan” as defined in Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), which is subject to the provisions of Title I of ERISA, a “plan”
        described in and subject to Section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), an entity whose underlying assets include “plan assets” of any of the foregoing by reason of an employee benefit plan’s or plan’s investment in
        such entity (each of the foregoing, a “Plan”), or any other plan that is subject to a law that is similar to Title I of ERISA or Section 4975 of the Code or (ii) (a) the Series 2018-2 Notes are rated investment grade or better and have not been
        characterized as other than indebtedness for applicable local law purposes and (b) the acquisition, holding and disposition of the Series 2018-2 Note will not give rise to a non-exempt prohibited transaction under Section 406 of ERISA, Section 4975
        of the Code or a violation of any similar applicable law.

       

      Each Holder of a Series 2018-2 Note (i) agrees to treat this Series 2018-2 Note for United States federal, state and local income, single business
        and franchise tax purposes as indebtedness, (ii) agrees that the Series 2018-2 Note shall not have any interest in any Series Account of any other Series or Class and (iii) ratifies and confirms the terms of the Indenture and the other Series
        2018-2 Related Documents.

       

      This Series 2018-2 Note, and the rights and obligations of the parties hereunder, shall be governed by, and construed and interpreted in accordance
        with, the laws of the State of New York without giving effect to the principles of conflict of laws thereof (other than Section 5-1401 of the New York General Obligations Law) that would permit or require the application of the law of any other
        jurisdiction.

       

      All terms and provisions of the Indenture and the Series 2018-2 Supplement are herein incorporated by reference as if set forth herein in their
        entirety.  To the extent any provision of this Series 2018-2 Note conflicts or is inconsistent with the provisions of the Indenture or the Series 2018-2 Supplement, the provisions of the Indenture or Series 2018-2 Supplement, as applicable, shall
        govern and be controlling.

       

      IT IS HEREBY CERTIFIED, RECITED AND DECLARED, that all acts, conditions and things required to exist, happen and be performed precedent to the
        execution and delivery of the Indenture and the Series 2018-2 Supplement and the issuance of this Series 2018-2 Note and the issue of which it is a part, do exist, have happened and have been timely performed in regular form and manner as required
        by law.

       

      Unless the certificate of authentication hereon has been executed by the Indenture Trustee by manual signature of one of its authorized officers,
        this Series 2018-2 Note shall not be entitled to any benefit under the Indenture and the Series 2018-2 Supplement, or be valid or obligatory for any purpose.

       

      
        5

        
          

      

      IN WITNESS WHEREOF, CAL FUNDING III LIMITED has caused this Series 2018-2 Note to be duly executed by its duly authorized representative, on this __
        day of February 2018.

       

      	 	
              CAL FUNDING III LIMITED

            
	 	 	 
	 	
              By:

            	 
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      This Series 2018-2 Note is one of the Notes described in the within-mentioned Indenture and the Series 2018-2 Supplement.

       

      	
              WELLS FARGO BANK, NATIONAL ASSOCIATION,

            	 
	
              as Indenture Trustee

            	 
	 	 	 
	
              By:

            	 	 
	 	
              Name:

            	 
	 	
              Title:

            	 

      

      

      
        
          

      

      EXHIBIT B

       

      FORM OF

      CERTIFICATE TO BE GIVEN BY SERIES 2018-2 NOTEHOLDER

       

      [Euroclear Bank S.A./N.V., as operator

      of the Euroclear Clearance System

      1 Boulevard du Roi Albert II

      B‐1210 Brussels, Belgium]

       

      [Clearstream Banking, société anonyme

      67 Boulevard Grand‐Duchesse Charlotte

      L‐1331 Luxembourg]

       

      
        	

              	Re:	
                Fixed Rate Asset-Backed Notes, Series 2018-2, [Class A][Class B] (the “Series 2018-2 Notes”) issued
                  pursuant to the Supplement, dated as of September 19, 2018, between CAL Funding III Limited (the “Issuer”) and Wells Fargo Bank, National Association (the “Indenture Trustee”) to the Indenture, dated as of July 6, 2017, between the Issuer and the Indenture Trustee.

              

      

       

      This is to certify that as of the date hereof, and except as set forth below, the beneficial interest in the Series 2018-2 Notes held by you for our
        account is owned by Persons that are not U.S. Persons (as defined in Rule 902 under the Securities Act of 1933, as amended).

       

      The undersigned undertakes to advise you promptly by tested telex on or prior to the date on which you intend to submit your certification relating
        to the Series 2018-2 Notes held by you in which the undersigned has acquired, or intends to acquire, a beneficial interest in accordance with your operating procedures if any applicable statement herein is not correct on such date. In the absence
        of any such notification, it may be assumed that this certification applies as of such date.

       

      [This certification excepts beneficial interests in and does not relate to U.S. $_________ principal amount of the Series 2018-2 Notes appearing in
        your books as being held for our account but that we have sold or as to which we are not yet able to certify.]

       

      We understand that this certification is required in connection with certain securities laws in the United States of America. If administrative or
        legal Proceedings are commenced or threatened in connection with which this certification is or would be relevant, we irrevocably authorize you to produce this certification or a copy thereof to any interested party in such Proceedings.

       

      	
              Dated:*

            	 	 	By:	
              

              

            	 
	 	 	 	 	
              Account Holder

            	 

       

      

      *Certification must be dated on or after the 15th day before the date of the Euroclear or
        Clearstream certificate to which this certification relates.

       

      

      
        
          

      

      EXHIBIT C

       

      FORM OF

      CERTIFICATE TO BE GIVEN BY EUROCLEAR OR CLEARSTREAM

       

      Wells Fargo Bank, National Association,

        as Indenture Trustee and Note Registrar

      MAC N9300-061

      600 S. 4th Street

      Minneapolis, Minnesota 55479

      Attention: Corporate Trust Services/Asset-Backed Administrator

      

      

      
        	

              	Re:	
                Fixed Rate Asset-Backed Notes, Series 2018-2, [Class A][Class B] (the “Series 2018-2 Notes”) issued
                  pursuant to the Supplement, dated as of September 19, 2018, between CAL Funding III Limited (the “Issuer”) and Wells Fargo Bank, National Association (the “Indenture Trustee”) to the Indenture, dated as of July 6, 2017, between the Issuer and the Indenture Trustee.

              

      

       

      This is to certify that, based solely on certifications we have received in writing, by tested telex or by electronic transmission from member
        organizations appearing in our records as Persons being entitled to a portion of the principal amount set forth below (our “Member Organizations”) as of the date hereof,
        $__________ principal amount of the Series 2018-2 Notes is owned by Persons (a) that are not U.S. Persons (as defined in Rule 902 under the Securities Act of 1933, as amended (the “Securities

            Act”), and used in Regulation S) or (b) who purchased their Series 2018-2 Notes (or interests therein) in a transaction or transactions that did not require registration under the Securities Act.

       

      We further certify (a) that we are not making available herewith for exchange any portion of the related Regulation S Temporary Book-Entry Note
        excepted in such certifications and (b) that as of the date hereof we have not received any notification from any of our Member Organizations to the effect that the statements made by them with respect to any portion of the part submitted herewith
        for exchange are no longer true and cannot be relied upon as of the date hereof.

       

      We understand that this certification is required in connection with certain securities laws of the United States of America. If administrative or
        legal Proceedings are commenced or threatened in connection with which this certification is or would be relevant, we irrevocably authorize you to produce this certification or a copy hereof to any interested party in such Proceedings.

       

      	
              Date:

            	 	 	
              Yours faithfully,

            
	 	 	 	 
	 	 	 	
              By:

            
	 	 	 	
              [Morgan Guaranty Trust Company of New York, Brussels Office, as Operator of the Euroclear Clearance System] [Clearstream Banking, société anonyme]

            

      

      
        
          

      

      EXHIBIT D

       

      FORM OF

      CERTIFICATE TO BE GIVEN BY TRANSFEREE OF BENEFICIAL INTEREST IN A

      REGULATION S TEMPORARY BOOK-ENTRY NOTE

       

      [Euroclear Bank S.A./N.V., as operator

      of the Euroclear Clearance System

      1 Boulevard du Roi Albert II

      B‐1210 Brussels, Belgium]

       

      [Clearstream Banking, société anonyme

      67 Boulevard Grand‐Duchesse Charlotte

      L‐1331 Luxembourg]

       

      
        	

              	Re:	
                Fixed Rate Asset-Backed Notes, Series 2018-2, [Class A][Class B] (the “Series 2018-2 Notes”) issued
                  pursuant to the Supplement, dated as of September 19, 2018, between CAL Funding III Limited (the “Issuer”) and Wells Fargo Bank, National Association (the “Indenture Trustee”) to the Indenture, dated as of July 6, 2017, between the Issuer and the Indenture Trustee.

              

      

       

      This is to certify that as of the date hereof, and except as set forth below, for purposes of acquiring a beneficial interest in the Series 2018-2
        Notes, the undersigned certifies that it is not a U.S. Person (as defined in Rule 902 under the Securities Act of 1933, as amended, and used in Regulation S).

       

      The undersigned undertakes to advise you promptly by tested telex on or prior to the date on which you intend to submit your certification relating
        to the Series 2018-2 Notes held by you in which the undersigned intends to acquire a beneficial interest in accordance with your operating procedures if any applicable statement herein is not correct on such date. In the absence of any such
        notification, it may be assumed that this certification applies as of such date.

       

      We understand that this certification is required in connection with certain securities laws in the United States of America. If administrative or
        legal Proceedings are commenced or threatened in connection with which this certification is or would be relevant, we irrevocably authorize you to produce this certification or a copy thereof to any interested party in such Proceedings.

       

      	
              Dated:

            	
              By:

            

      

      

      
        
          

      

      
      EXHIBIT E

       

      FORM OF

      TRANSFER CERTIFICATE FOR EXCHANGE OR

      TRANSFER FROM 144A BOOK-ENTRY NOTE

      TO REGULATION S BOOK-ENTRY NOTE

       

      Wells Fargo Bank, National Association,

        as Indenture Trustee and Note Registrar

      MAC N9300-061

      600 S. 4th Street

      Minneapolis, Minnesota 55479

      Attention:  Corporate Trust Services/Asset-Backed Administrator

       

      
        	

              	Re:	
                Fixed Rate Asset-Backed Notes, Series 2018-2, [Class A][Class B] (the “Series 2018-2 Notes”) issued
                  pursuant to the Supplement, dated as of September 19, 2018, between CAL Funding III Limited (the “Issuer”) and Wells Fargo Bank, National Association (the “Indenture Trustee”) to the Indenture, dated as of July 6, 2017, between the Issuer and the Indenture Trustee.

              

      

       

      Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture.

       

      This letter relates to U.S. $___________ principal amount of Series 2018-2 Notes that are held as a beneficial interest in the 144A Book-Entry Note (CUSIP No. _____)
        with DTC in the name of [insert name of transferor] (the “Transferor”). The Transferor has requested an exchange or transfer of the beneficial interest for an interest in
        the Regulation S Book-Entry Note (CUSIP No. _____) to be held with [Euroclear] [Clearstream] through DTC.

       

      In connection with the request and in receipt of the Series 2018-2 Notes, the Transferor does hereby certify that the exchange or transfer has been effected in
        accordance with the transfer restrictions set forth in the Indenture and the Series 2018-2 Notes and:

       

      (a)  pursuant to and in accordance with Regulation S under the Securities Act of 1933, as amended (the “Securities

            Act”), and accordingly the Transferor does hereby certify that:

       

      (i)  the offer of the Series 2018-2 Notes was not made to a Person in the United States of America,

       

      (ii) either (A) at the time the buy order was originated, the transferee was outside the United States of America or the Transferor and any Person
        acting on its behalf reasonably believed that the transferee was outside the United States of America, or (B) the transaction was executed in, on or through the facilities of a designated offshore securities market and neither the Transferor nor
        any Person acting on its behalf knows that the transaction was pre‐arranged with a buyer in the United States of America,

       

      
        1

        
          

      

      (iii)  no directed selling efforts have been made in contravention of the requirements of Rule 903 or 904 of Regulation S, as applicable, and the
        other conditions of Rule 903 or Rule 904 of Regulation S, as applicable, have been satisfied and

       

      (iv)  the transaction is not part of a plan or scheme to evade the registration requirements of the Securities Act, and

       

      (b) with respect to transfers made in reliance on Rule 144A under the Securities Act, the Transferor does hereby certify that the Series 2018-2 Notes are being
        transferred in a transaction permitted by Rule 144A under the Securities Act.

       

      This certification and the statements contained herein are made for your benefit and the benefit of the Issuer and Merrill Lynch, Pierce, Fenner & Smith
        Incorporated, Wells Fargo Securities, LLC, BBVA Securities Inc., Fifth Third Securities, Inc. and MUFG Securities Americas Inc. as the Initial Purchasers.

       

      	 	[Insert name of Transferor]
	 	 
	
              Dated:

            	
              By:

            
	 	
              Title:

            

      

      

      
        2

        
          

      

      EXHIBIT F

       

      FORM OF

      INITIAL PURCHASER EXCHANGE INSTRUCTIONS

       

      Depository Trust Company

      55 Water Street

      50th Floor

      New York, New York 10041

       

      
        	

              	Re:	
                $__________ of the Fixed Rate Asset-Backed Notes, Series 2018-2, [Class A][Class B] (the “Series 2018-2 Notes”)

                  issued pursuant to the Supplement, dated as of September 19, 2018, between CAL Funding III Limited (the “Issuer”) and Wells Fargo Bank, National Association (the
                  “Indenture Trustee”) to the Indenture, dated as of July 6, 2017, between the Issuer and the Indenture Trustee.

              

      

       

      Pursuant to Section 207 of the Supplement, [Merrill Lynch, Pierce, Fenner & Smith Incorporated][Wells Fargo Securities, LLC][BBVA Securities Inc.][Fifth Third
        Securities, Inc.][MUFG Securities Americas Inc.] (the “Initial Purchaser”), hereby requests that $____________ aggregate principal amount of the Series 2018-2 Notes held
        by you for our account and represented by the Regulation S Temporary Book-Entry Note (CUSIP No. _____) (as defined in the Supplement) be exchanged for an equal principal amount represented by the 144A Book-Entry Note (CUSIP No. _____) to be held by
        you for our account.

       

      	
              Dated:

            	
              [Merrill Lynch, Pierce, Fenner & Smith Incorporated][Wells Fargo Securities, LLC][BBVA Securities Inc.][Fifth Third Securities, Inc.][MUFG
                Securities Americas Inc.], as Initial Purchaser

            
	 	
              By:

            
	 	
              Title:

            

      

      

      
        
          

      

      
      SCHEDULE 1

      Minimum Targeted Principal Balances

      

      

      
        

        

        
          1

          
            

        

        

      SCHEDULE II

      Scheduled Targeted Principal Balances

      

      

      

      

      

      
        1

        
          

      

      SCHEDULE III

      Maximum Concentrations of Lessees

      

      

      	
              Lessee

            	 	
              Concentration Limit

            	 
	 	 	 	 
	
              CMA CGM SA

            	 	 	
              35.0

            	
              %

            
	
              MSC Mediterranean Shipping Co. S.A.

            	 	 	
              35.0

            	
              %

            
	
              Hyundai Merchant Marine Co., Ltd

            	 	 	
              30.0

            	
              %

            
	
              Pacific International Lines (Pte) Ltd.

            	 	 	
              30.0

            	
              %

            
	
              Yang Ming Marine Transport Corp.

            	 	 	
              30.0

            	
              %

            
	
              Cosco (Cayman) Mercury Co., Ltd.

            	 	 	
              30.0

            	
              %

            
	
              SeaLease N.V.

            	 	 	
              25.0

            	
              %

            
	
              Ocean Network Express Pte. Ltd1

            	 	 	
              25.0

            	
              %

            
	
              Maersk Line A/S

            	 	 	
              20.0

            	
              %

            
	
              Evergreen International S.A.

            	 	 	
              20.0

            	
              %

            
	
              Hapag-Lloyd

            	 	 	
              20.0

            	
              %

            

      

      

      

       

      

      1 Includes legacy lease exposures to Mitsui O.S.K. Lines, Ltd, Nippon Yusen Kaisha and Kawasaki Kisen Kaisha Ltd.

     

    

     

    

     1Exhibit 10.7

 

EXCLUSIVE SALES
AND MARKETING AGREEMENT

 

THIS EXCLUSIVE
SALES AND MARKETING AGREEMENT (this “Agreement”) dated as of August 11, 2017 (the “Effective Date”), is
entered into between EYEMAX LLC, a Massachusetts limited liability company (“Eyemax”), with a place of business at
74 Chestnut Street, Weston, Massachusetts 02493, and ETON PHARMACEUTICALS, INC., a Delaware corporation (“Eton”),
with a place of business at 21925 Field Pkwy, Suite 235, Deer Park, Illinois 60010. The parties hereby agree as follows:

 

1.             Definitions.
For the purposes of this Agreement, the following terms shall have the respective meanings set forth below, and grammatical
variations of such terms shall have corresponding meanings:

 

1.1           “Affiliate”
shall mean, with respect to any Person, any other Person which directly or indirectly controls, is controlled by, or is under
common control with, such Person. A Person shall be regarded as in control of another Person if it owns, or directly or indirectly
controls, more than fifty percent (50%) of the voting stock or other ownership interest of the other Person, or if it directly
or indirectly possesses the power to direct or cause the direction of the management and policies of the other Person by any means
whatsoever.

 

1.2           “Eyemax
IP Rights” shall mean, collectively, the Eyemax Patent Rights, Eyemax Know-How Rights and Eyemax Registrations.

 

1.3           “Eyemax
Know-How Rights” shall mean all trade secret and other know-how rights in which Eyemax or its Affiliates heretofore
or hereafter has an ownership or (sub)licensable interest, in and to the Technology.

 

1.4           “Eyemax
Patent Rights” shall mean (a) all patents and patent applications that claim or cover the Technology in which Eyemax
or its Affiliates heretofore or hereafter has an ownership or (sub)licensable interest, (b) all divisions, continuations, continuations-in-part,
that claim priority to, or common priority with, the patent applications described in clause (a) above or the patent applications
that resulted in the patents described in clause (a) above, and (c) all patents that have issued or in the future issue from any
of the foregoing patent applications, including utility models, design patents and certificates of invention, together with any
reissues, reexaminations, renewals, extensions or additions thereto.

 

1.5           “Eyemax
Registrations” shall mean all Regulatory Filings and Registrations regarding Product.

  

1.6           “FDA”
shall mean the Food and Drug Administration of the United States or any successor thereto.

 

1.7           “First
Commercial Sale” shall mean, with respect to any Product, the first sale of such Product to a Third Party after Registration
of such Product.

 

    	 	1	 

     

    

 

1.8           “Minimum
Annual Royalty Payment” shall mean, with respect to any calendar year period, royalty payments from Eton to Eyemax of
an amount equal to One Hundred Thousand Dollars ($100,000USD).

 

1.9           “Minimum
Royalty Cure Payment” shall mean, with respect to any calendar year period, the positive remainder, if any, of the Minimum
Annual Royalty Payment minus the amount of royalties paid by Eton for such calendar year period.

 

1.10         “Net
Sales” shall mean the gross sales price of Products invoiced by Eton or its Affiliates to customers who are not Affiliates
(or are Affiliates but are the end users of such Product) less (a) credits, allowances, discounts and rebates to, and chargebacks
from the account of, such customers; (b) freight and insurance costs in transporting Products; (c) cash, quantity and trade discounts,
rebates and other price reductions for Products; (d) sales, use, value-added and other direct taxes; (e) customs duties, tariffs,
surcharges and other governmental charges incurred in exporting or importing Products; (f) the fully-burdened cost of goods sold
determined in accordance with generally accepted accounting principles; (g) selling, general and administrative expenses determined
in accordance with generally accepted accounting principles, including sales commissions incurred on the sale of such Product;
and (h) an allowance for uncollectible or bad debts determined in accordance with generally accepted accounting principles.

 

1.11         “Net
Sublicensing Revenues” shall mean, with respect to a Product, the aggregate cash consideration received by Eton or its
Affiliates in consideration for a sublicense under the Eyemax IP Rights by Eton or its Affiliates to a Third Party sublicensee
with respect to such Product (including royalties received by Eton or its Affiliates based on sales of such Product by such sublicensee,
but excluding amounts received (a) for the sale of such Product by Eton or its Affiliates to such sublicensee, or (b) in consideration
for the purchase of any debt or securities of Eton or its Affiliates).

 

1.12         “Person”
shall mean any individual, partnership, firm, corporation, association, trust, unincorporated organization or other entity, as
well as any syndicate or group of any of the foregoing.

 

1.13         “Product”
shall mean any product, in any form or formulation, including (without limitation) unit dose vials or multi-dose containers, for
ophthalmic administration, containing preservative free ketotifen.

 

    	 	2	 

     

    

 

1.14         “Recovery
Amount” shall mean all reasonable costs and expenses (including reasonable attorneys’ fees and costs) incurred
by Eton or its Affiliates in connection with the development, commercialization, obtaining and maintaining regulatory approvals,
or other exploitation or use of Product, but excluding any items covered by clauses (f) and (g) of Section 1.10 provided; however,
the dollar amount of the Recovery Amount shall not exceed Two Million Dollars ($2,000,000) without the prior written consent of
Eyemax.

 

1.15         “Registration”
shall mean any registration, license, permit or governmental approval or clearance from the FDA necessary for the purchase, distribution,
promotion, marketing or sale of a product.

 

1.16         “Regulatory
Filing” shall mean any New Drug Application or Abbreviated New Drug Application, or any other application, notification
or submission made to or with the FDA for Registration of a product, together with all amendments and supplements to any of the
foregoing.

 

1.17         “Technology”
shall mean, collectively, all forms and formulations comprising ketotifen, all methods of manufacture or use thereof, and all data,
information, compositions, formulae, procedures, protocols, techniques and results of experimentation and testing and other technology
relating to or reasonably necessary or useful to make, use, sell, offer for sale, import, develop, seek regulatory approval, market,
commercialize or otherwise exploit the foregoing.

 

1.18         “Territory”
shall mean collectively all the territories and possessions of the United States of America; provided, however, that (a) Eyemax
shall first offer to Eton any rights to exploit Product outside of the then-current Territory, and (b) if accepted by Eton, then
the parties shall negotiate and enter into a mutually acceptable amendment to this Agreement to add such geographic territory
to the Territory.

 

1.19         “Third
Party” shall mean any Person other than Eton, Eyemax or their respective Affiliates.

 

    	 	3	 

     

    

 

		2.	Commercialization.

 

2.1          Grant
of Rights. Subject to the terms and conditions of this Agreement, Eyemax hereby grants to Eton an exclusive right and license
(with the right to grant sublicenses to Affiliates, contractors (including manufacturers), consultants and representatives; provided,
however, sublicenses to other Third Parties require the prior written consent of Eyemax) under the Eyemax IP Rights (a) to research,
develop, make, have made, use, offer for sale, sell, import, or otherwise exploit, commercialize or dispose of Products in the
Territory, and (b) to make or have made Products worldwide for use, offering for sale, sale, importation or other exploitation,
commercialization or disposition of Products in the Territory. Subject to the satisfaction of Eyemax’s obligations hereunder
and obtaining applicable Registration(s) for Product, Eton shall use commercially reasonable efforts to commercialize such Product
in the Territory.

 

2.2          Technology
Transfer. Eyemax shall provide Eton with a copy of all Technology and Eyemax IP Rights (or copies thereof if applicable) at
such time and in such manner as reasonably requested by Eton.

 

2.3          Product
Branding. Eton shall have the exclusive right to determine the names and trademarks, trade names, designs, logos and markings
used in connection with the research, development, promotion, marketing and sale of Product in the Territory.

 

		3.	Product Development and Registration

 

3.1          Regulatory
Submission

 

3.1.1           Eyemax
shall own any Registrations for Product and hereby grants to Eton exclusive rights under all such Registrations.

 

3.1.2           Eyemax
shall be responsible for submission of all initial Regulatory Filings to obtain Registration for Product at its own expense. For
purposes of clarity, the preceding sentence only covers the NDA filing fee only. Subject to the foregoing, Eton shall take all
reasonably necessary actions to support and obtain Registration thereafter by performing such development and obtaining such data
and information as reasonably necessary therefor at its own expense. Without limiting and subject to the foregoing, Eton shall
have the right to prepare, file, prosecute, submit and control all Regulatory Filings for Product. Eyemax shall provide to Eton
all reasonable assistance as Eton may request from time to time in connection therewith. Eton shall provide to Eyemax reasonably
requested updates as to the Registration and Regulatory Filings as Eyemax may request from time to time.

 

3.1.3           Eyemax
hereby appoints Eton as Eyemax’s authorized representative, agent and attorney in fact to pursue and maintain Registration
of Product. Eton hereby accepts such appointment. Without limiting the foregoing, Eton shall have the exclusive right, subject
to the first sentence of Section 3.1.2, (a) to submit relevant Regulatory Filings; (b) to interact and communicate with the FDA
and other regulatory authorities in the Territory regarding Regulatory Filings and Registration of Product; (c) to collect information
on the adverse effects of Product and report the same to the FDA; and (d) to coordinate and control any Recall (as defined below)
of Product in accordance with this Agreement and applicable laws and regulations and reporting relevant information to the FDA.

  

    	 	4	 

     

    

  

3.1.4           Without
limiting anything set forth herein, Eyemax shall reasonably assist, execute such certificates and other instruments and otherwise
cooperate with Eton in connection with any Regulatory Filings as necessary to permit the promotion, marketing and sale of Product
in the Territory and comply with all Registration requirements therein.

 

3.2          Pharmacovigilance.

 

3.2.1           Each
party shall maintain an effective system for the review, evaluation and reporting of Product complaints and adverse drug experiences,
as defined in 21 C.F.R. 314.80(a) and as required under applicable law and in accordance with the Quality Agreement.

 

3.2.2           Each
party shall promptly (but in any event within three (3) business days) advise the other of any safety or toxicity problem of which
either party becomes aware regarding the Product. Eyemax shall, within five (5) business days following notification to Eyemax,
inform Eton in the event of any FDA or other U.S. regulatory inspection relating to the Product and shall immediately (but in
any event within one (1) business day) notify Eton in writing of any adverse event relating to the Product.

 

3.3          Recall.
Each party promptly shall notify the other party if a Product is determined to be the subject of a recall, market withdrawal,
or correction (collectively, “Recall”). In the event of a Recall, Eton shall be responsible for coordinating and managing
such Recall. Eyemax shall reasonably cooperate with Eton and take all necessary actions that may be necessary for Eton to manage
the Recall, including providing Eton with any and all data, information and documents requested by Eton within three (3) days
of such request. The parties agree to cooperate in case of a Recall and provide such information as may be necessary to effectuate
the Recall and to satisfy any regulatory requests about the Recall.

 

		4.	Representations and Warranties.

 

4.1          Representations
and Warranties of Eyemax. Eyemax hereby represents and warrants to Eton as follows:

 

4.1.1           Eyemax
is a limited liability company duly organized, validly existing and in good standing under the laws of the State of Massachusetts.

 

4.1.2           Eyemax
(a) has the requisite power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder,
and (b) has taken all necessary action on its part to authorize the execution and delivery of this Agreement and the performance
of its obligations hereunder. This Agreement has been duly executed and delivered on behalf of Eyemax, and constitutes a legal,
valid, binding obligation, enforceable against Eyemax in accordance with its terms.

  

    	 	5	 

     

    

 

4.1.3           All
necessary consents, approvals and authorizations of all governmental authorities and other Persons required to be obtained by
Eyemax in connection with this Agreement have been obtained.

 

4.1.4           The
execution and delivery of this Agreement and the performance of Eyemax’s obligations hereunder (a) do not conflict with
or violate any requirement of applicable laws or regulations, and (b) do not conflict with, or constitute a default under, any
contractual obligation of it. Neither Eyemax, its (sub)contractors, nor any of its or their officers, directors, employees or
consultants, have been debarred by the FDA or other applicable governing health authority (or authorities), under any existing
or prior law or regulation.

 

4.1.5           All
material data, information, results of experimentation and testing provided by Eyemax to the FDA or Eton are accurate and complete
in all respects.

 

4.1.6           To
the best of Eyemax’s knowledge after due inquiry but without performing a freedom of operate, neither Product nor any use
thereof infringes, misappropriates or otherwise violates the intellectual property rights of any Third Party.

 

4.2          Representations
and Warranties of Eton. Eton hereby represents and warrants to Eyemax as follows:

 

4.2.1           Eton
is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.

 

4.2.2           Eton
(a) has the corporate power and authority and the legal right to enter into this Agreement and to perform its obligations hereunder,
and (b) has taken all necessary corporate action on its part to authorize the execution and delivery of this Agreement and the
performance of its obligations hereunder. This Agreement has been duly executed and delivered on behalf of Eton, and constitutes
a legal, valid, binding obligation, enforceable against Eton in accordance with its terms.

 

4.2.3           All
necessary consents, approvals and authorizations of all governmental authorities and other Persons required to be obtained by
Eton in connection with this Agreement have been obtained.

 

4.2.4           The
execution and delivery of this Agreement and the performance of Eton’s obligations hereunder (a) do not conflict with or
violate any requirement of applicable laws or regulations, and (b) do not conflict with, or constitute a default under, any contractual
obligation of it. Neither Eton, its (sub)contractors, nor any of its or their officers, directors, employees or consultants, have
been debarred by the FDA or other applicable governing health authority (or authorities), under any existing or prior law or regulation.

 

    	 	6	 

     

    

 

		5.	Financial Terms

 

5.1          Upfront
Fee. Within five (5) business days after the Effective Date, Eton shall pay to Eyemax an upfront fee of two hundred fifty
thousand dollars ($250,000).

  

5.2          Milestone
Payments. Within thirty (30) days following the first achievement of each of the following milestone events, Eton shall pay
to Eyemax the corresponding milestone payment:

 

	Milestone Event	 	Milestone Payment	 
	Eyemax obtaining Registration for Product	 	$	250,000	 
	First Commercial Sale of Product	 	$	500,000	 

 

5.3          Royalties.

 

5.3.1           Royalty
Rate. During the Term, subject to the terms and conditions of this Agreement, Eton shall pay to Eyemax royalties equal to
ten percent (10%) of Net Sales and Net Sublicensing Revenues, in each case in excess of the Recovery Amount.

 

5.3.2           Combination/Bundled
Products. In the event that a Product is sold by Eton or its Affiliates in combination with one or more products which is
itself not a Product, then Net Sales shall be calculated by multiplying the sales price of such combination sale by the fraction
A/(A+B) where A is the fair market value of the Product(s) and B is the fair market value of the other product(s) in the combination
sale, each as reasonably determined by Eton after consultation with Eyemax.

 

5.3.3           Third
Party Royalties. If Eton or its Affiliates is required to pay royalties to any Third Party in order to exercise its rights
hereunder to make, have made, use, offer for sale, sell or import any Product, then Eton shall have the right to credit fifty
percent (50%) of such Third Party royalty payments against the royalties that would otherwise be owing with respect to sales of
such Product prior to giving effect to this Section 5.3.3; provided, however, that Eton shall not reduce the amount of royalties
paid to Eyemax by reason of this Section 5.3.3 to less than fifty percent (50%) of the royalties that would otherwise be owing
with respect to sales of such Product.

 

5.4          Royalty
Reports and Payments. Within sixty (60) days after the end of each calendar quarter, Eton shall deliver to Eyemax a report
showing for such calendar quarter in reasonably specific detail the calculation of the royalties owing to Eyemax. Eton shall remit
the total payments due during such calendar quarter at the time such report is made. Payment in whole or in part may be made in
advance of such due date. No such reports or payments shall be due for any Product before the First Commercial Sale of such Product.

 

5.5          Withholding
Taxes. Eton shall be entitled to deduct the amount of any withholding taxes, value-added taxes or other taxes, levies or charges
with respect to such amounts payable by Eton or its Affiliates, or any taxes required to be withheld by Eton or its Affiliates,
to the extent Eton or its Affiliates pay to the appropriate governmental authority on behalf of Eyemax such taxes, levies or charges.
Eton shall use reasonable efforts to minimize any such taxes, levies or charges required to be withheld on behalf of Eyemax by
Eton or its Affiliates. Eton promptly shall deliver to Eyemax proof of payment of all such taxes, levies and other charges, together
with copies of all communications from or with such governmental authority with respect thereto.

  

    	 	7	 

     

    

 

		5.6	Audits.

 

5.6.1           Upon
the written request of Eyemax and not more than once in each calendar year, Eton shall permit an independent certified public
accounting firm of nationally recognized standing selected by Eyemax and reasonably acceptable to Eton, at Eyemax’s expense,
to have access during normal business hours to such of the financial records of Eton as may be reasonably necessary to verify
the accuracy of the reports hereunder for the eight (8) calendar quarters immediately prior to the date of such request (other
than records for which Eyemax has already conducted an audit under this Section).

 

5.6.2           If
such accounting firm concludes that additional amounts were owed during the audited period, Eton shall pay such additional amounts
within ten (10) days after the date Eyemax delivers to Eton such accounting firm’s written report so concluding. The fees
charged by such accounting firm shall be paid by Eyemax; provided, however, to the extent the auditor determines an underpayment
discrepancy greater than five percent (5%), Eton shall pay the reasonable fees and expenses charged by such accounting firm.

 

5.6.3           Eyemax
shall cause its accounting firm to retain all financial information subject to review under this Section 5.6 in strict confidence;
provided, however, that Eton shall have the right to require that such accounting firm, prior to conducting such audit, enter
into an appropriate and reasonable non-disclosure agreement with Eton regarding such financial information. The accounting firm
shall disclose to Eyemax only whether the reports are correct or not and the amount of any discrepancy. No other information shall
be shared. Eyemax shall treat all such financial information as Eton’s confidential information, and shall not disclose
such financial information to any Third Party or use it for any purpose other than as specified in this Section 5.6.

 

		6.	Indemnification and Insurance.

 

6.1          Indemnification
by Eyemax. Eyemax shall indemnify, defend and hold harmless Eton, its Affiliates, and its and their respective officers, directors,
shareholders, employees, agents and representatives (collectively “Eton Indemnitees”) from any and all losses, liabilities,
damages and expenses, including reasonable attorneys’ fees and costs (collectively, “Losses”) arising from any
claim, demand, action or other proceeding by a Third Party, to the extent arising out of or caused by (a) gross negligence or
willful misconduct of Eyemax, its agents or Affiliates; (b) any breach of any representation, warranty or covenant of this Agreement
by Eyemax; or (c) Eyemax’s failure to fully comply with all applicable laws regarding Product, its use, or any part thereof.

 

    	 	8	 

     

    

 

6.2           Indemnification
by Eton. Eton shall indemnify, defend and hold harmless Eyemax, its Affiliates, and its and their respective officers, directors,
shareholders, employees, agents and representatives (collectively “Eyemax Indemnitees”) from any and all Losses arising
from any claim, demand, action or other proceeding by a Third Party, to the extent arising out of or caused by (a) gross negligence
or willful misconduct of Eton, its agents or Affiliates; (b) any breach of any representation, warranty or covenant of this Agreement
by Eton; or (c) Eton’s failure to fully comply with all applicable laws regarding Product, its use, or any part thereof.

 

6.3           Procedure.
A party seeking indemnification (the “Indemnitee”) shall promptly notify the other party (the “Indemnifying
Party”) in writing of a claim, demand, action or proceeding; provided that an Indemnitee’s failure to give such notice
or delay in giving such notice shall not affect such Indemnitee’s right to indemnification under this Section 6 except to
the extent that the Indemnifying Party has been prejudiced by such failure or delay. The Indemnifying Party shall have the right
to control the defense of all indemnification claims hereunder. The Indemnitee shall have the right to participate at its own
expense in the claim, demand, action or proceeding with counsel of its own choosing. The Indemnifying Party shall consult with
the Indemnitee in good faith with respect to all non-privileged aspects of the defense strategy. The Indemnitee shall cooperate
with the Indemnifying Party as reasonably requested, at the Indemnitee’s sole cost and expense. The Indemnifying Party shall
not settle any claim, demand, action or proceeding with respect to which without the Indemnitee’s prior written consent,
which consent shall not be unreasonably withheld.

 

6.4           Insurance.
Each party shall maintain insurance, including product liability insurance, with respect to its activities under this Agreement
regarding Product in such amount as such party customarily maintains with respect to similar activities for its other products,
but not less than such amount as is reasonable and customary in the industry. Each party shall maintain such insurance for so
long as it continues its activities under this Agreement, and thereafter for so long as such party customarily maintains insurance
for itself covering similar activities for its other products.

 

6.5           LIMITATION
OF LIABILITY. NOTWITHSTANDING ANYTHING TO THE CONTRARY HEREIN, EXCEPT FOR THE OBLIGATIONS TO INDEMNIFY, DEFEND AND HOLD HARMLESS
PURSUANT TO THIS SECTION 6 OR THE CONFIDENTIALITY OBLIGATIONS PURSUANT TO SECTION 7, NEITHER PARTY SHALL BE LIABLE FOR ANY SPECIAL,
INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER FORESEEABLE OR NOT, ARISING OUT OF THIS AGREEMENT OR THE EXERCISE OF ITS
RIGHTS HEREUNDER, REGARDLESS OF ANY NOTICE OF SUCH DAMAGES.

 

		7.	Confidentiality.

 

7.1           Confidential
Information. During the Term and for a period of five (5) years thereafter, each party shall maintain in confidence all information
of the other party that is disclosed by the other party and identified as, or acknowledged to be, confidential at the time of
disclosure (the “Confidential Information”), and shall not use, disclose or grant the use of the Confidential Information
except on a need-to-know basis to those directors, officers, affiliates, employees, permitted licensees, permitted assignees and
agents, consultants, clinical investigators or contractors, to the extent such disclosure is reasonably necessary in connection
with performing its obligations or exercising its rights under this Agreement. To the extent that disclosure is authorized by
this Agreement, prior to disclosure, each party hereto shall obtain agreement of any such Person to hold in confidence and not
make use of the Confidential Information for any purpose other than those permitted by this Agreement. Each party shall notify
the other promptly upon discovery of any unauthorized use or disclosure of the other party’s Confidential Information.

  

    	 	9	 

     

    

 

7.2           Permitted
Disclosures. The confidentiality obligations contained in Section 7.1 above shall not apply to the extent that (a) any receiving
party (the “Recipient”) is required (i) to disclose information by law, regulation or order of a governmental agency
or a court of competent jurisdiction, or (ii) to disclose information to any governmental agency for purposes of obtaining approval
to test or market a product, provided in either case that the Recipient shall provide written notice thereof to the other party
and sufficient opportunity to object to any such disclosure or to request confidential treatment thereof; or (b) the Recipient
can demonstrate that (i) the disclosed information was public knowledge at the time of such disclosure to the Recipient, or thereafter
became public knowledge, other than as a result of actions of the Recipient in violation hereof; (ii) the disclosed information
was rightfully known by the Recipient (as shown by its written records) prior to the date of disclosure to the Recipient by the
other party hereunder; (iii) the disclosed information was disclosed to the Recipient on an unrestricted basis from a source unrelated
to any party to this Agreement and not under a duty of confidentiality to the other party; or (iv) the disclosed information was
independently developed by the Recipient without use of the Confidential Information disclosed by the other party.

 

7.3           Terms
of this Agreement. Except as otherwise provided in Section 7.2 above, neither party shall disclose any terms or conditions
of this Agreement to any Third Party without the prior consent of the other party. Notwithstanding the foregoing, prior to execution
of this Agreement, the parties have agreed upon the substance of information that can be used to describe the terms of this transaction,
and each party may disclose such information, as modified by mutual agreement from time to time, without the other party’s
consent.

 

7.4           Injunctive
Relief. Each party acknowledges that it will be impossible to measure in money the damage to the other party if such party
fails to comply with the obligations imposed by this Section 7, and that, in the event of any such failure, the other party may
not have an adequate remedy at law or in damages. Accordingly, each party agrees that injunctive relief or other equitable remedy,
in addition to remedies at law or damages, is an appropriate remedy for any such failure and shall not oppose the granting of
such relief on the basis that the disclosing party has an adequate remedy at law. Each party agrees that it shall not seek, and
agrees to waive any requirement for, the securing or posting of a bond in connection with the other party seeking or obtaining
such equitable relief.

 

		8.	Term and Termination.

 

8.1           Term.
The Agreement shall commence on the Effective Date and shall continue for a period of ten (10) years thereafter unless (a)
renewed under Section 8.2 or (b) earlier terminated under Section 8.3 (the “Term”).

 

    	 	10	 

     

    

 

8.2          Renewal
Term. This Agreement shall automatically renew for successive two (2) year terms unless Eton provides to Eyemax written notice
of non-renewal at least ninety (90) days prior to the end of the then-current term.

 

8.3          Termination.

 

8.3.1           In
the event of a material breach of this Agreement by either party, the non-breaching party may provide written notice of such breach
to the breaching party, including a description of the breach, and indicating the non-breaching party’s intent to terminate
this Agreement. The breaching party will have sixty (60) days from its receipt of such notice to cure the breach, provided the
breach is capable of being cured within the sixty (60) day period. If the breaching party fails to cure the breach within such
period, then unless otherwise agreed by the non-breaching party, this Agreement shall terminate on the date that is sixty (60)
days following the breaching party’s receipt of the notice of breach from the non-breaching party. If the breach is not
capable of being remedied within sixty (60) days, the Agreement terminates upon the written notice.

 

8.3.2           Eton
shall have the right to terminate this Agreement in its sole discretion at any time upon ninety (90) days prior written notice
to Eyemax.

 

8.3.3           If
(a) Eton fails to meet the Minimum Annual Royalty Payment for any full calendar year following the First Commercial Sale of the
Product and (b) Eton has not provided the Minimum Royalty Cure Payment within sixty (60) days after the end of such calendar year,
then Eyemax may elect (at its sole and absolute discretion) to: (1) terminate this Agreement by providing sixty (60) days written
notice, (2) not terminate this Agreement but convert the exclusivity provisions of this Agreement to non-exclusive, or (3) provide
a waiver without effecting its rights to future violations.

 

8.3.4           If
Eton fails to file an initial Regulatory Filing for Product pursuant to Section 3.1.2 by August 15, 2019, Eyemax has the right
to terminate this Agreement by providing thirty (30) days’ prior written notice and providing Eton with a thirty (30) day
cure period.

 

8.3.5           If
Eton determines that the Recovery Amount is reasonably likely to exceed two million dollars ($2,000,000), then Eton shall have
the right to terminate this Agreement upon thirty (30) days’ prior written notice to Eyemax.

 

8.4          Effect
of Termination or Expiration. Termination or expiration of this Agreement shall be without prejudice to any rights which shall
have accrued to the benefit of any party prior to such termination or expiration. Without limiting the foregoing, Sections 3.2,
3.3, 4, 6, 7, 8.4 and 9 shall survive any termination or expiration of this Agreement.

  

    	 	11	 

     

    

 

		9.	Miscellaneous.

 

9.1          Relationship
of Parties. The relationship between Eyemax and Eton, with respect to this Agreement, is only that of independent contractors
notwithstanding any activities set forth in this Agreement. Neither party is the agent or legal representative of the other party,
and neither party has the right or authority to bind the other party in any way. This Agreement creates no relationship as partners
or a joint venture, and creates no pooling arrangement.

 

9.2          Governing
Law and Resolution of Disputes.

 

9.2.1           This
Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without reference to its conflict
of laws principles.

 

9.2.2           Any
and all disputes or claims arising from or out of this Agreement shall be litigated exclusively before a court of the State of
Delaware or, if subject matter jurisdiction exists, the United States District Court for the District of Delaware. Each party
hereto hereby irrevocably and unconditionally consents to the exclusive personal jurisdiction and service of, and venue of, any
such court, and further irrevocably and unconditionally waives and agrees not to plead or claim that any action, lawsuit or proceeding
brought in any such court has been brought in an inconvenient forum. Any judgment issued by such a court may be enforced in any
court having jurisdiction.

 

9.3          Assignment.
Neither party shall assign its rights or obligations under this Agreement without the prior written consent of the other party,
which shall not be unreasonably withheld or delayed; provided, however, that a party may, without such consent, assign this Agreement
and its rights and obligations hereunder (a) to any Affiliate, or (b) in connection with the transfer or sale of all or substantially
all of its business to which this Agreement relates, or in the event of its merger, consolidation, change in control or similar
transaction. Any permitted assignee shall assume all obligations of its assignor under this Agreement. Any purported assignment
in violation of this Section 9.3 shall be void.

 

9.4          Counterparts.
This Agreement may be executed in several counterparts that together shall be originals and constitute one and the same instrument.

 

9.5          Waiver.
The failure of any party to enforce any of its rights hereunder or at law shall not be deemed a waiver of any of its rights
or remedies against another party, unless such waiver is in writing and signed by the party to be charged. No such waiver shall
be deemed a waiver of any subsequent breach or default of the same or similar nature or any other breach or default by such other
party. All rights and remedies conferred herein shall be cumulative and in addition to all of the rights and remedies available
to each party at law, equity or otherwise.

 

9.6          Severability.
If any provision of this Agreement, or part thereof, is declared by a court of competent jurisdiction to be invalid, void
or unenforceable, each and every other provision, or part thereof, shall nevertheless continue in full force and effect.

 

9.7          Notices.
Any consent, notice or report required or permitted to be given or made under this Agreement by a party to the other party
shall be in writing, delivered by any lawful means to such other party at its address indicated below, or to such other address
as the addressee shall have last furnished in writing to the addressor and (except as otherwise provided in this Agreement) shall
be effective upon receipt by the addressee.

  

    	 	12	 

     

    

 

	If to Eyemax:	Eyemax LLC
	 	74 Chestnut Street
	 	Weston, Massachusetts 02493
	 	Attention:  Dr. Elias Reichel
	 	 
	If to Eton:	Eton Pharmaceuticals, Inc.
	 	21925 Field Pkwy, Suite 235
	 	Deer Park, Illinois 60010
	 	Attention:  Chief Executive Officer

 

9.8           Further
Assurances. The parties agree to execute such additional documents and perform such acts as are reasonably necessary to effectuate
the intent of this Agreement.

 

9.9           Entire
Agreement. This Agreement constitutes the entire agreement between the parties regarding the subject matter hereof, and supersedes
all prior or contemporaneous understandings or agreements regarding the subject matter hereof, whether oral or written. This Agreement
shall be modified or amended only by a writing specifically referring to this Agreement signed by both Eton and Eyemax.

 

9.10         Force
Majeure. Neither Party shall be liable for delays in its performance caused by events beyond its control, such as fires, floods,
labor shortages, strikes, epidemics, computer virus, earthquakes, riots, acts of terror, acts of God, storms, acts of civil or
military authority or similar occurrences, provided the affected party gives the other party written notice of such event within
three (3) business days of its occurrence. Such notice shall state the estimated duration of such event and the cause thereof
and the affected party shall use commercially reasonable efforts to work around such event beyond its control.

 

9.11        Headings
and Construction. No rule of construction shall be applied to the disadvantage of a party because that party was responsible
for the preparation of this Agreement or any part of this Agreement. The Article and Section headings in this Agreement are for
convenient reference only and shall be given no substantive or interpretive effect. With respect to all terms used in this Agreement,
words used in the singular include the plural and words used in the plural include the singular. The word ‘including’
means including without limitation, and the words ‘herein’, ‘hereby’, ‘hereto’ and ‘hereunder’
refer to this Agreement as a whole. Unless the context otherwise requires, references found in this Agreement: (i) to Articles
and Sections mean the Articles and Sections of this Agreement, as amended, supplemented and modified from time to time; (ii) to
an agreement, instrument or other document means such agreement; (iii) to an agreement, instrument or other document means such
agreement, instrument or other document as amended, supplemented and modified from time to time, to the extent provided by the
provisions thereof and by this Agreement; and (iv) to a statute or a regulation mean such statute or regulation as amended from
time to time.

 

    	 	13	 

     

    

 

[Remainder of
Page Intentionally Left Blank]

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF,
each party has caused a duly authorized representative to execute this Agreement as of the Effective Date.

 

	 	EYEMAX LLC
	 	 
	 	By: 	/s/ Elias Reichel
	 	Name: 	Elias Reichel
	 	Title: 	President
	 	 
	 	ETON PHARMACEUTICALS, INC.
	 	 
	 	By: 	/s/ Sean Brynjelsen
	 	Name: 	Sean Brynjelsen
	 	Title:	CEO

 

    	 	15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00287-of-00352.parquet"}]]